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Abstract
Solar radiation currently represents the most important source of renewable energy. Existing
technologies to collect and distribute solar energy are expensive, difﬁcult to manufacture, non-
recyclable and not very cost-effective. Recent advances in physics and materials engineering
have pointed to photovoltaic (PV) perovskites (orCH3NH3MI3, where M=Pb, Sn) as the future
solution for sustainable energy because of their simple fabrication procedure, low price, and
high efﬁciency. Several companies are already building perovskites-based PV devices for
commercialization in the near future. Nevertheless, perovskites contain heavy metals, and
safety concerns during PV fabrication and transportation have not yet been addressed, not to
mention recycling, and environmental hazards in case of any failure of large-area solar panels.
This dissertation documents my investigation of the potential health and environmental
effects of perovskites. I have performed a “zoom-in approach” on human cells to study gene
expression and biochemical changes, and a “zoom-out approach” in vivo to investigate toxicity
at an organism level. The time frame during which living cells can be manipulated on the
same substrate is short, therefore we selected concentrations in the range of 50−200μg/ml
(from 80 to 400 μM)) to observe a measurable effect in vitro. These concentrations may seem
relatively high, however, an accidental exposure scenario with such concentrations may occur
during material fabrication if safety measures are not taken properly.
In the in vitro study using human cells, I have discovered not only a dose- and time-dependent
response to perovskites exposure, but also a cell-type dependent effect. Within 24 hours
following perovskites exposure, neuronal cells died whereas lung cells became giant and
polynucleated. Complementary assays showed that mitochondria were heavily damaged,
with an increase in their activity when compared to untreated cells. Furthermore, genome
proﬁle studies showed many differences in gene expression levels. Extra analysis identiﬁed
the co-regulated gene networks rather than individual coding genes, which indicated that
some pathways critical to basic cellular functions were heavily affected by perovskite exposure
(such as regulation of the metabolism, cell division, cell signaling etc.).
To understand more thoroughly, I applied the Scanning Fourier Transform Infrared Mi-
crospecrometry (S-FTIRM) to study cell toxicity. This has never been done before. I in-
vestigated the biochemical changes displayed on infrared absorption spectra. The results are
complementary to other techniques, which makes the use of S-FTIRMS applicable to real-time
toxicity studies because of its submolecular sensitivity and high-resolution.
I also explored the eco-toxic effects of photovoltaic perovskites on smallmodel organisms: fruit
ﬂies (Drosophila melanogaster) and nematodes (Caenorhabditis elegans). In both models, life
span and organism development were reduced by the exposure. Moreover, the fertility of
v
young adults was drastically affected.
My in vitro and in vivo studies showed that CH3NH3PbI3 and CH3NH3SnI3 are acutely and
chronically toxic compounds. The obtained results are conclusive, and encourage the scientiﬁc
community not only to conduct further tests on more complex organisms, but to ﬁrst search
for novel solutions with non-toxic properties.
Keywords
Photovoltaic halide perovskites, solar energy, health hazard, toxicity, cytotoxicity, eco-toxicity,
apoptosis, mitochondrial stress, gene proﬁling, small organism, Fourier transform Infrared
spectroscopy.
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Résumé
Le rayonnement solaire représente, de nos jours, la source la plus importante des énergies du-
rables. En revanche, les technologies actuelles permettant de collecter et redistribuer l’énergie
solaire sont coûteuses, difﬁciles à fabriquer, non-recyclables et peu rentables. Les avancées ré-
centes en physique et en science des matériaux ont prodigué aux pérovskites photovoltaïques
(ou CH3NH3MI3, où M=Pb, Sn) la réputation de solution du future pour les énergies renouve-
lables. Ceci, notamment, grâce à la simplicité et rapidité de fabrication de panneaux contenant
des pérovskites, leur prix avantageux, et leur haute efﬁcacité à convertir l’énergie solaire. Plu-
sieurs entreprises industrialisent d’ores et déjà des panneaux photovoltaïques contenant des
pérovskites pour une commercialisation dès 2018. Cependant, ces pérovskites contiennent des
métaux lourds, et les questions de sécurité pendant la fabrication et le transport des panneaux
n’ont pas encore été considérées, tout comme leur recyclage et les enjeux environnementaux
lors de brisure d’installations de grande surface. La présente thèse documente mes recherches
sur les impacts potentiels des pérovskites photovoltaïques sur la santé de l’Homme et de
l’environnement. J’ai utilisé une approche in vitro pour « zoomer » sur les conséquences des
pérovskites sur les cellules, leur expression génétique, et leur état biochimique, ainsi qu’une
approche in vivo pour observer les effets sur un organisme entier (Drosophila melanogaster
et Caenorhabditis elegans). Nous avons sélectionné des concentrations entre 50 et 200 μg/ml
(équivalentes à 80-400 μM), dans le but d’évaluer les effets mesurables in vitro. Ceci, parce
que le lapse de temps où des cellules vivantes peuvent être manipulées sur un même substrat
est court (Maximum 10 jours). Ces concentrations peuvent paraître relativement élevées,
néanmoins, un tel scénario d’exposition accidentelle est très probable pendant la phase de
fabrication dans un laboratoire où les mesures de sécurité ne seraient pas respectées. Dans
l’étude in vitro sur des cellules humaines exposées aux pérovskites, j’ai découvert non seule-
ment un effet dépendant de la dose et du temps d’exposition, mais aussi une réponse propre
à chaque type cellulaire. Vingt-quatre heures après exposition, les cellules neuronales sont
mortes d’apoptose par voie mitochondriale, contrairement aux cellules pulmonaires devenues
géantes et polynucléaires. Des essais complémentaires ont révélé que leurs mitochondries ont
été sévèrement endommagées avec une hausse d’activité. De plus, des études que j’ai mené
sur le proﬁl génétique ont montré des différences au niveau de l’expression de certains gènes.
Des analyses approfondies ont permis d’identiﬁer des réseaux de gènes co-régulés impliqués
dans des voies de signalisation importantes pour certaines fonctions vitales des cellules, qui
ont été perturbées par l’exposition au CH3NH3PbI3 (comme la régulation du métabolisme,
la division cellulaire, signalisation cellulaire etc.) Pour une meilleure compréhension, j’ai
appliqué pour la première fois la Microspectrométrie à balayage Infrarouge à Transformée de
vii
Fourier (S-FTIRM) pour une étude de toxicité sur des cellules ﬁxées ou vivantes. J’ai exploré
les changements biochimiques sur des spectres d’absorption infrarouge, et les résultats ont
été complémentaires à ceux obtenus par des techniques conventionnelles. Ceci fait de la
S-FTIRM une methode applicable aux études de toxicité in vitro en temps réel, notamment
grâce à sa sensibilité et sa haute-résolution. J’ai aussi étudié les effets écotoxiques des pé-
rovskites photovoltaïques sur des petits organismes modèles : la mouche des fruits, ou du
vinaigre (Drosophila melanogaster) et les nématodes (Caenorhabditis elegans). Dans les deux
modèles, j’ai observé une baisse dans la durée de vie et dans la croissance des organismes,
ainsi qu’une perturbation drastique de la fertilité de jeunes adultes. Mes études in vitro et
in vivo démontrent que CH3NH3PbI3 et CH3NH3SnI3 sont toxiques de manière aiguë et
chronique. Les résultats obtenus sont concluants et encouragent la communauté scientiﬁque
à établir des tests sur des organismes plus complexes, et surtout à chercher de nouvelles
solutions pour les énergies vertes.
Mots-clés
Pérovskites halogénés photovoltaïques,energie solaire, Risques pour la santé, toxicité, cytotoxi-
cité, écotoxicité, apoptose, stress mitochondrial, proﬁle génétique, petit organism, Spectroscopie
infrarouge à transformée de Fourier
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Prologue
The increasing world population presents new challenges. One of the most severe is its increas-
ing demand for energy, which is accompanied by an increasing awareness for environmental
concerns like pollution and health hazards that deteriorate quality of life, and present long-
term dangers for humanity. This energy challenge is accentuated by the rapid reduction
of fossil energy resources and the disgrace of nuclear energy following the Chernobyl and
Fukushima disasters. Today there is a strong tendency to turn towards clean energy sources
like solar energy or hydrogen as fuel. But the efﬁcient conversion of these energy sources into
electricity requires new concepts, efﬁcient technology and, especially, new materials. With the
advent of nanoscale research (popularly called nanoscience) there has been tremendous pro-
gress in new materials and nanostructures, which improve solar energy conversion, hydrogen
storage, and the design of efﬁcient fuel cells. The history of the use and production of asbestos,
however, teaches us that all promising new materials should be tested for health hazards
before their large-scale application. My PhD program seeks to address this issue: starting with
testing the toxicity of a novel molecular system called Metal-Organic-Frameworks (abbrevi-
ated MOFs), and switching to a hybrid organic lead halide perovskite (a class of materials)
which has demonstrated remarkable progress in solar energy conversion over the last four
years (Figure 1).
Figure 1 – a) Illustration of the crystal structure of MOFs; b) Possible application of MOFs for hydrogen storage
for cars equipped with fuel cells; c) Sketch of the crystal structure of the photovoltaic perovskite, and d) and their
foreseen application in large scale photovoltaic panels like shown here (source: google image gallery).
By examining only the list of keywords, I was exposed to: solar energy, conversion, novel
materials, health hazard, gene proﬁling, toxicity etc. This shows that the research program
I was following in my PhD training was interdisciplinary, and involved a close collaboration
between biologists, chemists, material scientists and physicists.
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Being a biologist by training, I joined professor László Forró at the Laboratory of Physics of
Complex Matter, where besides physics, there is a strong emphasis on materials synthesis
and a permanent questioning and concern about the toxicity of novel materials. This was the
case previously for carbon nanotubes, titanium dioxide nanowires, graphene, just to mention
a few. In this laboratory, I learnt concepts like solubility, ionic radii, stoichiometry, infrared
spectroscopy, principal component analysis and many more. To be able to investigate and
understand the potential impact of novel materials on human health, I needed to perform the
in vitro and in vivo toxicity studies in dedicated laboratories. Therefore, I initially collaborated
with Professor Beat Schwaller at the Department of Medicine in Fribourg, and later on in the
Laboratory of Molecular Neurobiology and Neuroproteomics of my co-supervisor and mentor
Professor Hilal Lashuel. Some of the test measurements I performed were at synchrotron light
sources in the United States, France and Switzerland. During these four years, on daily basis, I
was “commuting” between biology, physics and chemistry. I was more than motivated to be
proactive whenever facing a scientiﬁc difﬁculty, and to discuss with other scientists. This is
how I progressed during my PhD in a multidisciplinary research by collaborating with over 15
laboratories. I was not annoyed for a single moment and it has been an exciting period of my
life.
I will now share a few words about the materials: MOFs launched in the 90’s by Omar Yaghi
and collaborators130,233 , who emphasized their high-porosity and their suitability for gas
storage.24,231 Since then, the ﬁelds of application have extended to catalysis,191 optics,219
magnetism,123 ferroelectrics,99 and even drug delivery.30,107,142 BASF is already producing
MOFs in large quantities. At the time I started my PhD training, not much was known about
their toxicity. At the time I started my PhD training, not much was known about their toxicity.
However, as my project progressed, another compound, the perovskite methylammonium
lead iodide (CH3NH3PbI3, hereafter M APbI3) stole the spotlight. In a photovoltaic device
conﬁguration, this compound has shown an astonishing increased efﬁciency. It is being
picked-up by many research groups, and already at the beginning of 2016, its light conversion
efﬁciency was shown to reach an unprecedented 22%. Furthermore, thematerial is found to be
promising in other applications like bright and cheap light emitting diodes lasing at a relatively
low pumping threshold, in thermoelectrics, and is proven to be an excellent photodetector.
Many research laboratories are focusing on this material and in the case for my PhD program,
M APbI3 represents the core of my dissertation.
The chemical formula of the compound contains lead, which has been known for many years
to be toxic. We are exposed to lead everyday: burning coal releases lead into the atmosphere,
we have lead-containing pipes, paints, batteries, etc. Across the globe, it is a general aim to
reduce or eliminate lead as much as we can. This is, for example, why leaded gasoline has been
banned. Concerning the photovoltaic perovskite, it is important to understand the stabil-ity of
the material, especially that of the devices, and how one can protect from the release of Pb into
the environment. It is very likely that researchers will not give up studying M APbI3 simply
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because of the lead content, since the energy conversion beneﬁt is too high. But a ques-tion
worth pondering is why exactly is this material so efﬁcient, and is there perhaps another
material with similar performances but composed of non-toxic elements? The photovoltaic
community supposes that M ASnI3 might be a good alternative, because tin is not harmful to
the organism. But this is still more a conjecture than a fact. Therefore, I have included this
compound in my research, as well.
Figure 2 – Different forms, different appearances of CH3NH3PbI3 material: they can be bulk crystals, platelets,
wires of micron and nanometer size and tiny crystals. Their shape and size is relevant in physical measurements.A
typical quantity used for one toxicity study (assay) is shown in the upper panel, the scale is given by the dice. In
this case the shape of the crystals is not important, since they will be dissolved in water or physiological liquids.
How did I do my investigations? The crystallites of the material (Figure 2) were dissolved
in water or in physiological ﬂuids and administrated to cultured cells, or to living small
organisms at various concentrations. I then monitored the observed phenotypic changes in a
time-dependent manner. The biological models used for this work are cell-based (neuronal
and lung cells) and small model organisms (fruit ﬂies and nematodes). The ﬁrst goal was to
better understand the effect of M APbI3 at the cellular level. Despite the intense research to
investigate the circumstances and the mechanisms of lead toxicity over the past 20 years,80
there are still many unknowns. For example, I found that lung cells respond differently to
con-tact with the material than neurons do (the latters die while the formers do not). Why? I
had to “zoom” into the cells to study the molecular changes, including the genome proﬁle,
caused after exposure to perovskites. This necessitated a special technique, and from an
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enormous data set I managed to identify the subcellular structures or molecules that are
affected in treated cells.
As these ﬁne details became clearer, I had to “zoom out” to see what these changes meant for a
living organismof a different complexity, such asDrosophilamelanogaster or Caernorhabdi-tis
elegans, which are the gold standards for many biological tests (Figure 3). Such manipulations
required a lot of patience. For example, in the case of Drosophila, I had to inspect eggs,
larvae, and adults by gender. In some cases I tracked the emergence of young adults to be
able to quickly separate virgin females before mating. All these tasks were done on large
populations in order to assess toxicity at various concentrations, for different time-points.
Each independently repeated 3 times for biological replicate. Sometimes, I was dreaming ﬂies!
Figure 3 – Illustration of the living organism by increasing complexity which were tested against CH3NH3PbI3
exposure: single cell, D. melanogaster and C.elegans. (source: google image gallery)
This detailed endeavor is documented within the pages of this dissertation. In chapter I, I pro-
vide highlights on the use of perovskite materials for energy purposes, introduce technology
vs. toxicology by presenting some toxicity cases, and also give a detailed outline on the PhD
work. Chapter II reports on the physico-chemical characterization of the material. Chapter
III contains some ﬁndings on the in vitro toxicity of the perovskites: from the whole cell to
the signaling pathway to the genome. Chapter IV describes a new and non-conventional
approach to follow the toxicity of compounds: infrared microspectroscopy. This chapter also
covers some of the ﬁndings on perovskites toxicity. Chapter V presents what happens at a
whole or-ganism level when exposed to M APbI3 and its counterpart M ASnI3. Finally, all the
key results of this PhD work are summed up in chapter VI, where I discuss their impacts and
provide some outlooks.
This is the journey of my four and half years towards a PhD. I appreciated every challenge,
which helped to develop my personal, professional and scientiﬁc skills, as well as all my
colleagues who contributed to the accomplishment of this project.
xx
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1.1. A growing need for energy
1.1 A growing need for energy
The world’s population has more than doubled since the 1960s and continues to grow by
approximately 1.1% annually.76 According to a recent report from the United Nations’ depart-
ment of economic and social affairs, the world’s population is estimated to reach 9.7 billion in
2050214 and the distribution is illustrated in (Figure 1.1. Thereafter, the demographic growth
is expected to keep rising, exceeding 10 billion at the end of the century. This ascending trend
will certainly be accompanied by an increase in energy demand.
Figure 1.1 – Projected population growth between 2015 and 2016 by the united nations (With permission from
the United Nations214).
It should be stressed that the world’s total energy demand is twofold. For example, after the
oil is extracted, it has to be reﬁned and transported long distances to gas stations (upstream
energy), then used for many purposes (downstream energy). Therefore, most of the consumed
energy needs an upstream energy supply. Institutions such as the International Energy Agency
(IEA), the Energy Information Administration (EIA) and the European Environment Agency
(EEA) publish energy-related reports periodically. They help to frame current energy issues
and to encourage the community to ﬁnd solutions. In 2013, the IEA published the world
energy consumption by type of power source which showed that fossils (oil, coal, and natural
gas) were the most frequently used fuels (Table 1.1).17
Fossil fuels have been used extensively worldwide for centuries, causing not only oppressive
geopolitical conﬂicts, but also extremely deleterious human64 and environmental215 effects.
As for nuclear power, its exploitation for energetic purposes began in 1951 in the United
States during the Cold War,133 where president Eisenhower spoke about “atoms for peace”.
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Source of energy Percentage
Oil 31.3
Coal 28.6
Natural gas 21.2
Biofuels and waste 10.3
Nuclear 4.8
Hydro 2.4
Other 2 1.4
1 World includes also international aviation and marine
bunkers.
2 Other includes geothermal, solar, wind, heat, etc.
Table 1.1 – Distribution of the world1 ﬁnal energy consumption by source in 2013.17
The United States (U.S.) Department for Energy assured that nuclear power would generate
a “future electricity too cheap to meter”.14 Nuclear powerplants spread to many countries,
satisfying the increasing energy demand, especially during the oil crisis when atomic power
represented a good alternative to fossil energy. In the 60’s, however, a few accidents occurred
in the U. S. and the Soviet Union, raising local opposition amongst members of the scientiﬁc
community who began to express their concerns.47,182 Following the Three Mile Island (1979)
and Chernobyl (1988) accidents, nuclear energy production started to decrease; contingent
to this were rising economic costs (related to extended construction times due to regulatory
changes and pressure-group litigation). Moreover, falling fossil fuel prices made nuclear power
plants under construction less attractive.74 Later on though, the prices of fossil fuels rose, and
concerns about greenhouse gas emission limits encouraged a nuclear renaissance.228 This
came to a halt, however, with the Fukushima Daiichi nuclear disaster in 2011 that brought
about a one-year moratorium on nuclear power development. Today, some countries (Bel-
gium, Germany, Spain and Switzerland) are phasing-out nuclear power, and Italy is the only
country that has closed all of its functioning nuclear plants and withdrawn all plans to build
new facilities. At the same time, the use of hydropower and other renewable energies have
grown at a rate faster than any other time in history during the last 15 years. This indicates that
the international community is concerned with environmental and security issues. Recently,
there has been a large increase in international agreements and national energy action plans,
such as the EU 2009 Renewable Energy Directive,4 or more lately on December 2015, the
United Nations Climate Change Conference COP21,61 which negociated a worldwide agree-
ment on the reduction of global warming and pollution. A signiﬁcant trend that has come
out following the COP21 is the promotion of solar panels. The International Solar Alliance
(ISA)213 was launched by Narendra Modi during the COP21 gathering of “sunshine countries”
to develop the conversion of solar energy into electricity. On June 30, 2016 the World Bank
announced a project to accelerate the mobilization of ﬁnances for solar energy exploitation
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by investing more than US $1 trillion that will be needed by 2030 to meet ISA’s goals for the
massive deployment of affordable solar energy.6
1.2 History of photovoltaics
The sun is the world’s non-exhaustible renewable source of energy. However, barely 0.1% of
the world’s energy production comes from solar photovoltaics. The reason why the sun is
insufﬁciently utilized is because of the limits that photovoltaic technology still faces. The ﬁrst
solar cell prototype was developed in 1954; as of today we have three generations of solar cells
(Table 1.2). Unfortunately, none of them combines both high power-conversion efﬁciency and
low production costs. In the following subsections, the historical development of solar panels
will be brieﬂy reviewed.
1.2.1 Evolution of engineered materials in photovoltaics
Nowadays, Si-based (1st generation) technology represents 90% of the photovoltaic market
versus 10% for thin ﬁlm (2nd generation) technology.197 It is important to note that different
semiconducting materials (CdTe,CuInGaSe2 (CIGS) and GaAs) have contributed to the devel-
opment of second generation solar panels.166 Each of these materials has been engineered to
increase light conversion efﬁciency. The cost of such technologies remains expensive because
of the high purity grade requirements of the silicon and thin ﬁlms.
1st generation 2nd Generation 3rd Generation
Si- based technology CdTe, CIGS, GaAs DSSC, Nanotechnology based
Large pn junction diode pn junction thin ﬁlm No pn junction
Up to 25% efﬁciency Up to 29% efﬁciency Up to 10-12% efﬁciency
90% market 10% market 0% market
Table 1.2 – Summary of the main characteristics of the three solar cell generations.93
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Figure 1.2 represents the evolution over time of the efﬁciency of certain technologies (a more
detailed chart can be found on the website of the National Renewable Energy Laboratory
(NREL), Golden, CO) .3 The chart shows that efﬁciency improvements within the same genera-
tion is due to progress in processing of engineered novel materials (ENMs). For example, in
thin ﬁlm technology, different materials were competing over 25 years to show a maximum
efﬁciency of 3.9% to 20.1%. The third generation of photovoltaics integrate multiple technolo-
gies. One of them is the dye-sensitized solar cell, also known as a Graetzel-cell, which over two
decades of development has reached a conversion efﬁciency of 12% .236 But a real revolution
in this generation of photovoltaic devices started in 2009 121 with the use of methylammonium
lead iodide (CH3NH3PbI3, hereafter M APbI3), which has a perovskite structure.
Figure 1.2 – The evolution of certain solar cell efﬁciencies for different photovoltaic technologies. (Chart
simpliﬁed from the NREL3).
1.2.2 The revolution of hybrid halide perovskites
Perovskites are natural minerals that were discovered in Russia’s Ural Mountains, and named
after the mineralogist Lev Perovski. Their general formula of composition is ABX3. Even
synthesized compounds (not minerals) having this formula are called perovskites. The ﬁrst
explored perovskite was calcium titanium oxide (CaTiO3) in 1839, and coincidentally that
same year, Edmond Becquerel discovered the photovoltaic effect. Nevertheless, perovskites
entered the ﬁeld of photovoltaics only in 2009 with M APbI3. This hybrid perovskite was
ﬁrst synthetized by D. Weber224 in 1978 with some other sister compounds having different
dimensionalities. They were studied mostly in an optoelectronics context by Mitzi Miura
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and collaborators, and later by many other scientists. Kojima and his collaborators 121 have
reported that M APbI3 might be interesting for photovoltaic applications because it has shown
an efﬁciency of 3.8%. Three years later, a historical paper was published by Lee et al.,126 which
shook the scientiﬁc community working in photovoltaics: over a short amount of time, the
efﬁciency of M APbI3 literally jumped to 10.9%. Since then, and again in a short amount of
time, many researchers have improved the perovskites technology (Figure 1.2). Due to these
efforts, the perovskite-based solar cell technology has been developped over the last four years
by optimizing all the constituents of a device: the processing of the perovskite, the hole and
the electron conducting layers and the contacts. Its efﬁciency has improved tremendeously. To
date there is no other solar cell technology that has been developed so rapidly, with efﬁciencies
growing from 3.9% to 22.1% in just 7 years.
Nonetheless, the photovoltaic-perovskite fever faces challenges: i) Long- and short-term sta-
bility of the material greets the photovoltaic community with skepticism. ii) Sensitivity of the
material to temperature changes and water vapour makes the devices prone to rapid degrada-
tion. For this reason, the group of H. Snaith replaced the organic hole transport material with
polymer-functionalized single-walled carbon nanotubes (SWNTs) embedded in an insulating
polymer matrix .97 With this structure, they observed a delay in device degradation. However,
no long-term studies and comprehensive encapsulation techniques have been demonstrated
yet for perovskite solar cells. iii) The heavy metal content in perovskite solar cells addresses
potential health and environmental hazards.
Figure 1.3 – Examples of the health hazards related to the photovoltaic perovskite a) contacts during synthesis
and manipulation and b) its release into the environment after device failure (with permission from the Royal
society of chemistry .11,156
Not only is human exposure during device production and handling a concern, but its release
into soil and waterways after a failure of large area solar cells also represents major health and
environmental risks, especially due to a potential thermal shock or damaged encapsulation.
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The initial material is powder-like, and during the device fabrication, small particles can be
accidentally inhaled, ingested or absorbed by the skin (see Figure 1.3 a.). After device produc-
tion, transport, and mounting, it is likely that serious health and environmental hazards can
be caused (see ( Figure 1.3 b.), especially because of the instability of the light harvester, which
contains heavy metals. The different routes of exposure and their potential consequences will
be discussed in the next subsections.
1.3 Routes of exposure
Before discussing the potential toxicity of M APbI3, the various routes of human exposure
have to be mentioned. Exposure may come through direct contact with humans during
synthesis and manipulation (occupational) as well as through its release into the environment
(environmental). It is important to note that these considerations are valid for most ENMs that
are used in large-scale applications, regardless of their size or their scientiﬁc ﬁeld of interest.
1.3.1 Sources of pollution and exposure
The diagram in Figure 1.4 gives a more general picture of the pollution cycle related to
engineered materials in any ﬁeld. During the manufacturing processes (waste discharge,
storage and transportation) materials at any scale may leak into the atmosphere or to the
ground leading to further transport and diffusion. Engineered materials may also penetrate
the soil and groundwater through farming and husbandry applications such as pollution
remediation or pesticide use. Like other pollutants, they are capable of environmental and
adverse health effects above certain concentrations in the air, drinking water, or food chain.
Once released into the environment, these materials can spread into many ecosystems and
cause deleterious effects. Under certain conditions at workplaces, the engineered materials
may be inhaled in signiﬁcant amounts. Also, nanoscale-sized particles may enter more easily
into the body than larger particles.45
1.3.2 Endogenous pathways of exposure
Respiratory paths represent the main route of exposure to humans for any airborne material.51
The lungs, where the total area of airways including alveoli represents approximately 143 m2,87
are continuously exposed to airborne particles. Aerosols penetrate the nose, and if they are
soluble, they can reach the brain via themucus surrounding the olfactory system ( Figure 1.5 a.).
Otherwise they cross the trachea, encounter the alveolar epithelium and the mucus, or the
lining ﬂuid of the lumen (Figure 1.5 b.). Once in the lungs, the deposit of particles may
either be cleared by macrophages and monocytes, or penetrate the interstitium to encounter
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Figure 1.4 – The various sources and cycles of exposure to engineered materials are valid for the photovoltaic
perovskite, as well.
ﬁbroblasts, endothelial cells and other immune cells in the connective tissue, before they can
potentially be transported into the blood circulation.156
The biokinetics of inhaled small particles after deposition has been quantiﬁed using micro-
scopic and macroscopic techniques in rodents. In general, non-soluble microparticles, with a
diameter of 0.5 - 10 μm, remain on the epithelium in airways and alveoli, and are accessible
to branchoalveolar lavage, and at least the same can be expected for nanoparticles.88 The
clearance of deposited particles in the respiratory tract is made possible via two processes:
a) physical translocation of particles by different mechanisms and b) chemical clearance
processes and leaching. Chemical dissolution of biosoluble particles occurs either in the
lipidic or hydrophilic environment both in the intracellular and extracellular ﬂuids. Soluble
components can undergo absorption, diffusion or binding to proteins and to other subcellular
structures. They may also be cleared into blood or lymphatic circulation. Chemical clearance
for soluble materials can happen at any location within the three regions of the respiratory
tract (nasopharyngeal, tracheobronchial and alveolar, ( Figure 1.5) depending on local extracel-
lular and intracellular conditions (biochemical composition of the ﬂuid, pH etc.). In contrast,
a number of diverse processes involving physical translocation of inhaled particles exist in the
respiratory tract and are different in the three regions. This part is discussed in the context
of various toxicity studies in the following section, where toxicity regulations, most frequent
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Figure 1.5 – Exposure of humans to ENMs through the respiratory paths: a) Human olfactory system; 1. Olfactory
bulb, 2. Mitral cells, 3. Bone, 4. Nasal epithelium, 5. Glomerulus, 6. Olfactory receptor neurons. (source: Image
gallery modiﬁed). b) Human bronchi system (source: organsofthebody.com modiﬁed)
ENMs and their chronic and acute consequences in human exposure will be reviewed.
1.4 The importance of toxicity studies of ENMs
Engineered materials are attracting a lot of attention not only because of their tunable proper-
ties (as seen in 1.1 ), but also in order to evaluate their potential environmental and health
hazards. Epidemiological studies have shown a positive correlation between the level of par-
ticulate air pollution and increased morbidity and mortality rates; respiratory diseases are
associated with the number of ambient ultraﬁne particles inhaled. In the following subsec-
tions, we will discuss the historical case of asbestos, and the current regulations for novel
materials.
1.4.1 A historical case study: Asbestos
Asbestos is the most famous non-soluble material that gained much attention, ﬁrst because
of its desirable physical properties, but then because of its high toxicity. The silicate mineral
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is ﬁbrillar and has been mined for more than 4000 years. Details on the historical use and
development in applications can be found in appendix A of this dissertation. The very ﬁrst
observation of asbestos toxicity was found in a letter addressed by Pliny the Younger (61-
113 AD),86 and the second one appeared in the 16th century but was forgotten until 1898
when a letter by Lucy Deane, an inspector of factories in the UK, signaled a concern. A year
later, Dr. Montague Murray reported a death related to chronic exposure to asbestos via
inhalation.184,211 Toxicity studies for asbestos started after serious epidemiological cases, and
accidents were documented at workplaces. Scientists discovered that the dangers related to
asbestos arose mainly when the ﬁbers become airborne and inhaled. Because of the small size
of the ﬁbers, lungs cannot expel them. All types of asbestos ﬁbers are toxic to humans and
animals, and consequent exposure results in asbestosis or mesothelioma (the most common
diseases). Mossman and Churg145 documented that asbestosis and other lung cancers have
been reported primarily in asbestos workers with long-term exposure at high concentrations.
In the same paper, they considered instead a long latency period (the time taken between
exposure and appearance of the illness) as being inversely proportional to exposure level. An
examination of various epidemiological studies about dose-and-time response of the different
forms of asbestos was shown to have a linear or square relationship for all the respiratory
cancers.104 Today, asbestos is no longer traded or used. The lessons learned from this story
are not about the mining, manufacture and uses of a dangerous product. There are hundreds
of companies selling products more dangerous than asbestos—such as deadly chemicals,
poisons or explosives—with thriving employees and customers. The lesson is not even the
recurrent failure of companies to act after concrete proof of damage toworkers’ health. Instead,
what should be learnt is that warnings were not enough to prevent the tragedy. What might
have prevented the asbestos situation is if toxicity studies had begun before accidents and
illnesses were documented. Therefore, advances in novel materials should be accompanied
by accurate toxicological research and their industrial applications accompanied by relevant
regulations.
1.4.2 Current regulation aspects
The use of engineered materials in Europe, especially at the nanoscale, is free of any strict
regulation or approval.10 For example, the European Commission (EC) obliges manufacturers
to mention the use of engineered materials including nanomaterials. However, potential
reactivity and other hazardous properties are not properly regulated. In the U.S., The Food and
Drug Administration (FDA) has not established regulatory deﬁnitions of “nanotechnology,”
“nanomaterial,” “nanoscale,” or other related terms.157 In June 2014, the FDA issued industry
guidelines entitled, “Considering Whether an FDA-Regulated Product Involves the Application
of Nanotechnology.”, which describes that a product involving the application of technology
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is considered FDA-regulated when: “(1) a material or end product is engineered to have
at least one external dimension, or an internal or surface structure, in the nanoscale range
(approximately 1 nm to 100 nm), and (2) whether a material or end product is engineered
to exhibit properties or phenomena, including physical or chemical properties or biological
effects, that are attributable to its dimension(s), even if these dimensions fall out-side the
nanoscale range, up to one micrometer (1,000 nm)”. Just like its counterpart in Europe, the
FDA requires proper labeling for engineered material excipients of up to 1000 nm in a ﬁnal
product. Another example comes out of cosmetics, in which the ingredients (other than color
additives) are FDA-regulated but no approval is required before their commercialization.153
Additionally, the Environmental Protection Agency (EPA) in the U.S. gathers environmental
and health safety data, and needs exposure testing that can be used to set inventories216
and then suggests a regulation. However, manufacturers are not obligated to apply for EPA
guidance. The absence of strict regulations and lack of approvals in the application of engi-
neered mate-rials at any scale (bulk, micro or nano) is probably due to both the absence of
an ofﬁcial classiﬁcation and a lack of toxicological studies. This dissertation focuses on the
promising photovoltaic perovskites, because their energy conversion efﬁciency has signiﬁ-
cantly improved within few years, which led some industrials, such as Dysol, Oxford PV and
Nesli, to rapidly exploit them as a sustainable, cheap, and “clean” solution for solar power
harvesting.
1.4.3 Toxicity of the materials used for solar panels
In terms of the currently available photovoltaic solar panels on the market (as seen in sec-
tion 1.2 History of photovoltaics and Figure 1.2), TiO2, CdTe, CuInGaSe2 (CIGS) and GaAs
are the materials to be considered in toxicity evaluation and safety measures. A short review
on their toxicity is presented in the following sub-sections.
Titanium dioxide
Titanium dioxide represents the highest total production volume of pigments worldwide.15 It
has been used to provide whiteness and opacity to various products (paints, papers, foods,
toothpastes etc.). TiO2 can also be found in skin care products (sunscreens), and has been
used in the second generation of solar cells Figure 1.2. The latter represents 10% of all solar
panels on the market.
Titanium dioxide dust, when inhaled, has been classiﬁed by the International Agency for
Research on Cancer (IARC)75 as an IARC Group 2B carcinogen, meaning it is possibly car-
cinogenic to humans.227 The ﬁndings of the IARC are based on the discovery that high
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concentrations of powdered and ultraﬁne titanium dioxide dust cause respiratory tract cancer
in rats when exposed by inhalation and intratracheal instillation.210 The series of biological
steps that trigger lung cancer in rats (e.g. particle deposition, impaired lung clearance, cell
injury, ﬁbrosis, mutations and ultimately cancer)235,238 were considered by IARC as relevant
to employees with exposures to titanium dioxide dust. Concerns about the safety of using
nanoparticle sized titanium dioxide has been criticized because the mechanism by which
TiO2 may cause cancer is unclear. However, many studies have focused on the cellular and
in vivo uptake of TiO2, and it has been demonstrated that ultraﬁne TiO2 particles have a
signiﬁcantly greater pulmonary potency for inﬂammatory response than larger TiO2 ones,
and that this response is accompanied by an increased interstitial access of these particles.155
This argument convinced the brand “Dunkin’ Donuts” in the United States to switch to bulky
titanium dioxide in its powdered sugar donuts.140 However, public pressure forced the brand
to drop the use of TiO2 in food.111
Different studies have shown that nano-sized TiO2 translocates along the lung to the blood
stream then disperses into different organs (Skin, heart, liver, spleen and lung).154,165,165,230
In vitro studies showed how cellular toxicity of TiO2 at the molecular level results from the
interaction between TiO2 nanoparticles and the lysosomal compartment.238 The dermal
sorption of TiO2 in the epidermis and dermis were observed by the daily application of
sunscreens containing micro- and nanosized TiO2 to subjects for 2 to 6 weeks.203 Puccetti et
al. have published the layer distribution of nanoTiO2 within the human skin,177 and under
sunlight illumination, nano-sized TiO2 internalized in skin cells, oxidative stress was catalyzed
and DNA was damaged.73
In 2009, Wu and collaborators evaluated the penetration proﬁle and potential toxicity of
TiO2 nanoparticles in vitro and in vivo via a dermal route.230 The results showed for the
ﬁrst time how—after chronic dermal exposure—materials of various size could penetrate the
skin and reach different organs to induce tissue damage and trigger oxidative stress. This
latter signiﬁcantly increases MDA levels (malondialdehyde, a marker for oxidative stress)
and decreases SOD activities (superoxide dismutase, Enzyme that catalyzes the superoxide
radical into O2 or H2O2) in the penetrated tissues. This paper warned the community about
dermal toxicity with topical application of nano-sized TiO2 for a prolonged period, and how
its association with free radical generation, oxidative stress, and collagen depletion can pose
a risk to human health after dermal exposure over a relatively long time period. Research
focusing on the carcinogenicity of different particle sizes of titanium dioxide has led the US
National Institute for occupational Safety and Health (NIOSH)150 to recommend two separate
exposure limits: 1) ﬁne TiO2 particles are set at an exposure limit of 2.4 mg/m3, 2) ultraﬁne
TiO2 are set at an exposure limit of 0.3 mg/m3, as time-weighted average concentrations up
to 10 hour s a day for a 40-hour work week.149 These recommendations are in agreement with
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the scientiﬁc ﬁndings showing how smaller titanium dioxide particles are more likely to pose
carcinogenic risk than the larger ones.
Figure 1.6 – Liver tumor (malignant lymphoma) of a hamster after intratracheal instillation of GaAs for
15 weeks.159
Gallium Arsenide, Cadmium Telluride, Cupper Indium Gallium Selenide
Pulmonary toxicity Acute toxicity studies of GaAs, when administered by instillation to the
trachea of rats, reported the solubility and dose-related increases in blood levels of arsenic,
and gallium in the blood was not detected.221 A single delivery of 100 mg/kg of GaAs particles
resulted in a dose-dependent increase in lung wet weight associated with acute pulmonary
inﬂammation and pneumocyte hyperplasia after two weeks.222 Furthermore, the same group
documented that smaller-sized GaAs particles induced more serious acute pulmonary lesions
including a marked inﬂammatory response and a mild pulmonary ﬁbrosis. In their previous
studies, they showed a more rapid onset of arsenic toxicity with larger GaAs particles.223
At 18 days following injection of 100 mg/kg GaAs, marked body weight loss, lung weight
increase, moderate seropurulent pneumonia, and type II pneumocyte hyperplasia were also
evidenced.91
Regarding the chronic toxicity, weekly treatment of hamsters with GaAs particles by repetitive
intratracheal injections, for 15 weeks, resulted in survival reduction and pulmonary inﬂam-
mation although no tumors occurred over a 2-year observation period.159 On the other hand,
GaAs inhalation caused an increased incidence of both benign and malignant lung tumors in
female rats, which had been exposed to 0.01, 0.1, or 1.0 mg/m3 of GaAs particles for 2 years,
but not in male rats.152 In addition to GaAs, Tanaka et al.205 reported that indium arsenide
(InAs 1.27 mg/kg ) triggered pulmonary lesions across a 2-year observation period. The same
molar amounts signiﬁcantly suppressed body weight gain in hamsters compared to controls.
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Pneumonia, alveolar or bronchiolar cell hyperplasia, pulmonary proteinosis-like lesions, and
metaplastic ossiﬁcation in the lung were observed in InAs-treated animals.
Testicular toxicity Following intratracheal administration in rats and hamsters of 7.7mg/kg
of GaAs particles twice a week for 8 weeks, Omura et al.161,163 showed a decrease in sperm
count, an increase in abnormal sperm in the epididymis, and degeneration of late elongated
spermatids at the post-spermiation stages. The same group observed testicular damage,
including testicular spermatid retention and epididymal sperm reduction in hamsters.162
Moreover, InAs produced deﬁnitive testicular damage to hamsters in a long-term study164
because injection of indium twice a week for 8 weeks in hamsters decreased reproductive
organ weight and caudal sperm count, and caused severe histopathologic lesions in the testis.
Circulatory system When the toxicological effects of semiconductor materials containing
arsenic are evaluated, not only has the toxicity of arsenic been a main focus but also research
into whether the other constitutive elements may be toxic as well. In hamsters treated with
7.7 mg/kg of InAs, the serum arsenic concentration was approximately 0.4 μM during the en-
tire observation period of 88 weeks, showing little change. Serum indium levels after injection
were about 7.62 μM and these levels decreased gradually until the end of the observation pe-
riod. In a subchronic study204 in which twice the dose of InAs was administered intratracheally,
indium serum level was about the same amount injected. However, 0.4 μM of arsenic was
detected in the serum, which might be the maximum concentration to remain in the serum
of hamsters when InAs particles were given intratracheally, regardless of varied treatment
protocols. Therefore, the presence of these two elements in the blood might be responsible for
the damages observed in pulmonary and testiculary systems.
Toxic effects on other organs When gallium-containing semi-conductors were intraperi-
toneally injected into rodents, the survival was reduced and different tumors signiﬁcantly
developped204( Figure 1.6). Toxicity in kidneys was also clearly evidenced91 after exposure of
50, 100, or 200 mg/kg of GaAs, where mitochondrial swelling was observed in renal proximal
tubule cells. Furthermore, inhibition of γ-aminolevulinic acid dehydratase (ALAD, a precursor
of hemoproteins) was also observed in the blood, kidney, and liver in a dose-dependent man-
ner. Some reports documented the potential immunotoxicity of GaAs particles in both in vitro
and in vivo model systems.48,192,193 Oral administration of GaAs resulted in impairment of
the heme synthesis and immune system.81,82
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Toxicity of hybrid materials for future energy-related applications
Metal Organic Frameworks (MOFs) are hybrid materials with a porous structure130,233 suitable
for many applications30,99,106,107,123,191,219 including medicine, optoelectronics, but also gas
storage (namely hydrogen). BASF is already producing them on an industrial scale. Thus
far, only a few reports have focused on the question of toxicity involving MOFs for medical
applications. Couvreur and colleagues, who promoted MOFs in medecine, examined the
toxicological effects of iron carboxylate MOFs both in vitro and in vivo and tested the effects
of acute or subacute exposure to very high doses (up to 220 mg/kg) of three different iron
carboxylate MOFs administered intravenously to rats. They found no observable toxicity and
reported that these iron carboxylate MOFs were rapidly sequestered by the liver and spleen,
biodegraded and directly eliminated through the urine or feces without causing obvious
toxicity.31 Another study, however, looking at the toxicity of MOF containing zinc reported a
disrupted cellular zinc homeostasis and down-regulation of GAP-43 protein.178 Nonetheless,
the health hazards of MOFs for applications other than for drug delivery remain unexplored.
The core of this dissertation is on the toxicity of hybrid halide perovskites because such studies
has not been done yet. Concerns about their potential hazards rose primarily because of the
lead content,11,100 and so the photovoltaic community is currently interested in replacing Pb
by Sn, another heavy metal. At the same time, many reports on the toxicity of tin have to be
considered, since themetal triggers tumor formation in the lungs, infertility by downregulation
of sperm creatine kinase, skin and retinal irritation, heavily affects the hematological system as
well as kidney cells and interferes with neurotransmitters.33,40,44,89,113,127,132,198 Exposure to
tinmay be dietary40 (by consumption of food stored in unlacquered tin cans) or occupational33
(by inhalation, skin contact, and eye contact in the workplace). The Swiss Occupational Safety
and Health Administration (OSHA) has set the legal permissible exposure limit for tin exposure
in the workplace as 2 mg/m3 over an 8-hour workday.65 Heavy metals mainly harm the body
by creating an imbalance between the production of free radicals and the body’s ability to
repair free radical damage. When applied to photovoltaics, the perovskite layer (containing Pb
or Sn) is neither thermally stable nor in a water-rich environment; one of the main degradation
products could be Lead iodide (PbI2) and Tin iodide (SnI2). Both halides are available in the
market and several reports documenting their negative effects together with regulations about
their use are summarized in safety data sheets.8,176 PbI2 has been found to be a carcinogen
causing irreversible damage to fertility, respiration and digestion. It is cumulative and very
toxic to aquatic organisms and the environment.8 At the molecular level, it interacts with
sulfhydryl groups, impacting various enzymes, receptors and proteins. It also interferes
with metabolic pathways in mitochondria, and in systems that regulate cellular energy and
metabolism. It causes activation/inactivation of many enzymes via its competing effects with
other cations, notably calcium, ferrous iron, and zinc. Lead inhibits several enzymes involved
in heme synthesis, and impairs erythrocyte membrane stability, causing anemia.37 SnI2 is also
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acutely and chronically destructive. It impairs vision, skin, lungs and the digestive system.65
The toxicity of the entire perovskite materials has not been documented at all before this
dissertation. A detailed outline of the toxicity of photovoltaic lead and tin halide perovskites
will follow in the next paragraphs of this chapter.
1.5 Motivation and objectives of the study
Figure 1.7 shows the number of publications on materials developed for photovoltaic appli-
cation versus the number of published studies on their hazards. For the last 20 years, there
has been little research on the potential toxicity of novel materials when we compare the
advances in material science and engineering. Today, approximately 170 publications warn
the scientiﬁc community about the potential hazards of photovoltaic materials, which repre-
sents less than 0.8% of the total number of publications on photovoltaic materials. Clearly,
there is a need for toxicological research. We contribute to this effort with a detailed toxicity
study on two novel photovoltaic light harversters: methylammonium lead and tin iodide per-
ovskites. These two compounds will soon join the market of photovoltaic solar panels (in 2018
according to Oxford PV, Dyesol and Nesli companies). If no robust studies on these promising
compounds are published, no speciﬁc regulations will be able to handle the manufacture,
amount, use and recycling of the fabricated solar panels.
Figure 1.7 – Chart representing the number of publications over the last 20 year s on materials for photovoltaic
application (left axis) versus the number of publications reporting hazards or toxicity of the same materials (right
axis). Research done November 3rd , 2016 on Scopus with the keywords “Material AND Photovoltaic”, and “Material
AND Photovoltaic AND Hazard OR Toxicity”.
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1.5.1 Study design
The overall design of this study starts with the physical/chemical characterization of the
studied material with its molecular environment. Various microscopic and spectroscopic
techniques were used. In addition, the solubility of the photovoltaic perovskites was evaluated
in a time- and dose-dependent approach in water and physiological media. Human neurob-
lastoma and lung epithelial cells were selected according to section 1.3.2. The cellular uptake
was monitored using speciﬁc protocols and the phenotypical, physiological and molecular
effects were tracked accurately using standard protocols. The chemical and structural changes
induced by exposure of human cells to perovskites were also observed with a very efﬁcient
and uncommon technique: infrared microspectroscopy using synchrotron radiation. The
toxic effects of perovskites were also studied at the organism level. The use of small model
organisms, Drosophila melanogaster and Caenorhabditis elegans, represents an important
step before studying toxicity on more complex animal models.
1.5.2 Characterization of hybrid halide perovskites
M APbI3 was synthetized using the method described by Poglitsch and Weber172 in organic
solvents. The elemental composition of the obtained crystallites was analyzed using Xray
diffraction and the presence of lead and iodine was conﬁrmed and the atomic percent ratio
Pb:I was found to be 25:75. Lead- and tin-containing perovskites were synthesized at various
shapes and sizes ( Figure 1.8); a powder-like material was used for the toxicity study reported
in this dissertation. Prior to assessing their hazards, perovskite was added to water and
physiological solutions and characterized using spectroscopic analytical chemistry. The
results of the material characterization will be detailed in chapter 2.
1.5.3 Administration of perovskites to various biological model systems
Cellular models
The lungs are regarded as one of the main portals of entry for tiny particles, something
which underscores the importance of pulmonary toxicity evaluation. The ﬁrst barrier that the
inhaled particles encounter, when deposited on conducting airways or the alveolar region,
is the epithelium. If the particles are soluble in the nasal mucosa, they are conducted to the
brain via the neuronal receptors of the olfactory system or via the nerve endings embedded
in the tracheobronchial region through the afferent vagal nerves Figure 1.5. Consequently,
we targeted the toxicity study on human lung epithelial cells and human neuroblastoma
cell lines. The importance of cell lines lies in their ability to provide a renewable source of
cells for repeated studies. Unlike in vivo tests, cellular studies make it possible to identify
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Figure 1.8 – Scanning electron micrographs of the photovoltaic perovskite crystals synthesized in our laboratory
in different sizes and shapes.
the biological pathways and mechanisms involved in toxic reactions observed on a whole
organism. In vitro tests can be used to rapidly determine important parameters inﬂuencing
toxicity, such as dose; exposure time; isolation of speciﬁc pathways etc. In order to mimic the
occupational exposure to photovoltaic perovskites dust and byproducts, test particles were
added to a cell culture medium using short-term sonication. We tested various doses in vitro,
from 5 to 1000 μg/ml , in order to probe the most signiﬁcant range of concentration to observe
a traceable effect within a signiﬁcant time-lapse in the cellular study. We will present the
methodology of administering the perovskites to our cellular models, the performed assays
in examining different cellular processes and we will also discuss the corresponding results.
These in vitro studies on human cells provided a preliminary understanding of the ﬁrst signs
of perovskites toxic effects. However, using cell derived from cancer cells is often subject to
debate because they reﬂect the properties of their original cancers. For this reason, we also
worked with primary cultures from mice as a substitute for human cells. Other disadvantages
include a mismatch in doses, lack of engagement of the complete biological responses in
a whole organ and lack of validation against in vivo effects. Therefore, we selected model
animals to observe the effects of perovskites on a whole organism and to compare the results
with our in vitro data.
in vivo models
In vivo testing remains a crucial step for evaluating the relevance of in vitro ﬁndings. Although
genetic differences are responsible for the unicity of subspecies or individuals within the
same species, there are multiple genetic and proteic similarities between them. For this
reason, in vivo studies have the potential to offer better insights into the toxicity and potential
diseases caused by a material and eventually serve to ﬁnd the right medication. The most
used animal models are rodents because 85% of their protein-coding regions are identical
to humans’. Moreover, both rodents and humans often suffer from the same diseases, react
similarly to infection and injury as well as control their body chemistry using similar hormones.
Therefore, research on rodents has contributed signiﬁcantly to advance modern medicine.
In the 17th century, the use of vertebrates and mammalian models in the laboratory raised
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concerns because of vivisection. Since then, ethical guidelines, laws for animal testing and
the animal welfare act are signiﬁcantly emphasized. One alternative to vertebrates are small
organisms. They represent good biological models and do not require ethical approval. With
their small size, they are easy to handle, inexpensive to buy and maintain, and produce many
offspring in a short period of time. Consequently, we have also assessed the toxicity of M APbI3
and M ASnI3 on small organism models, namely Drosophila melanogaster (or the fruit ﬂy)
and Caenorhabditis elegans (or the earthworm). A description of the models and details on
experimentation can be found in chapter 5. In vivo, we used the same doses as in vitro tests
suspended in the animals’ food (bacteria for the worms and yeast/grapefruit for the ﬂies). This
administration method makes it possible to monitor both the toxicity by ingestion, and also
by skin contact and breathing since ﬂies and worms are in direct contact with their food, and
have a thin permeable skin through which oxygen penetrates.
Figure 1.9 – Illustration of the strategy in my dissertation to study the toxicity of photovoltaic perovskites: at the
cellular and molecular levels (zoom-in) and at the living organism level (zoom-out) approach
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1.5.4 Thesis objectives
In this dissertation, the main goal was the toxicity study of perovskites before their large-scale
commercialization in the next-generation of solar panels. The study started by the chemical
characterization of the material, which allowed understanding its behaviour in a humid
environment. Next, we used a battery of assays to assess the degree to which perovskites can
damage living cells and their subcellular mechanisms. In addition to cellular studies, effects
on a whole organism were also evaluated using small model organisms. Figure 1.9 and the
following speciﬁc aims summarize the main achievements of this thesis.
Speciﬁc aim 1: Chemical characterization of the photovoltaic hybride perovskites and im-
provement of the experimental set up to use them for toxicity evaluation. Size and shape of
the materials were characterized using electron microscopy. Moreover, analytical chemistry
methods were used to determine their behavior in solution, which helped the design of toxicity
experiments. This speciﬁc aim was achieved within the ﬁrst year of my PhD.
Speciﬁc aim 2: For toxicity assessment in vitro, we targeted accidental exposure to the solid
material, by inhalation, to select the cellular models. We reproduced this scenario of expo-
sure in vitro on neuronal cells (SH-SY5Y human cell line and murine primary hippocampal
neurons), and on human lung epithelial cells (A549). These cells were grown and exposed
to perovskites at different concentrations and during various time points. We ﬁrst evaluated
the plasma membrane integrity, caspases activity (programmed cell death markers) to assess
the overall state of cells over perovskite administration. Then, we investigated the subcel-
lular mechanisms from intracellular uptake, to cell cycle to mitochondrial function, before
analyzing the gene expression proﬁle following perovskite exposure. We have also used IR
spectroscopy under synchrotron illumination to elucidate the biochemical ﬁngerprints of
perovskites’ toxicity. This sophisticated method was employed for the ﬁrst time to conduct
toxicity studies.
Speciﬁc aim 3: A third independent speciﬁc aim consisted on evaluating the toxicity of
perovskites on an entire model organism, namely, Drosophila melanogaster (or the fruit ﬂy)
and Caenorhabditis elegans. We ﬁrst focused on the impact of perovskites on the life span of
young adults, then focused on the impacts on their fertility, and development of their progeny.
In the following chapters, we present the experimental procedures, results and conclusions
towards achieving those speciﬁc aims.
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2.1. Overview of the studied photovoltaic materials
2.1 Overview of the studied photovoltaic materials
The development of organo-metal halide perovskites represents one of the top ten science
breakthroughs of 2013.13 They are a promising class of compounds126 used for making
highly efﬁcient photovoltaic solar cells because of their high photon to electron conversion
efﬁciency, low material and manufacturing costs, and the simplicity of their device architec-
tures. Indeed, over the past three years, these materials have shown a record improvement
of efﬁciency3,126,234 (see chapter I). In general, all novel materials destined for large-scale
commercial applications should be tested for health hazards, and this is especially important
for these perovskites because of their heavy metal content (Pb, Sn). The condition sine qua
non for any toxicity screening strategy is a detailed and comprehensive physico-chemical char-
acterization of the tested material. A chemical characterization is crucial for correlating the
materials’ characteristics with any measured biological/toxicological responses. The health
hazard of photovoltaic perovskites is ampliﬁed by the fact that they are unstable and degrade
in a humid environment: they may be easily dissolved in water and physiological liquids. This
chapter deals with a detailed analytical investigation of the starting powder compound in
aqueous environments.
2.2 Shape and size of the MAPbI3 and MASnI3 materials
M APbI3 and M ASnI3 can be synthesized, depending on the purpose of their use, into various
forms: big crystals, nano-crystals, thin ﬁlms, nanowires, or quantum dots Figure 2.1. All these
forms are the result of a solution-based process described by Poglitsch and Weber.172
Figure 2.1 – SEM micrographs showing the morphology of a typical polycrystalline perovskite based ﬁlms
implemented in high performance perovskite solar cells.
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In this study, we used a powder composed of microcrystalline species since this is more
abundant and easier to synthesize. As a ﬁrst step towards assessing the potential toxicity of
M APbI3 and M ASnI3, it is important to conduct a quantitative assessment of their volatility
and stability in an aqueous environment with respect to chemical and microbial degradation.
It is well known that M APbI3 and M ASnI3 have a hygroscopic character, i.e. they are sensitive
tomoisture and decompose into their water-soluble constituents. Therefore, in a health hazard
investigation, the shape and size do not play a role since the material is dissolved.
2.3 The behavior of the photovoltaic perovskites in solution
We determined the solubility of M APbI3 and M ASnI3 polycrystalline powder in deionized
water (close to outdoor environmental conditions) as well as in two types of cell culture
media (DMEM and DMEM:F12) which mimic the ﬂuid conditions of the human body. The
perovskite powder was dispersed into these liquids at different concentrations (from 50 μg/ml
to 100 mg/ml). The starting step of the perovskite dissolution was identical in deionized water
and in the cell culture media, where the initial powder turned instantly to a silver-grey and
then a white solid precipitate. After a few minutes in water, the latter dissolved completely at
the lowest concentration, and the process was faster for the M ASnI3 compound.
Figure 2.2 – The methylammonium metal (M: Pb or Sn) perovskite in water for analytical chemistry evaluation.
The different steps of the solution preparation in water at a high dose (100 mg/ml): The polycrystalline powder
was suspended in water (a); dissolution of the perovskite material started instantly (b). After several hours, a
white/yellow precipitate formed but disappeared after 4 days (c). This solution was ﬁltered for elemental analysis
(d); Pictures of the perovskites-containing water solutions after one week before ﬁltration (e).
At the highest dose, a clear and transparent liquid was obtained in deionized water after
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4 days, indicating that the M ASnI3 or M APbI3 was completely dissolved (Figure 2.2). In a cell
culture medium, the initially silver-grey colored M APbI3 or M ASnI3 decomposed into a solid,
white-yellow precipitate and water-soluble methyl ammonium iodide derivatives within a few
seconds. Importantly, altered dissolution mechanisms were observed after longer soaking
times (Figure 2.3). The white precipitate remained present in the M APbI3 solution, even
30 days post-preparation, while opaque ﬂakes appeared in the M ASnI3 solution. The next
characterization steps were focused on the precipitate and the ﬁltered solution independently.
The related experimental procedure and results are discussed in the following paragraphs.
Figure 2.3 – The methylammonium metal (M: Pb or Sn) perovskite and its preparation for the toxicity tests. The
different steps of the solution preparation in the cell culture medium (DMEM) at a high dose (100 mg/ml): The
polycrystalline powder was suspended in DMEM (a); dissolution of the perovskite material started instantly (b).
After several hours, in the M APbI3 solution, the majority of the Pb
2+ ions formed a white/yellow solid deposit,
whereas in the M ASnI3 solution, some Sn
2+ ions precipitated into transparent ﬂakes (c). The solutions were
ﬁltered for elemental analysis and cellular administration (d). Pictures of the perovskites-containing solutions
after one week before ﬁltration (e).
2.4 Analysis of perovskites in aqueous environment
The structure of the perovskite presented in Table 2.1 shows the octahedral building block
and the organic cation. The atomic distribution of the perovskite components is estimated
according to the chemical formula. For example, M APbI3 has a molecular weight percentage
of lead, iodine and methylamine of 33.42, 61.41 and 5.17%, respectively. In the same way,
M ASnI3 has a percentage of tin, iodine and methylamine in the total molecular weight of
22.34, 71.63 and 6.04%, respectively. In the next section, we present an analysis of the M APbI3
and M ASnI3 by-products after ﬁltration.
27
Chapter 2. Characterization of MAPbI3 and MASnI3 in solution
M APbI3
content
Atomic
mass (A.U.)
Percentage
(%)
M ASnI3 Atomic
mass (A.U.)
Percentage
(%)
Lead (Pb) 207.20 33.42 Tin (Sn) 118.71 23.34
Iodide (I3) 380.70 61.41 Iodide (I3) 380.70 71.63
Methylammonium
(CH3NH3)
32.08 5.17 Methylammonium
(CH3NH3)
32.08 6.04
Total
(M APbI3)
619.98 100 Total
(M APbI3)
531.49 100
Table 2.1 – Chemical structure and molecular weight distribution of the pervoskite CH3NH3MI3 (M: Metal, Pb
or Sn)
2.4.1 Analysis of the precipitates
The precipitates formed in the M APbI3 and M ASnI3 solutions were lyophilized and grinded
before analysis. The elemental composition of the M APbI3 and M ASnI3 crystallites and their
solid decomposition by-products were analyzed using Energy-dispersive X-ray spectroscopy
(EDX). The measurements were done with an X-MAX EDS detector mounted at a 35-degree
take-off angle with a SATW window. EDS spectra were taken at a working distance of 8.5 mm
with 20 keV accelerating voltage and a current held at 200 pA. The results revealed that the
white deposit that appeared in the M APbI3 solution is composed of a mixture of lead (II)
hydroxide, lead (II) carbonate, and lead (II) phosphate compounds (Table 2.2), which were
formed by the reaction of Pb2+ with the carbonate, phosphate and hydroxide anions of the
cell culture medium (the full composition of the cell media can be found in the appendix).
On the other hand, the ﬂakes formed in the M ASnI3 solution contained mainly iodine, oxygen
and carbon complexes of tin (Table 2.3). These compounds were formed by the reaction of
Sn2+ with the carbonate and hydroxide anions of the cell culture medium. According to the
elemental composition analysis of the precipitate, tin ions do not seem to form complexes
with phosphates, but instead they likely precipitate with sodium in a hydroxide form.
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a
b
Element Line Type Apparent Concentration k Ratio Wt% Wt% Sigma
C K series 5.52 0.05521 29.26 0.27
O K series 6.41 0.02157 17.98 0.19
P K series 0.75 0.00420 0.79 0.03
Ca K series 0.13 0.00119 0.26 0.04
Cu K series 0.15 0.00146 0.27 0.09
As L series 0.03 0.00017 0.05 0.06
Pb M series 28.54 0.26563 51,39 0.27
Total 100.00
Table 2.2 – Elemental analysis of the white/yellow solid precipitate formed by reacting M APbI3 powder with
the cell culture medium (DMEM). (a) The elemental composition of the solid decomposition by-products of the
M APbI3 dispersed in the cell culture medium were analysed using Energy-dispersive X-ray spectroscopy (EDX);
(b) The elemental analysis revealed that the white, solid precipitate contains signiﬁcant amounts of Pb. Ca and P.
The yellow/white solid precipitate is presumably a mixture of lead (II) hydroxide, lead (II) carbonate, and lead (II)
phosphate compounds, which were formed by the reaction of Pb2+ with the carbonate, phosphate and hydroxide
anions of the cell culture media.
2.4.2 Analysis of the ﬁltered solution
Elemental composition
The M APbI3 and M ASnI3 solutions in deionized water and the cell culture media were ana-
lyzed using Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES, Shimadzu
ICPE-9000). From a stock solution (about 30 mg/ml), aliquots were taken at various time
points (1-30 days), diluted at the desired concentrations and ﬁltered using 220 nm pore cellu-
lose ﬁlters (Merck Millipore, Switzerland). The metal and iodine concentrations of the clear
solutions were measured three times. Analytical chemistry by ICP-OES was used to detect the
metal ions and iodine in a ﬁltered solution of the perovskite. However, this method cannot
distinguish between soluble elements or particles smaller than 220 nm (i.e. ﬁlter pore size).
The concentrations of the perovskite ﬁltrates were determined after a preliminary screening
of cell viability in a dose-time response using microscopy (detailed in the next chapter). Con-
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a
b
Element Line type Apparent Concentration k Ratio Wt% Wt% Sigma
C K series 3.44 0.03435 11.55 0.23
O K series 4.93 0.01657 6.24 0.12
P K series -0.02 -0.00012 -0.02 0.02
N K series 3.55 0.00631 3.03 0.55
Sn K series 2.15 0.02149 2.52 0.07
Na L series 2.92 0.01232 4.28 0.06
Al M series 0.03 0.00024 0.05 0.02
Si K series 1.17 0.00930 1.55 0.03
S K series 0.08 0.00065 0.08 0.02
Cl L series 1.67 0.01459 1.76 0.03
I M series 17.44 0.17440 21.06 0.14
Total 52.12
Table 2.3 – Elemental analysis of the ﬂakes formed by reaction M ASnI3 powder with cell
culture medium (DMEM). a) The elemental composition of the solid decomposition by prod-
ucts of the M ASnI3 dispersed in cell culture medium were analyzed by Energy dispersive
X-ray spectroscopy (EDX); (b) The elemental analysis revealed that the precipitate contains
signiﬁcant amounts of Sn, Ca and P. The yellow/white solid precipitate is presumably a mixture
of lead (II) hydroxide, lead (II) carbonate, and lead (II) phosphate compounds, which were
formed by the reaction of Pb2+ with the carbonate, phosphate and hydroxide anions of the
cell culture media. Note that the toxicity effect of this solid precipitate is out of the scope of
the present study.
sequently, we targeted concentrations of 50,100 and 200 μg/ml of M APbI3 and M ASnI3,
which were administrated to cell cultures on time scales extended to a few days. For simplicity,
the nominal M APbI3 concentration is used on the histograms and ﬁgures.
The recorded concentration value of lead, tin and iodine in the ﬁltered solutions were sub-
tracted from the initial concentration before ﬁltration using Table 2.1. For example, a M APbI3
solution of 100 μg/ml before ﬁltration contains 33.42 μg/ml of Pb. The ﬁltered solution
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Figure 2.4 – The elemental analysis of the M APbI3 and M ASnI3 solutions after one week incubation at RT and
ﬁltration at 220 nm. Concentration levels of lead and iodine in the M APbI3 solution in water (a) and in the DMEM
cell culture medium (b); and the concentration levels of the M ASnI3 solution in water (c) and in the DMEM cell
culture medium (d). All the histograms show an average of 3 independent repeats. Bars are means +/- S.D.
analysed by ICP-OES contains only 2.07 μg/ml of lead; which means 6.19% of the initial lead
passes through the ﬁlter and is detected. This analysis was done for iodine, tin and lead at dif-
ferent concentrations. As seen in Figure 2.4 a and c, when the buffer is water, both perovskite
solutions contain between 80 and 90% of the initial metals in the ﬁltrate. However, more than
90% of the initial iodine and 6% of the initial lead are recovered in the ﬁltered cell culture
medium ( Figure 2.4 b). Methylamine is known to be soluble181 in a water-rich environment
and cannot be quantiﬁed using elemental analysis due to the presence of carbon, hydrogen
and nitrogen, which are light elements. This result is in accordance with the precipitate anal-
ysis by EDS in section 2.4.1, where the precipitate was found to be mainly composed of Pb
complexes. The solution of M ASnI3 in the cell culture medium shows a higher content of tin
and iodine when ﬁltered ( Figure 2.4 d). The quantiﬁcation of both elements by ICP-OES in the
ﬁltered DMEM is similar to the initial concentration before ﬁltration. This result suggests that
the ﬂake precipitate observed in ( Figure 2.3 e) contains only a little amount of tin compounds
as well.
pH assessment
Most mammalian cell lines grow well in media at a pH between 7 and 7.8, depending on
the cell type, and physiological pH is critical for cellular function. Aside from the proton-
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driven membrane transporters in cellular membranes and organelles, proper protein and lipid
interactions are dependent upon the available charges of the cytosolic atoms and molecules.
The pH in a cell culture can deviate from the optimum ranges in static cultures inside the
incubator because of the build-up of acidic metabolic metabolites by cultures that have grown
too dense or too long in the same medium. Generally, cell culture media are formulated
for a speciﬁc CO2 gas level in the incubator (5% or more), but the ambient atmosphere
is far lower in CO2 (less than 1%). This leaves cultured cells in carbonic-based buffered
media exposed to pH changes during cell handling ambient conditions. If the pH varies
signiﬁcantly (pH<6.6 or pH>8.3), the acidic and alkaline environments become toxic to the
cells and unbalance growth.59 When conducting in vitro toxicity studies, it is very important to
determine whether the studied material inﬂuences the pH of the solution where the biological
model is being cultured. In this study, pH was probed in the solution where a maximum
dose was administered to the cells (200 μg/ml ). The results in different cell culture media are
reported in Table 2.4.
Media only Media +
M APbI3
(200μg/ml )
Media +
M ASnI3
(200μg/ml )
DMEM 7.31 7.53 7.45
DMEM;F12 7.69 7.85 7.72
Neuronal primary
culture medium
7.46 7.48 7.51
Table 2.4 – pH of the M APbI3 and M ASnI3 solutions in cell culture media.
The cell culture media used in this study have a pH between 7.3 and 7.7. When M APbI3 and
M ASnI3 perovskites were added, very little change was observed. Overall, the pH remains in
a physiological range after administration of the perovskites.
2.5 Conclusions on the chemical characterization of MAPbI3 and
MASnI3
The perovskites used in this study are powder-like and polycrystalline. Size and shape do not
matter in toxicity assessment, since the material is soluble in both water and physiological
media. The results of our characterization conﬁrm the instability of the perovskite in an
aqueous environment. In water, the starting material degrades very fast and in less than
one week the solution becomes transparent. After ﬁltration, analytical chemistry revealed
that almost 100% of the initial content of iodine and lead remain in the ﬁltrate. We assume
that the material is completely water-soluble. When a cell culture medium was used as a
buffer, a precipitate was observed even after a long soaking period: a solid white precipitate
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in the M APbI3 solution and opaque ﬂakes in the M ASnI3 solution. Elemental analysis
showed the presence of metal ions in both precipitates but in much lower concentration for
Sn. Consequently, in the ﬁltered solution the concentration of Pb ions was much lower than
that of Sn. The marked differences in the behavior of M APbI3 and M ASnI3 in water and cell
culture media clearly demonstrate that the physico-chemical properties of these materials
and their potential environmental impact can be modulated through different parameters
(temperature, pH and chemical environment dependent equilibrium of soluble and solid
forms). For this reason, the toxic properties of not only the ﬁltered solutions but also the
powder-like material were evaluated on human lung epithelial cells (A549), and neuronal
cells (SH-SY5Y, and murine primary hippocampal neurons). The effects of M APbI3 and
M ASnI3 exposure were measured using ﬂow cytometry, ﬂuorogenic and colorimetric assays,
immunocytochemistry (ICC) and transmission electron microscopy (TEM). The combination
and complementarity of these assays made it possible to assess the effect of the photovoltaic
perovskites on cellular properties, metabolic activity, morphology and viability. Interestingly,
the two cell types (brain and lung) responded in radically different ways to exposure to the
perovskites. The details of these observations are discussed in the next chapter.
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3.1. Cellular effect of MAPbI3 and MASnI3
Chemical characterization is a very important step in the study of potential toxicity of any
material of interest. The previous chapter discussed the solubility of the organometallic per-
ovskites in aqueous environments and in physiological solutions. This instability already
indicates that cells are exposed to the hydrated ions or the precipitate. I have shown that the
methyl ammonium lead halide, CH3NH3PbI3 (hereafter M APbI3) and methyl ammonium
tin halide or CH3NH3SnI3 (hereafter M ASnI3) are completely dissolved in water while in
physiological solution an important part of the metallic ions form precipitates mainly com-
posed of carbonate, hydroxide and phosphate. In this chapter, we address the consequences
of exposure of cell cultures to the ﬁltered solution and to the formed precipitate of the two
perovskites. We also report on time- and dose-dependent cytotoxicity and on the cell-type
dependent responses. The choice of cellular models was done by taking into consideration
the following properties of accidental inhalation: M APbI3 and/or M ASnI3 may start a disso-
lution process inside the nasal mucosa and penetrate the brain through the olfactory nerves.
Furthermore, airborne particles of the perovskites follow the respiratory path and deposit on
the epithelium. For this reason, the in vitro toxicity studies of the photovoltaic perovskites
M APbI3 and M ASnI3 focused mainly on two human cell lines: neuroblastoma cells (SH-
SY5Y) and lung mesothelioma cells (A549). It should be noted that the assays reported in this
section were conducted on cell lines derived from cancerous cells that can divide indeﬁnitely.
These cytotoxic tests represent good models for initial studies aimed at understanding the
mechanisms of action of the perovskite compounds after accidental inhalation.
3.1 Cellular effect of MAPbI3 and MASnI3
Our ﬁrst approach towards assessing the toxicity of perovskites consisted in observing SH-
SY5Y and A549 cells upon exposure to perovskites using bright ﬁeld microscopy, and the
compounds induced serious damages to the cells. Next, we exposed cells to the precipitates or
to the ﬁltered solution only. In this section, we explain how the material is likely to reach the
targeted cellular models used for this study, and we show the results of our observations.
3.1.1 The precipitate
In the scenario where the photovoltaic perovskite airborne particles are inhaled, body ﬂuids in
the respiratory pathways degrade the material. The formed precipitate may reach the alveoli
and deposit on the epithelial layer and is not likely to penetrate the brain. To mimic such a
scenario in vitro, perovskite powder was incubated during 5 days with cell culture medium
and the formed precipitate was left for sedimentation overnight, the medium was then aspired
and replaced with 50% methanol in water. The precipitate was lyophilized overnight in vials
cappedwith perforated paraﬁlm. The obtained powder was then administered to the epithelial
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lung cells at 50, 100 and 200 μg/ml . The dose response of cellular exposure to the precipitated
perovskites was evaluated using bright ﬁeld microscopy after 3 days ( Figure 3.1).
Figure 3.1 – Bright ﬁeld microscopy images of A549 lung cells following exposure to increasing concentrations of
the precipitate of M APbI3 and M ASnI3 after 3 days.
Morphology of the human lung epithelial A549 cells is affected over the treatment with
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M APbI3 and M ASnI3 , some cells become giant and polynucleated within 3 days of ex-
posure, and their number has not changed much. This observation is emphasized when
the dose is increased. It has to be mentioned that the human neuroblastoma SH-SY5Y cells
were not treated by the precipitates insoluble compounds can neither reach the brain via the
olfactory system located in the nose, nor cross the blood-brain-barrier after deposition in
the lungs, therefore neurons are unlikely to be directly exposed to the insoluble perovskite
precipitates.
3.1.2 The ﬁltered solution
The soluble part of the material, which stays in ionic form, is likely to reach the brain through
the olfactory system. In the same way, particles may also reach the lungs where chemical
dissolution can happen in the pleural mucus. This scenario was mimicked in vitro by exposing
human SH-SY5Y and A549 cell lines to the ﬁltered solutions of M APbI3 or M ASnI3 (shown in
appendix C). Bright ﬁeld images of the cells ( Figure 3.2) showed the same effects observed
for A549 cells exposed to the precipitates (Sub-section 2.4.1): The morphology was heavily
affected by the exposure, some cells become giant and display more than one nucleus, and
their conﬂuence slightly decreased after 5 days. On the other hand, SH-SY5Y cells suffer the
treatment in a different way: cells tend to shrink and ﬂoat following the exposure. These
observations are clearly more pronounced with an increasing concentration.The next step
consisted in quantifying living cells. To do so, we used a counting Neubauer chamber (see
details in appendix C) and the results are plotted as a percentage of total non-treated cells in
Figure 3.3.
After 5 days of culture, the non-treated A549 cells reached conﬂuency whereas the density
of cells exposed to M APbl3 or M ASnI3 decreased signiﬁcantly in a dose-dependent manner
( Figure 3.3). For example, exposure at 100 μg/ml of M APbI3 induced a decrease of over
80% in viable SH-SY5Y cells, and around 60% in A549 cells. The conﬂuence decrease is more
striking in the neuronal cell line, and stronger when cells are exposed to M ASnI3 perovskite.
As exposure of the cell lines to perovskites (either the precipitates or the ﬁltered solution)
results in major changes in morphology and conﬂuence, we sought to investigate the integrity
of the plasma membrane after treatment to understand the cellular response.
3.2 Cell membrane disruption
The cell membrane is a phospholipid bilayer with embedded proteins that separates the
internal from external environments of the cell. It is mainly involved in protecting the cell
from the surroundings but also in adhesion, cell signaling, controlling the ionic and molecular
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Figure 3.2 – Bright ﬁeld images of SH-SY5Y neuroblastoma cells and A549 lung epithelial cells exposed to
M APbI3 ﬁltered solution during 5 days.
trafﬁc and many other processes. An external cellular stress may result in damage to the cell
membrane. Full function may return to cells but in some cases a degree of injury will remain.
Depending on the extent of injury, the cellular response may be adaptive, and where possible,
homeostasis is restored. Electrolyte balance is highly regulated by the cell membrane and
serious disturbances may lead to severe adverse effects. Cell death occurs when the severity of
the injury exceeds the cell’s ability to repair itself.22
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Figure 3.3 – Quantiﬁcation of living cells upon exposure to M APbI3 and M ASnI3 ﬁltered solutions in SH-SY5Y
neuroblastoma cells (a, c), and in A549 lung epithelial cells (b, d). All the histograms show an average of at least
3 independent repeats (each condition in triplicate). Bars are means ± S.D. One-way ANOVA test followed by a
Tukey-Kramer post-hoc test were performed (non-treated vs. M APbI3 or M ASnI3 treated conditions), *p<0.01,
**p<0.005, ***p<0.0005.
In this section, we present the assessment of cell membrane state upon exposure of cells
to the photovoltaic M APbI3 and M ASnI3 ﬁltered solutions. We evaluated the time and
concentration dependent effects on the cell membrane by dye exclusion method using Sytox
green (SG, a speciﬁc ﬂuorescent marker that penetrate the cells when the plasma membrane
is disrupted) and ﬂow cytometry. Flow cytometry is a high-throughput analysis technique
used in cell counting, cell sorting and markers detection. Flow cytometers are able to analyze
several thousand particles (in this study, cells) every second, and can actively separate and
isolate particles having speciﬁed properties. The cell suspension is sucked by a syringe into a
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sheath stream carrying and aligning single cells through the light beam for sensing (generally
lasers at different wavelengths). A detector converts not only analogue measurements of
forward-scattered light (FSC) and side-scattered light (SSC) –which inform about the size
and granularity– but also the dye-speciﬁc ﬂuorescence signals into digital signals. The data
generated by ﬂow cytometers can be plotted in one dimension (histograms of ﬂuorescence of
speciﬁc markers), or in two-dimensional dot plots or even in three-dimensions. The regions
in the plots can be sequentially separated based on the ﬂuorescence intensity, the FSC and the
SSC, by creating subsets called “gates”. In our study, the precipitate of the material in solution
represented an artifact in data analysis because the deposited particles were counted and
sorted in the ﬂow as cells. Since the precipitate of the material produces the same effect on
epithelial cells as the ﬁltered solution, only the latter one was considered in further analysis to
avoid false positive or negative counts and contamination.
3.2.1 Methodology of membrane integrity assessment
SH-SY5Y cells and A549 cells were plated in 24 well plate. The following day, the original
culture medium was removed from the cells and replaced by medium spiked with increasing
concentrations of M APbI3 or M ASnI3 (50, 100 and 200 μg/ml ). After 1, 3, 5 or 7 days of
exposure, cell death was quantiﬁed using the vital dye Sytox Green (SG), which only penetrates
in cells with damaged plasma membrane. The supernatant and adherent cells were collected
at each indicated time point. After 5 min of centrifugation at 250 g, cells were re-suspended in
PBS containing SG at a ﬁnal concentration of 330 nM. Cells were then analyzed (20’000 events
per condition were counted) by ﬂow cytometry using Accuri C6 (BD Biosciences, Switzerland).
SG emission was collected in Fl1 channel and FlowJo software (Treestar, USA) was used for
subsequent analysis. Hippocampal primary neurons were plated in 96 well plates. After
2 weeks of culture, the original culture medium was removed from the cells and replaced
by medium spiked with increasing concentration of M APbI3 or M ASnI3 (of 50, 100 and
200 μg/ml ). Cell death was quantiﬁed as previously described by Mahul-Mellier et al.19
using the vital dye exclusion method using Sytox Green (SG, Life Technology, Switzerland), a
membrane impermeable dye which will enter only in cells with damaged plasma membranes
after 3, 10, 17 and 25 days of exposure to perovskite solutions. Brieﬂy neuronal cells were
washed three times with PBS before being incubated with SG at a ﬁnal concentration of
330 nM. After 15minutes of incubation, cells werewashed twicewith PBS and ﬂuorescencewas
quantiﬁed by using Tecan inﬁnite M200 Pro plate reader (Tecan, Switzerland) with respective
excitation and emission wavelengths of 487 nm and 519 nm.
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3.2.2 Results on the membrane disruption of neuronal cells
In this part, the reported histograms show the percentage of SG positive cells being the cells
with a damaged plasma membrane. The membrane disruption of SH-SY5Y cells is shown in
Figure 3.4 (a, b). The results show a time-and-concentration-dependent toxicity of M APbI3
and M ASnI3. Exposure of SH-SY5Y cell line to M APbI3 or M ASnI3 at a concentration as
low as 50 μg/ml , was sufﬁcient to trigger signiﬁcant damage to the cell membrane (from
10 to 30% of SG-positive cells in treated conditions) after 7 days, whereas at the highest
concentration (200 μg/ml ) of perovskites more than half of the SH-SY5Y cell population
suffered the exposure 3 days after incubation with the perovskite solution, and almost all of
them did not resist the treatment after 7 days. Once again, the Tin-containing perovskite had
a stronger effect than its lead counterpart. To validate our ﬁndings we next investigated the
effect of perovskites in the differentiated mice hippocampal primary neurons. These neurons
have the advantage to spontaneously differentiate in their growth cell culture medium after
two weeks in culture34 allowing long term toxicity studies (up to four weeks). The treatment
with perovskites was added to the cell culture medium of the primary hippocampal neurons
at various concentrations and up to 25 days. Figure 3.4(c, d) shows that M APbI3 also induced
cell membrane injury in a time- and concentration-dependent manner in these primary cells.
The striking effect on neuronal health observed by bright ﬁeld microscopy and consistently
conﬁrmed by SG uptake is subject to viability evaluation. We will cover this part in the next
section.
3.2.3 Results on the integrity of lung epithelial cells
Figure 3.4 (e, f) shows the absence of Sytox Green uptake by A549 cells upon perovskites
exposure. This result suggests that the plasma membrane integrity of lung epithelial cell line is
not compromised over the treatment. Details on ﬂow cytometry dot plots analysis are shown
in appendix C.
These studies on plasma membrane show that the response of cells to exposure to perovskites
is cell type-dependent. The membrane of neuronal cells (primary neurons or neuroblastoma
cells) get damaged, therefore the soluble material can easily penetrate the cells. On the other
hand, the membrane of lung cells remains intact, since it is impermeable to SG. Considering
the phenotypical changes observed previously, we next sought to explore whether the material
is internalized into A549 cells.
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Figure 3.4 – Plasma membrane disruption quantiﬁed by Sytox green uptake upon M APbI3 and M ASnI3
treatments. Neuronal cells: Human SH-SY5Y cell line (a, b) and mice primary hippocampal neurons (c, d), and
Human lung epithelial cell line (e, f). All the histograms show an average of at least 3 independent repeats (each
condition in triplicate). Bars are means ± S.D. One-way ANOVA test followed by a Tukey-Kramer post-hoc test were
performed (non-treated vs. M APbI3 or M ASnI3 treated conditions), *p<0.01, **p<0.005, ***p<0.0005.
3.3 Cellular uptake of the perovskites
The dissolved ions, especially Pb2+, can get easily into the cells via the calcium channels.
These channels have 24 times higher permeability for lead than for calcium ions,237 and once
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inside the cytoplasm they can start their deleterious effects. However, if larger ionic complexes
are created, or precipitates form, their internalization happens differently. Cells internalize
extracellular material by a mechanism called endocytosis. In order to be taken up into cells
and subcellular targets, extracellular material must ﬁrst be able to cross the plasma membrane
in the spatio-temporal dimension.
Figure 3.5 – Pathways described by L. T. Chou and colleagues of the cellular uptake regulating the signaling
routes and cargo transport. Each pathway is mechanistically distinct and highly regulated at the molecular level.57
(with permission from the Royal Society of Chemistry).
There is an increasing number of pathways of internalization so far grouped into three main
mechanisms (Figure 3.5): 1. Phagocytosis; 2. Pinocytosis and 3. Receptor-mediated endo-
cytosis. Some scientists subdivide the endocytosis pathways into those that are Clathrin-
(CLT)-dependent and those that are CLT-independent.57 For cytotoxicity studies, an under-
standing of the cellular uptake mechanisms would be crucial to determine how they modulate
the signaling pathway and the subsequent molecular response of the cell.108,114,196,207 CLT-
mediated endocytosis is the most understood pathway of receptor-mediated endocytosis. In
this pathway, ligand binding triggers the recruitment of receptors to CLT through adaptor pro-
teins. CLT then polymerizes, driving the invagination of the pit, which is eventually released
into the cytoplasm through the scission of the enzyme Dynamin (DYN). Therefore, there is the
CLT-dependent/DYN-dependent and the CLT-dependent/DYN-independent pathways. The
latter is mediated by primary carriers called clathrin-independent carriers (CLICs), which fuse
to form tubular early endocytic compartments called Glycosylphosphatidylinositol enriched
endosomal compartments (GEECs).169 This process is highly complex given that more than
50 different proteins can be found in CLT-coated pits.146,187 On the other hand, many other
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forms of endocytosis exist, including Caveolae- or lipid-raft dependent endocytosis. Caveloae
are a special form of lipid rafts on the plasma membrane of many cell types more speciﬁ-
cally in endothelial, epithelial cells and adipocytes. These structures are rich in proteins and
lipids and have several functions in signal transduction including endocytosis.26 Caveolins
were shown to form and maintain caveolae and also lead to a local morphological change of
the membrane in presence of extracellular material to be internalized.170 Although various
signaling pathways have been identiﬁed in external material uptake by cells, we currently
understand little about the membrane trafﬁcking principles of endocytic routes. In our cellular
models, the uptake of the non-soluble precipitates of the M APbI3 and M ASnI3 perovskites
was probed by the inactivation of CLT and DYN by siRNA transfection. We also used a control
siRNA of a viral protein (VSVG) which is not expressed in mammalian cells to show that the
effect is not induced by the transfection process. In the next subsections, we report the used
protocol for such silencing and show how the CLT/DYN-silenced cells interact with M APbI3
and M ASnI3.
3.3.1 Methodology to assess the cellular uptake
A549 cells were plated in 6-well platess at a conﬂuence of 60%. After cellular adherence to the
plate’s substrate (3-4 hours later), the original culture medium was removed and replaced by a
lipofectamine transfection buffer containing the diluted siRNA for CLT, a mix of DYN1/DYN2
(50/50) or VSVG prepared according to the manufacturer’s protocol (can be found in appendix
C). Cells were incubated at 37◦C for two days so that the genes coding for CLT and DYN are
silenced, then rinsed three times with PBS before being trypsinized and transferred to 24 well
plates, where they were treated with 100 μg/ml of M APbI3 or M ASnI3. The treatment was
3 days long. For this reason and to avoid hyper-conﬂuence after treatment, plating was initially
performed in 6 well plates, because the total time for cells preparation was 5 days (2 days
incubation with siRNA and 3 days of exposure to perovskites). At 3 days post-treatment, the
phenotype of cells was veriﬁed using bright ﬁeld microscopy, then gene silencing was veriﬁed
by immunoblotting against CLT andDYNusingWestern Blot (WB). Brieﬂy, cells were harvested
using trypsin and gently centrifuged before rinsing with cold PBS and re-suspension in the
lysis buffer (see protocol of lysis buffer preparation in the appendix C). Cells were incubated on
ice for 20 min in a rocking plate, then centrifuged 20 min at 12’000 rpm at 4◦C. We quantiﬁed
the total protein concentration in the supernatant using bicinchoninic acid (BCA) assay and
we kept it for WB analysis. (Protocol in the appendix C).
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3.3.2 Results of the cellular uptake
To conﬁrm the knockdown of CLT and DYN genes using siRNA transfection, we immunoblot-
ted the cell lysate using antibodies against CLT and DYN proteins. Figure 3.6 shows the
corresponding WB where Actin is used as a loading control, and the silencing of CLT (about
150 kDa) and DYN (about 90 kDa) is clearly obvious in both cell lines. No knockdown is seen
in the non-transfected (nt) or VSVG (-vsvg) controls.
Figure 3.6 – In vitro validation for the CLT/DYN silencing by Western Blot in non-treated (NT) A549 and SH-SY5Y
cell lines.
Now that we know that our silencing is efﬁcient, we can see whether DYN or CLT have a role
in perovskite uptake. As seen in Figure 3.7, bright ﬁeld microscopy images distinctly exhibit
the A549 cells’ phenotype 3 days post treatment with 100 μg/ml of M APbI3 and M ASnI3. In
the left panels, non-treated cells are shown (labeled NT), whereas cells treated with M APbI3
are presented in the medium panels, and the ones treated with M ASnI3 in the right panels.
CLT inactivation (upper row) did not alter the consequences of treatment with perovskites (i.e.
giant cell, polynucleation) as compared to the VSVG control. On the other hand, when DYN
was silenced (intermediate row), the outcome changed because the cells did not display an
increase in size and nuclei number, and seem healthier when treated with the perovskites as
compared to CLT-silenced cells.
These ﬁndings suggest that DYN might be important for cellular response to perovskite expo-
sure, but also contributes to the cellular uptake of the material because the perovskites did
not have an effect on the cells since they could not gain entry due to the silencing of dynamin.
Although subsequent pathways of endocytosis still need to be demonstrated, our data on
membrane integrity and endocytosis clearly show that the material is internalized into the
neuronal and lung cells. With this ﬁnding, we are going now to focus on the cellular and
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Figure 3.7 – Bright ﬁeld microscopy images of A549 cells reporting the phenotype after gene silencing by siRNA
transfection of Clathrin (CLT), Dynamin I & II (DYN), and a viral protein (VSVG) as a negative control, 3 days
post-treatment with M APbI3 or M ASnI3 perovskites.
molecular pathways involved in the phenotypical changes observed previously, starting with
cell survival quantiﬁcation.
3.4 Viability assessment
Several factors from the internal or the external environment called stimuli can trigger cell
death. This may be the result of the natural process of old cells being renewed, or may result
after an injury, a stress or death of the organism in which the cells are part of. Two types of
cell death are indexed: Programmed cell death (PCD), including apoptosis, necroptosis and
autophagy, and non-physiological cell death, including necrosis and mitotic catastrophe.84,167
The effects observed on our cellular models, especially neuronal cells, led us to investigate
whether cell demise occurs upon treatment with perovskites and which subcellular and
molecular pathways are involved. Our strategy included the use of ﬂow cytometry by dye
exclusionmethod to detect the apoptosis precursors: the caspase family. Caspases are protease
enzymes playing essential role in PCD (Figure 3.8).
Caspases activation means that cell death is programmed and apoptosis-like. Technical
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Figure 3.8 – Simpliﬁed illustration of the caspase family cascade inducing programmed cell death via the
extrinsic and the intrinsic pathways. In summary, when an external stress is sensed by the “death receptors” on
the plasma membrane (such as TNFR1, TRAIL etc.), caspase 8 is recruited and activates caspase 3. The latter
stimulates nuclear enzymes (ICAD, PARP and helicases) to start the degradation of DNA and to launch apoptosis
process. In the case of internal stress signals (oxidative stress, ischemia etc.), the mitochondrial receptors (BAX,
tBid, Bak. . . ) are stimulated and release pro-apoptotic factors that activate caspase 9. The latter induces the
activation of caspase 3 which initiates apoptosis.78
details are provided in the following sub-section, and the analysis method consisted in double
plotting the histograms of ﬂuorescence of Propidium iodide (PI), a vital dye, with the one of
the caspase-ﬂuorescein. This double plot is then divided into 4 regions (Figure 3.9): Caspase-
negative and PI-negative cells are considered as healthy; Caspase-positive and PI-positive
cells are considered as apoptotic cells; Caspase-negative and PI-positive cells are considered
as necrotic cells, Caspase-positive and PI-negative cells represent the cells that undergo PCD.
3.4.1 Methodology of the viability tests
SH-SY5Y cells and A549 cells were plated in 24 well plates. The following day, the original
culturing medium was removed from the cells and replaced by medium spiked with increasing
concentrations of M APbI3 or M ASnI3 (50, 100 and 200 μg/ml ). Caspases activity in living
cells was quantiﬁed using CaspaTagTM ﬂuorescein caspase 3, 8 or 9 activities kit (Enzo life
sciences, Switzerland). These ﬂuorogenic kits used speciﬁc Fluorochromes peptide Inhibitors
of Caspases (FLICA). These probes passively enter the cells and bind irreversibly to the active
caspases. After 5 days of exposure to perovskite solution, SH-SY5Y and A549 cells were har-
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Figure 3.9 – Schematic illustration of the dot plot of Propidium iodide vs. caspase 3 obtained by ﬂow cytometry.
The non-ﬂuorescent cells are considered as healthy; the caspase-positive cells (two quadrants in the right position)
represent cells undergoing apoptosis-like cell death; and the PI-positive caspase-negative cells (upper quadrant in
the left position) are dead cells with necrosis.
vested and incubated for one hour at 37◦C with FAM-DEVD-FMK (caspase 3), FAM-LETD-FMK
(caspase 8) or FAM-LEHD-FMK (caspase 9) and with the vital dye Propidium Iodide (PI) in
accordance with the supplier’s instructions. Fluorescein emission was analyzed by ﬂow cytom-
etry [Accuri C6 (BD Biosciences)] in Fl1 channel and PI emission was collected in Fl3 channel.
FlowJo software was used for subsequent analysis. For hippocampal primary neurons, cells
were plated in 96 well plates. After two weeks of growth, the original culture medium was
removed from the cells and replaced by medium spiked with increasing concentrations of
M APbI3 or M ASnI3 (50, 100 and 200 μg/ml ). Neurons were washed 3 times with PBS and
incubated for 30 minutes at 37◦C with FAM-DEVD-FMK (caspase 3), FAM-LETD-fmk (caspase
8) or FAM-LEHD-fmk (caspase 9) in accordance with the supplier’s instructions. Fluorescein
emission was quantiﬁed by using Tecan inﬁnite M200 Pro plate reader (Tecan, Switzerland)
with respective excitation and emission wavelength of 487 nm and 519 nm.
3.4.2 Results of neuronal cells survival when exposed to perovskites
We sought to investigate the molecular mechanisms by which the perovskite-ﬁltered solutions
induced death in our cellular models. Using ﬂuorogenic assays combined with ﬂow cytometry,
we observed that caspase 3, a key enzyme involved in the execution phase of apoptosis,
was signiﬁcantly activated in SH-SY5Y cells exposed for 5 days to M APbI3 (Figure 3.10 a,
green bars) and M ASnI3 (Figure 3.10b., green bars). In order to elucidate the M APbI3-
mediated apoptotic pathways, we monitored the activation of the caspase 8, a key initiator
caspase activated by the extrinsic/death receptors pathway, and the caspase 9, a key initiator
caspase activated by the intrinsic/mitochondrial pathway. The blue bars in Figure 3.9 a, b,
show a concentration-dependent caspase 9 activation in SH-SY5Y cells treated for 5 days
with M APbI3 or M ASnI3. No increase in caspase 8 activity was observed under the same
conditions (Figure 3.9 a, b, red bars). This ﬁnding suggests that apoptosis in SH-SY5Y cells is
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triggered through the mitochondrial pathway. These quantiﬁcations were made through the
analysis and double gating of the dot plots shown in Figure 3.11.
Figure 3.10 – M APbI3 and M ASnI3 induce intrinsic apoptosis neuronal cells. The cells were plated in 24
well and treated with increasing concentrations of perovskite solutions (50, 100 and 200 μg/ml ), and cell death
was quantiﬁed by ﬂow cytometry using ﬂuorogenic assays. The apoptotic pathways activated by the perovskite
solutions were identiﬁed by measuring the caspase 3, caspase 9 and caspase 8 activities after 5 days of treatment;
in human SH-SY5Y cell line (a, b) and in mice primary hippocampal neurons (c, d). All the histograms show an
average of at least 3 independent repeats (each condition in triplicate). Bars are means ± S.D. One-way ANOVA
test followed by a Tukey-Kramer post-hoc test were performed (non-treated vs. M APbI3 or M ASnI3 treated
conditions), *p<0.01, **p<0.005, ***p<0.0005.
The speciﬁc activation of the caspase 3 (Green bars) and the caspase 9 (Blue bars) together
with the absence of caspase 8 (Red bars) in Figure 3.10 c, also conﬁrmed the initiation of
the intrinsic apoptotic pathway in the differentiated hippocampal primary neurons, when
exposed to the solution of the photovoltaic perovskites, as already monitored in SH-SY5Y cells.
The dot plots in Figure 3.11show the ﬂuorescence of FLICA-Caspase 3 and propidium iodide
in SH-S5Y5 cells exposed to M APbI3 using ﬂow cytometry. The dot plots are divided into 4
quadrants (Q1, Q2, Q3 and Q4) that show the respective distribution expressed as a percentage
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of the healthy cells [negative for PI and for caspase 3 activity (Q4)], the cells undergoing
apoptosis but not yet dead [negative for PI but showing caspase 3 activity (Q3)], the apoptotic
dead cells [positive for PI and for caspase 3 activity (Q2)] or the necrotic dead cells [positive
for PI but negative for caspase 3 activity (Q1)]. The overall meaning of these plots conﬁrms
that necrotic cell death was not induced in SH-S5Y5 cells when exposed to perovskite. Under
these conditions, the cells died via apoptotic signaling pathways. We have obtained the same
result upon M ASnI3 treatment.
Figure 3.11 – Two-dimensional ﬂow cytometry dot plots (Propidium iodide and Caspase 3) of the SH-SY5Y cell
line. a) Non-treated (negative control) cells; or cells exposed to M APbI3 at b) 50 μg/ml , c) 100 μg/ml , and d)
200 μg/ml . M APbI3 does not induce necrotic cell death in SH-S5Y5 or in A549 cells.
3.4.3 Results of lung cells survival when exposed to perovskites
Exposure of A549 cell line to M APbI3 and M ASnI3 perovskite ﬁltered solutions did not
activate the caspases cascade (Figure 3.12). This result suggests that PCD is not initiated upon
perovskite treatment, which is consistent with the bright ﬁeld images that did not show visible
toxicity and with the absence of SG uptake reported in section 3.1.2, which shows that the
plasma membrane of A549 cells is not compromised over treatment with the ﬁltered solution
of perovskites. These results were extracted from the double gating in dot plots shown in
Figure 3.13, that also shows the absence of death by necrosis following exposure to perovskites.
The phenotypical changes observed using bright ﬁeld microscopy in subsection 3.1.2 were
then quantiﬁed to estimate the consequence of the exposure.
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Figure 3.12 – M APbI3 and M ASnI3 do not induce cell demise by apoptosis in A549 human lung epithelial
cells. The cells were treated with increasing concentrations of M APbI3 or M ASnI3 (50, 100 and 200 μg/ml )
and the cellular toxicity was evaluated using ﬂow cytometry (a). A549 cells were harvested after 1, 3, 5 or 7 days
post-treatment and stained with SG. Cell death level is expressed as the percentage of cells with compromised cell
membrane (SG positive cells) to the total cell number (b) A549 cells were harvested 5 days post-treatment and
caspase 3 (green), caspase 9 (blue) and caspase 8 (red) activities were measured using ﬂuorogenic assays. All the
histograms show an average of at least 3 independent repeats (each condition in triplicate). No signiﬁcance was
observed.
3.4.4 Quantiﬁcation of the morphological changes
To quantify the morphological changes induced by M APbI3 or M ASnI3 treatment, A549 cells
were plated in 24-well plates. The following day, the original culture medium was removed
from the cells and replaced by medium spiked with increasing concentrations of M APbI3
or M ASnI3 (50, 100 and 200 μg/ml ) during 5 days. A549 cells were imaged using an EVOS
bright ﬁeld microscope (Life Technologies). The respective sizes and shapes of the cells were
analyzed using FIJI186 software (NIH, Bethesda, MD, USA).
Interestingly, imaging by bright ﬁeld optical microscopy (Figure 3.14 a) revealed a hetero-
geneous population of cells with different morphologies. The non-treated cells exhibited
a homogeneous triangle-shape with an average size ranging from 15 to 20 μm, typical of
epithelial cells. After 5 days of exposure to MAPbl3, we observed different populations in
terms of morphology (Figure 3.14): the overall size of some cells signiﬁcantly increased (“giant
cells”, si ze > 50 μm) with a round-shaped aspect. Some cells were stretched and acquired
an elongated morphology (“elongated cells”, width < 7 μm). These changes were some-
times accompanied by an increase in the number of nuclei (more than one per cell). Once
again, treatment with M ASnI3 induced a more pronounced change in cell morphology, since
at100 μg/ml , over 20% of A549 cells were giant and polynucleated whereas M APbI3 altered
the phenotype of less than 15% of A549 cells. This experiment was done independently three
53
Chapter 3. In vitro toxicity of the photovoltaic halide perovskites
Figure 3.13 – Two-dimensional ﬂow cytometry dot plot (Propidium iodide and Caspase 3) of the A549 cell line. a.
Non-treated (negative control) cells; or cells exposed to M APbI3 at 50 μg/ml (b), 100 μg/ml (c) and 200 μg/ml
(d). M APbI3 does not induce necrotic cell death in A549 cells.
times yielding to the same observation. One could hypothesize that the decrease in cell density
and increase in cell size together with the change in the number of nuclei are due to an altered
cell division cycle. To verify this hypothesis, we performed various assays on the cell cycle
upon M APbI3 and M ASnI3 exposure to A549 cells. The experimental procedures and results
will be discussed in the following section.
3.5 Cell division under MAPbI3 or MASnI3 exposure
The organization and apparent function of microtubules in cultured mammalian cells vary
markedly as the cell cycle progresses from interphase to mitosis and back to interphase again.
During cell division, the genetic material has to be correctly segregated into the daughter
cells.239 This is achieved through the formation of a dedicated bipolar structure called the
mitotic spindle, which involves a profound remodeling of the microtubule network. This
reorganization of the cytoskeleton is very complex and depends on many proteins, enzymes
and other parameters reviewed recently by di Pietro et al.67 However, tubulin and actin are the
main cytoskeletal proteins that play a central role in the structure and function of dividing
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Figure 3.14 – Quantiﬁcation of the phenotypical changes observed on A549 cells: a) Example of bright ﬁeld
microscopy image of cells exhibiting regular (1), giant (2) and elongated (3) cells, and their quantiﬁcation when
exposed to M APbI3 (b) or M ASnI3 (c) after 5 days using FIJI software and the cell counter plugin.
cells.50,139 Their organization in a network orchestrates the mitotic spindle, where actin
distribution is in the region of the cleavage groove, while tubulin clusters in a ﬁbrous spindle
between the daughter cells.50 Although the cytoplasmic content is strongly involved in the
process of cell division, the nuclear state is also very critical. Cells at different stages of the
cell cycle can also be distinguished by their DNA content. As they contain two copies of
each chromosome at G1 phase (diploid cells) and this content is doubled during the S-phase.
Experimentally, the DNA content can be determined by incubation of cells with a ﬂuorescent
dye that binds to DNA, followed by analysis of the ﬂuorescence intensity of individual cells
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using ﬂow cytometers.60 In this section, we will show how M APbI3 and M ASnI3 perovskite
solutions affect some pathways involved in regulating the cell cycle and the kinetics of cell
division in A549 cells.
3.5.1 The cytoskeleton arrangement revealed by immunocytochemistry (ICC)
Experimental procedure for ICC
A549 cells were seeded at 20% conﬂuence onto glass coverslips coated with poly-L-lysine (Life
Technologies). After adhesion, cells were treated with M APbI3 at a ﬁnal concentration of
200 μg/ml . After 5 days, they were washed 3 times with PBS (Phosphate Buffer Saline) and
then ﬁxed in 4% PFA (paraformaldehyde, Sigma-Aldrich) for 20 min at RT. After blocking with
3% BSA (Bovine Serum Albumin) in 0.1% Triton X-100 mixed with PBS (PBST) for 30 minutes
at RT, cells were incubated with the rabbit anti-ß-tubulin primary antibody for two hours at
RT. The cells were rinsed ﬁve times in PBST and subsequently incubated with the secondary
anti-mouse Alexa488 at a dilution of 1/800 in PBST and with the labelled phalloidin AF594 at a
dilution of 1/1000 in PBST. The cells were washed ﬁve times in PBST and incubated 30 minutes
at RT in DAPI at 2 μg/ml , before mounting in polyvinyl alcohol mounting-medium with
DABCO. The cells were then examined with confocal laser-scanning microscope (LSM 700,
Zeiss) with a 40x objective and analyzed using Zen software (Zeiss).
Results of ICC
A549 cells proliferate rapidly, a population, in average, doubles after 1.5 days. Before immunos-
taining with actin and tubulin antibodies, cells were plated at 20% conﬂuency then exposed to
M APbI3 and M ASnI3 for 5 days. Figure 3.15 shows the immunostained cells after 5 days for
non-treated cells (upper panel), and cells exposed to M APbI3 and M ASnI3 (lower panels).
There is no difference in the effect of the two perovskites on cytoskeleton rearrangement.
In the control condition, the population of cells reached conﬂuency. The presence of two
nuclei in very few non-treated cells is a normal observation in cancer cell lines. Interestingly,
the organization of actin and tubulin was not affected by the exposure to the perovskites
after 5 days, suggesting that there is no major difference in cell division between treated and
untreated cells. Nevertheless, we observe once again that treated cells do not reach high
conﬂuency and their size and shape are heavily affected. This observation led us to investigate
other molecular pathways that regulate the cell cycle, namely the DNA content.
56
3.5. Cell division under MAPbI3 or MASnI3 exposure
Figure 3.15 – Morphological changes caused by M APbI3 in A549 human lung epithelial cells. Cells were
treated during 5 days with 200 μg/ml of M APbI3, and M ASnI3 . Tubulin and actin distribution was analyzed
by immunostaining ß-tubulin (green), actin (red) and nuclei using DAPI (blue), then imaged using confocal
microscopy. Non-treated condition is shown on the top panel and treated cells on the panels below. Scale bar =
100 μm.
3.5.2 Cell cycle following perovskites exposure studied by ﬂow cytometry
Experimental procedure
Quantiﬁcation of the cell cycle distribution of A549 cells A549 cells were plated in 24-well
plates. The following day, the original culture medium was removed from the cells and
replaced with a medium spiked with increasing concentrations of M APbI3 or M ASnI3 (50,
100 and 200 μg/ml ). After 5 days of exposure, the cell cycle was analyzed using propidium
iodide staining (PI) (Life Technologies) that binds to DNA. Cells were harvested using the
classical trypsin (Life Technologies) procedure. After 5minutes of centrifugation at 200 g at 4◦C,
cells were suspended in ice-cold buffer, gently mixed then added to an equal volume of cold
absolute ethanol and stored at 4◦C for 24 hours. Cells were then centrifuged for 10 minutes
at 200 g and washed with cold PBS. The pellets were resuspended in cold PBS containing
0.1 % (v/v) Triton X-100 (Sigma-Aldrich) and 0.4 % (v/v) 5 μg/ml PI (which allows the cellular
DNA content staining). Cell cycle distribution was analyzed (15’000 events per condition were
measured) by ﬂow cytometry using Accuri C6 (BD Biosciences). PI emission was collected in
Fl2 channel and FlowJo software (Treestar) was used for subsequent analysis.
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Quantiﬁcation of the cell proliferation kinetics of A549 cells A549 cells were plated in
24-well plates and the medium was replaced by PBS containing CFSE (Life Technologies),
a proliferation dye that penetrates every mammalian cell and diffuses passively into each
daughter cell. The ﬁnal concentration of 5 μM and left for 1 minute at 37◦C then rinsed with
PBS and left in complete medium overnight. The following day, medium was removed from
the cells and replaced with a medium spiked with increasing concentrations of M APbI3 and
M ASnI3 (50, 100 and 200 μg/ml ). After 0, 1, 3 and 5 days of exposure, treated and non-treated
A549 cells were harvested using trypsin procedure and PI was added to the cells suspension.
Cell proliferation capacity was then analysed (15’000 events per condition were measured) by
ﬂow cytometry using Gallios instrument (Beckman Coulter). CFSE emission was collected in
Fl1 channel and Kaluza software (Beckman Coulter) was used for subsequent analysis.
Results on the cell cycle study and the proliferation capacity tracking
We have shown previously that perovskites exposure induces a decrease in cell density in
A549 accompanied by a strong change in their phenotype. Moreover, these effects do not
involve the activation of cell death pathways in lung cells. We have also shown that actin and
tubulin networks do not suffer the treatment even 5 days post-exposure to M APbI3. In this
part, we present the results of DNA quantiﬁcation obtained by ﬂow cytometry. Figure 3.16
shows the quantiﬁcation of cells, based on their DNA content, in the cell cycle phases : sub-
G1 (growth phase after the mitosis), S (DNA replication or synthesis phase) and G2 (phase
of cell maturation before division). We observe that the distribution of cell cycle phases is
similar between the non-treated and treated cells with various concentrations of M APbI3
and M ASnI3 after 5 days. As the procedure of this assay infers nuclei isolation, the result
reports the DNA content per nucleus and not per cell. This is the reason why quantiﬁcation of
DNA appears the same between treated and non-treated cells. Nonetheless, this test suggests
that the cell cycle phases are not altered upon exposure to M APbI3 or M ASnI3, we therefore
sought to investigate the proliferation capacity using other methods.
The kinetics of proliferation were assessed by measuring the ﬂuorescence intensity of the
Carboxy-Fluorescein Succinimidyl Ester (CFSE) dye by ﬂow cytometry. This dye diffuses
passively into cells and its intensity decreases by half after every cell division cycle. The results
in Figure 3.17 show the ﬂuorescence intensity of CFSE normalized to non-treated cells after
5 days of exposure for increasing concentrations of M APbI3 or M ASnI3. Cells exposed to
the highest concentration of M APbI3 show a CFSE ﬂuorescence intensity that is 2.3 times
higher than non-treated cells, and in the case of M ASnI3 this factor is even higher. We can
also appreciate the dose-dependent increase of the ﬂuorescence intensity of CFSE. This result
suggests that division kinetics have decreased in perovskites-treated cells, which is the reason
for their slower proliferation and low density after 5 days likewise.
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Figure 3.16 – Cell cycle distribution of A549 cells upon exposure to perovskites. Cells were treated during 5
days with increasing concentrations of M APbI3 or M ASnI3 (50, 100 and 200 μg/ml ), their DNA was stained
with propidium iodide (PI) and sub-G1, S and G2 phases distribution were assessed by ﬂow cytometry: the
histograms show the distribution of sorted cells based on their DNA content which did not change even at the
highest concentration of perovskites.
Figure 3.17 – Proliferation kinetics changes caused by the photovoltaic perovskites in A549 human lung cells: 5
days after treatment with increasing concentrations (50, 100 and 200 μg/ml ) of M APbI3 (blue) or M ASnI3 (red),
the proliferation capacity of A549 cells was assessed by acquiring the ﬂuorescence intensity of CFSE using ﬂow
cytometry. The intensity in treated cells is normalized to the non-treated ones. All the histograms show an average
of at least 3 independent repeats (each condition in triplicate). Bars are mean ± S.D. One-way ANOVA test followed
by a Tukey-Kramer post-hoc test were performed (non-treated vs treated conditions), ***<0.0005.
To gainmore detailed insight into themolecular and cellular basis of M APbI3-induced cellular
dysfunction, we examined the real-time effect of M APbI3 and M ASnI3 on Geminin and Cdt1,
two complexes involved in the regulation of the cell cycle.
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3.5.3 Probing damages in real-time using live imaging
In addition to being regulated at the transcriptional and post-translational levels, the cell cycle
is also controlled by ubiquitin (Ub)-mediated proteolysis of two complexes, that function as a
feedback inhibitor for one another, via a ligase-mediated process. The two ligase activities
oscillate reciprocally during the cell cycle from late mitosis (M) and G1 phases to the S and
G2 phases18,151,183 Geminin and Cdt1 are the direct substrates of the ligase activities in cell
cycle proteolysis, and are thus produced only once per division. This carefully regulated
process ensures that replication occurs only once in a cell cycle. Due to cell cycle-dependent
proteolysis, protein levels of Geminin and Cdt1 oscillate inversely. In 2008, A. Miyawaki et
al.183 fused the ligases substrates to GFP and RFP to develop dual-colour ﬂuorescent probes
that indicate whether individual live cells are in G1 phase or S/G2/M phases (Figure 3.18).
Figure 3.18 – Illustration of a ﬂuorescent indicator for cell-cycle progression: Cell-cycle regulation by the
production of Cdt1 and Geminin maintains bistability between G1 and S/G2/M phases (left panel). A ﬂuorescent
probe that labels individual G1 phase nuclei in red and S/G2/M phase nuclei green (right panel). (From Miyawaki
et al.183 in Cell, with permission from Elsevier).
In the G1 phase of the cell cycle, geminin is proteolysed and only Cdt1 tagged with RFP may be
visualized, thus cells in the G1 phase emit red ﬂuorescence and can be imaged. On the other
hand, when in the S, G2, and M phases, Cdt1 is degraded and only geminin tagged with GFP
remains, therefore cells become green and can be imaged in these phases. During the G1/S
transition, as Cdt1 levels decrease and geminin levels increase, both proteins are present in
cells, resulting in the superposition of GFP and RFP at the same time, thus cells appear yellow.
On the other hand, after mitosis cells might remain in G0 phase, where no ﬂuorescence in
emitted. In this part, we report the live-assay in our cellular model exposed to M APbI3 or
M ASnI3 and we explain the experimental procedure together with the results.
Live imaging methodology
A549 cells were plated at 13′000 cel l s/cm2 in glass chambers (IBIDI, Germany) coated with
poly-L-lysine. After adhesion, cells were treated with 100 μg/ml of M APbI3 or M ASnI3. We
then stained the nuclei in blue using Hoechst33343 (Thermo Fisher) and used the Bacmam 2.0
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Premo Fucci cell cycle sensor (Thermo Fisher, Switzerland) according to the manufacturer’s
protocol.9 Live imaging was performed during 48 hours every 20 minutes, for treated and
non-treated cells, using an inverted Olympus Cell-R coupled with a CCD camera. We used FIJI
software for image analysis.
Live imaging results
We examined cell cycle progression in A549 cells exposed to M APbI3 or M ASnI3 after trans-
fection with ﬂuorescent, ubiquitination-based cell cycle indicator (Fucci) using live imaging.
After 24 h and 48 h, non-treated cells proliferated as clusters maintaining cell-cell adhesion
with their neighbors (Figure 3.19, upper panels). The high proliferation rate of these cells
was evidenced by the large fraction of cells with green nuclei. However, when cells were
exposed to M APbI3 (Figure 3.19 intermediate panels), a change in ﬂuorescence could hardly
be observed over time. In the case of M ASnI3 exposure, only the blue-stained nuclei were
observed, indicating that Cdt1 and geminin proteins are not expressed and therefore cells
remained in G0 phase. Additionally, the cells’ density was not changed (Figure 3.19 lower
panels). This observation is in accordance with the results obtained from the proliferation
capacity assay using CFSE (Section 3.5.2) witnessing a slower cell cycle. In combination with
these cellular labeling techniques, we next examined the subcellular ultrastructures using
electron microscopy. In the next sub-section, we will present a detailed procedure on how we
obtained high-resolution micrographs of the cytoplasmic content of A549 cells exposed to
perovskites.
3.6 Theutrastructural effects revealedbyTransmissionElectronMi-
croscopy (TEM)
3.6.1 Materials and methods for TEM
A549 cells were grown on plastic coverslips (Thermanox) coated with poly-L-lysin. The fol-
lowing day, the original culture medium was removed and replaced by a medium spiked with
100 μg/ml of M APbI3. After 5 days of exposure, cells were ﬁxed using 4% paraformaldehyde
during 10 minutes and washed ﬁve times with PBS. Cells were post-ﬁxed with 1% osmium
tetroxide reduced with 1.5% (w/v) potassium ferrocyanide in 0.1 M sodium cacodylate buffer
pH 7.4 for 40 min followed by 1% osmium tetroxide, then washed using double-distilled water
and enblock stained with 1% (w/v) uranyl acetate in water for 40 min. Brief wash with water
was followed by dehydration in graded alcohol series (2 × 50%, 1 × 70%, 1 × 90%, 1 × 95%, and
2 × 100%) for 3 min in each change. Then the cells were gradually inﬁltrated in the Durcupan
resin diluted with ethanol (1:2, 1:1, and 2:1) for 30 min each dilution and in fresh pure resin for
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Figure 3.19 – Live A549 cells stained with Hoechst and premo Fucci during 24 and 48h: Non treated (upper pan-
els), 100 μm of M APbI3 (intermediate panels), and 100 μm of M ASnI3 (lower panels). Scale bar = 100 μm. The
full videos can be found at http://go.epﬂ.ch/NT_A549_Live for non treated cells, http://go.epﬂ.ch/L100_A549_Live
for 100 μm M APbI3 treated cells, and http://go.epﬂ.ch/Sn100_A549_Live for 100 μm, M ASnI3 treated cells
1 hour. Finally, the cells were sandwich embedded. The 13 mm diameter Teﬂon ring, 1 mm
thick, was placed on the glass slide coated with mold separating agent and the inner volume
was ﬁlled with Durcupan resin and covered with the coverslips, cells facing down. The sand-
wich was then placed in the 65◦C oven to polymerize and cure the Durcupan resin overnight.
The plastic coverslip was removed from the cure resin block by alternation between immersing
into liquid nitrogen and hot water until departed from the resin block. Cells were marked
on the resin surface using pulsed laser of dissection under microscope (Leica LMD, Leica
Microsystems). Selected cells were cut off from the resin disk by single edge razor blade, glued
to dummy resin block with superglue and the cutting face was trimmed using ultramicrotome
(Leica Ultracut UCT, Leica Microsystems) and glass knife. Ultrathin sections (50-60 nm) were
cut with the diamond knife (DiATOME, Biel, Switzerland) and collected onto single slot (2 mm)
copper grids coated with formvar plastic support ﬁlms. Sections were contrasted with uranyl
acetate and lead citrate and examined using Tecnai Spirit TEM (FEI, Netherlands) equipped
with a bottom mounted 4k × 4k Eagle CCD camera controlled by TIA acquisition software (FEI,
Netherlands).
62
3.7. Alteration of the mitochondrial function after exposure to perovskites
3.6.2 Results of TEM
As shown previously, treatment with M APbI3 resulted in an increased size of cells, multiple
nuclei and a decrease in cellular density. Imaging with electron microscopy offers a high-
resolution visualization of the subcellular structures. In Figure 3.20 a, we can see a non-treated
A549 cell exhibiting a regular shape, we can also appreciate the presence of lamellar bodies,
small secretory organelles that store lung surfactants to protect the cell against extra cellular
material188 After exposure to M APbI3 ( Figure 3.20 b), the density of lamellar bodies increases
and the multiple nuclei present in the treated cells did not show any ultra-structural defects
with well-preserved nuclear membrane and also present multiple nucleoli. However, the
most striking effect of M APbI3 treatment was observed on the mitochondrial compartment.
The non-treated cells showed typical ultrastructure of the mitochondrial cristae organization
( Figure 3.20 c, light green), whereas cells treated with M APbI3 exhibited severely damaged
mitochondria ( Figure 3.20 d, dark green for damagedmitochondria). The size ofmitochondria
in these cells increased dramatically and the intra-mitochondrial space became highly dilated
with severe damage to the cristae organization. These results suggest that M APbI3 induces
adverse effects on the mitochondrial function of A549 cells. To verify this statement, we
measured the mitochondrial function using several assays.
3.7 Alteration of the mitochondrial function after exposure to per-
ovskites
A mitochondrion is an organelle found in the cytoplasm of almost all eukaryotic cells. They
have been described as "the powerhouse of the cell" because they generate most of the cell’s
supply of adenosine triphosphate (ATP), the source of chemical energy.53 Moreover, mito-
chondria are essential in regulating the vital cellular functions such as signaling, cellular
differentiation, cell survival, cell death, cell cycle and cell growth.141 Their size ranges between
0.75 and 3μm in diameter.226 In humans, mitochondria are composed of the outermembrane,
the intermembrane space, the inner membrane, the cristae and the matrix. These compart-
ments carry out specialized functions orchestrated by the means of different mitochondrial
proteins (615 in mitochondria from cardiac cells).206 DNA can also be found inside mitochon-
dria showing substantial similarities to bacterial genome.27 The density of mitochondria per
cell varies considerably depending on the cell type, the tissue and the species. In this section,
we report the mitochondrial activity of A549 cells exposed to M APbI3 or M ASnI3 using the
standard MTT assay.179 We have also investigated the mitochondrial membrane potential
that we compared to the total mass of mitochondria using the Mitotracker test coupled with
ﬂow cytometry.
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Figure 3.20 – Ultrastructural analysis by EM of A549 cells. (a) Low magniﬁcation electron micrograph of the
non-treated A549 cells. A typical cellular morphology is shown with single nucleus (blue) well preserved nuclear
membrane and multiple nucleoli and lamellar bodies (LB; white arrows);
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(b) Changed morphology of the A549 cells upon the treatment with M APbI3 nanoparticles. Low magniﬁcation
overview image of the large “giant” multinucleated cell containing 7 nuclei and signiﬁcantly increased number
of lamellar bodies depicted by white arrows; (c) Two characteristic higher magniﬁcation images of the normal
mitochondrial (green) morphology with typical cristae organization, tubular organization of the endoplasmic
reticulum (black arrowheads) together with lamellar bodies (white arrows); (d) Two characteristic higher magniﬁ-
cation images demonstrating the severe damage of the mitochondria, particularly their increased size compared
to the non-treated A549 cells and highly dilated intra-mitochondrial space and reduced cristae organization.
The lamellar bodies (white arrows) and tubular organization of the endoplasmic reticulum are marked (black
arrowheads). Scale bars: 5 μm in a and b; 1 μm in c and d.
3.7.1 Experimental methodology for the mitochondrial assays
The MTT assay
A549 cells were plated in 24-well plates. The following day, the original culture medium was
removed from the cells and replaced by medium spiked with increasing concentrations of
M APbI3 or M ASnI3 (50, 100 and 200 μg/ml ). Metabolic activity of the cells was measured us-
ing the tetrazolium derivative 3-[4,5- dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide
(MTT) assay. This colorimetric assay based on the capacity of the healthy cells to reduce MTT
(Sigma Aldrich, Switzerland) in a purple formazan product. Brieﬂy, after the indicated days of
exposure to M APbI3, 5 mg/ml MTT was added to the different cell cultures. After 3 hours of
incubation, the culture medium was aspired and replaced by 100 μl or 20 μl (respectively in 24
or 96 well plates) of DMSO (Sigma-Aldrich). The levels of formation of formazan products were
quantiﬁed by using Tecan inﬁnite M200 Pro plate reader (Tecan). Absorbance of the converted
dye was measured at a wavelength of 570 nm with background subtraction at 630–690 nm.
Normalization to the number of counted cells had to be performed, in order to take into
account both the changes in proliferation and the conﬂuence of A549 cells and thus to ﬁt the
measured MTT absorption to the relative mitochondrial activity.
The mitotracker assay
A549 cells were plated in 24 well plates. The following day, the original culture medium
was removed from the cells and replaced by medium spiked with 100 μg/ml of M APbI3 or
M ASnI3. After 5 days of exposure, the membrane potential ΔΨm was analyzed using the
ﬂuorochrome MitoTracker Red (CMXRos) dye, and the overall mass of mitochondria was
quantiﬁed using the ﬂuorochrome MitoTracker Green. In short, CMXRos is a dye which
passively enters in living cells and that is selectively taken up and retained in mitochondria
depending on ΔΨm , whereas MitoTracker Green can passively diffuse through the plasma
membrane and once inside the cells, this dye selectively binds to the lipids of themitochondria
and ﬂuoresces regardless the mitochondrial membrane potential. Therefore MitoTracker
Green allows the overall measurement of the mitochondrial mass. After 5 days of exposure
to M APbI3, cells were resuspended and incubated for 20 minutes at 37◦C with CMXRos and
MitoTracker Green in accordance with the supplier’s instructions. Mitotrackers emission was
65
Chapter 3. In vitro toxicity of the photovoltaic halide perovskites
analyzed by ﬂow cytometry [Accuri C6 (BD Biosciences)] in Fl2 channel for the CMXRos and
in Fl1 channel for the MitoTracker Green, 30’000 events per condition were measured. FlowJo
(Treestar) was used for subsequent analysis.
3.7.2 Results of the mitochondrial assays
In the previous sub-section we demonstrated with TEM the adverse effect of M APbI3 on
the mitochondrial structure. Here we present how these effects are translated into the mito-
chondrial activity. A549 cells were exposed to M APbI3 and M ASnI3 during 5 days, and their
metabolic activity was examined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide MTT assay normalized to the cells conﬂuence. We found a clear increase in mito-
chondrial activity ( Figure 3.21 a) in a time- and dose-dependent manner. Moreover, The
tin-compound has a more radical effect on the increase in metabolic activity. We then com-
pared the mitochondrial membrane potential (ΔΨm) in the non-treated and treated cells
by measuring the capacity of Mitotracker Red CMXRos to be taken up and retained into the
mitochondria. Figure 3.21 (b, c) shows a signiﬁcant increase of the membrane potential ΔΨm
in the cells exposed to M APbI3 or M ASnI3. This observation is in accordance with the MTT
result. Nonetheless, the overall mass of the mitochondria, assessed using the Mitotracker
green FM and ﬂow cytometry, was also slightly increased in the treated cells.
Figure 3.21 – Effect of M APbI3 and M ASnI3 on themitochondrial function of A549 cells. A549 cells were treated
with increasing concentrations of M APbI3 and M ASnI3 (50, 100 and 200μg/ml ) and theirmitochondrial activity
was evaluated. (a) MTT assay after 1, 3, 5 and 7 days of exposure to M APbI3 and M ASnI3 showing increasing
metabolic activity normalized to the number of counted cells; (b) Mitochondrial membrane potential (ΔΨm ) was
assessed in non-treated and treated cells (100 μg/ml of M APbI3 and M ASnI3) at 5 days post-treatment. Cells
were stained by Mitotracker Red CMXRos and analyzed by ﬂow cytometry. These results corroborate with the
increased mitochondrial activity seen in a; (c) Overall mass of mitochondria was measured in non-treated and
treated cells (100 μg/ml of M APbI3 or M ASnI3) at 5 days post-treatment. Cells were stained with Mitotracker
Green and analyzed by ﬂow cytometry. All the histograms show an average of at least 3 independent repeats (each
condition in triplicate). Bars are means ± S.D. One-way ANOVA test followed by a Tukey-Kramer post-hoc test were
performed (non-treated vs treated conditions), **p<0.005 and ***<0.0005.
The effects of M APbI3 and M ASnI3 on human lung epithelial cells were markedly different
compared to the neuronal cells. In summary, the photovoltaic perovskites do not induce
cell death of A549 cells but heavily affect their phenotype, proliferation kinetics and the
mitochondrial structure and function. Considering that the molecular mechanisms of the
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perovskites toxicity still need to be elucidated, we decided to inspect the genome proﬁle of
cells exposed to M APbI3 and compared it to the non-treated cells. In the next part of this
chapter, we will introduce the gene expression methods and present our preliminary data.
3.8 Study of the toxicity effect of MAPbI3 by genome proﬁling
To have a better insight on the microscopic changes inside A549 cells induced by perovskite ex-
posure, I have zoomed in further more by doing a genome proﬁling, and performed this study
only by the M APbI3. The proﬁle of gene expression contains the global picture of cellular
state and can be useful for discerning the mechanisms by which chemical compounds invoke
toxic effects. The human genome contains around 20’000 genes coding for 30’000 proteins
and hundreds of thousands of peptides.119 Because of the redundancy in regulations of many
genes, identifying individual markers that are responsible of a speciﬁc toxic effect can be chal-
lenging. In light of this complexity, new methods have been developed for studying the levels
of genes expression at high-throughput. Among them DNA microarray,173 a technology that
measures the relative activity of speciﬁc target genes. In this technology, the sample (mRNA) is
reverse-transcribed into cDNA and injected into a biochip where a collection of microscopic
single-strand DNA spots are attached to a solid surface. Each DNA spot is a probe that has
the capability to hybridize the target cDNA. The advent of next-generation sequencing has
made RNA sequencing (or RNA-seq)220 a digital alternative to microarrays. This technology
quantiﬁes total RNA in a biological sample at a given moment of time, including mRNA, small
RNA (miRNA, tRNA) and taking into account the post-transcriptional modiﬁcations and the
spliced transcripts. We chose the use of RNA-seq to analyze the continually changing tran-
scriptome of A549 cells exposed to M APbI3 versus non-exposed cells (Figure 3.22). RNA-seq
method is more sensitive than the conventional micro-array sequencing approach, and allows
transcriptome mapping and quantiﬁcation.
Figure 3.22 – Illustration of the genome proﬁling study: A549 cells were treated with M APbI3 at 100 μg/ml
during 3 days, then total mRNA was isolated and sequenced using Illumina machine. The sequence was then
aligned against human genome to probe the gene expression changes.
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3.8.1 Experimental procedure
Samples preparation for genome proﬁling
A549 cells were plated in a 6-well plate at 40% conﬂuency. The following day, the original
culturemediumwas removed from the cells and replaced bymedium containing 100μg/ml of
M APbI3. At 6 hours and 3 days, mRNA was isolated from treated and non-treated cells using
RNeasy mini kit (Qiagen, Switzerland) following the manufacturer’s protocol.12 Quality and
quantity measurements of extracted RNA was done using NanoDrop2000 (Thermo Scientiﬁc),
and wells were poured together to reach 1 μg of total RNA from the same condition.
RNA-seq approach
The purity and quality of the reads was trimmed with Cutadapt version 1.3,136 and seq_crumbs
(v. 0.1.8). Reads were aligned against Homo sapiens version GRCh38 genome using STAR69
(version 2.4.0f1). The number of read counts per gene locus was summarized with HTSeq-
count25 version 0.6.1, using H. sapiens GRCh38 Ensembl version 76 gene annotation. Quality
of the RNA-seq data alignment was assessed using RSeQC219 version 2.3.7. Reads were also
aligned to the H. sapiens GRCh38 Ensembl version 76 transcriptome using STAR and the
estimation of the isoforms abundance was computed using RSEM129 version 1.2.16.
Statistical and differential analysis
RNA samples from treated and non-treated cells were prepared independently in duplicate.
Statistical data analysis was performed for genes in R (R version 3.1.2). Genes with low counts
were ﬁltered out according to the rule of 1 count per million (cpm) in at least one sample.
Library sizes were scaled using TMM normalization (EdgeR v 3.8.5) and log-transformed with
limma (R version 3.22.4). Statistical quality controls were performed through pairwise sample
correlations, clustering and sample PCA (principle component analysis) using transformed
data. Differential expression was computed using LIMMA by ﬁtting data into a linear model
and extracting the contrast in two groups according to the time point. A moderated t-test was
used for the comparison. Adjusted p-values have been computed for each comparison by the
Benjamini-Hochberg (BH) method, controlling for false discovery rate (FDR).
Signaling pathways analysis
After the LIMMA, a gene set enrichment analysis (GSEA) and pathway analysis were performed
using GAGE and R. To do so, the log2 Fold Change (FC) of the comparison between treated and
non-treated samples was considered. Next we analyzed the gene ontology (GO) enrichment
for a gene set compared to the totality of genes. The latter is annotated in 3 main classes:
molecular function, cellular component and biological process. We selected biological process
since it includes the global cellular mechanisms with details on the molecular functions and
localization inside the cell. We also used TopGO (topology-based Gene Ontology scoring),
an R library, to analyze statistically gene sets. We used a standard Fisher statistical test
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because it uses the count of genes belonging to each GO term in the whole human genome
versus the selected gene list in order to calculate a gene enrichment score. The GO terms
are ranked by their p-value.41 To analyze the gene set and the signaling pathways, Ensembl
gene ID were converted into Entrez-gene ID. Then we used the Generally Applicable Gene-set
Enrichment (GAGE) method to link the known regulatory signaling pathways from differential
gene expression, and by connecting some KEGG published pathways with the phenotypic
conditions Treated versus Non-treated. It allows getting a systemic approach of the points
leading to different phenotypes (Treated versusNon-treated). Unlike the SPIA strategy focusing
on a limited number of differentially expressed genes (cutoff-based), GAGE focuses on sets of
related genes (log2FC). One GAGE advantage is that sometimes coordinated gene expression
changes that are not signiﬁcant according to our thresholds (adjusted p-value > 0.05) can have
a major pathway impact. With GAGE, we can have two different approaches for pair–wise
comparison between samples (LL/TT and LLTT/HEC): based on Log2FC or on the per gene
statistics (t-student test paired samples). That is to say, GAGE uses sample wise fold change
as per gene score/statistics in gene set test. We assume that gene set test on log2FC data
is not as powerful and sensitive as the GAGE pair-wise comparison scheme. However, this
experiment was done only in duplicate (two samples per condition). It seems that there is not
enough samples in each condition to have a powerful t-student test. We run GAGE to infer
gene sets (or pathways) that are signiﬁcantly perturbed comparing to all the considered genes
. GAGE compares expression level of a gene set to the whole set background. We select the
KEGG pathways that have a p value<0.05. In order to complete the GAGE results, we decided
to use another approach. The idea is to ﬁnd pathways speciﬁcally associated to the gene
set that we consider as differentially expressed (DE), or a cutoff-based approach, or to ﬁnd
pathways associated to our data (gene set statistically found). As the algorithms are different,
they can give complementary outcomes. Nevertheless the common pathways resolved by the
two methods are the ones modiﬁed by the perovskite treatment. We have also used another
bioinformatics method called SPIA or Signaling Pathway Impact Analysis. This analytical
method combines the classical pathway enrichment analysis of a gene set and compares it to
the gene background within two biological conditions. SPIA uses the log2 fold change and
predeﬁnes sets of DE genes. We chose to apply the thresholds adjusted pvalue <0.05 for a
statistical signiﬁcance. The next section will present the analyzed outcomes and discuss the
preliminary impact of M APbI3 on the genome of A549 cell line.
3.8.2 Gene proﬁling results
We performed RNAseq at the genomic technologies facility (GTF) at the university of Lau-
sanne.7 Common RNA fragmentation and other manipulations were made prior library
production, processing and alignment. We generated a table including referenced genes and
their speciﬁc fold change (FC) over exposure to M APbI3. Up-regulated genes have a positive
value of the FC and the down-regulated ones have a negative FC value. The preliminary results
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of the toxic effects of perovskites on the genome proﬁle of A549 cells are presented in this part.
Total sum > 0 In analysis
antisense 5408 3749 610
lincRNA 7403 4278 605
processed transcript 530 372 135
protein coding 19924 18162 13005
sense intronic 909 708 104
sense overlapping 189 151 42
Totals 34363 27420 14501
Table 3.1 – Number of genes measured by HTSeq method.
Quality control report
A global quality control report can be found in appendix C and includes alignment metrics,
gene body coverage proﬁles and read density over annotated regions. In summary, it shows
high number of total reads sequenced for all samples varying between 35 to 50 million of reads
and high percentage (> 99%) of aligned reads to the genome. Very low percentage of reads
mapping RNA sequences (< 1%) as expected for poly-A selection protocol and low percentage
of mitochondrial sequences (< 1%). Mapped reads are principally located in CDS regions of
the genome and they account for 29 to 41 million of reads. Gene body coverage proﬁles are of
very good quality and similar across samples.
Differential expression analysis
Differential expression was computed with LIMMA by ﬁtting data into a linear model and
extracting the contrast in treated versus non-treated conditions according to the time point
6 hours or 3Days. The number of genesmeasured by biotype category (HTSeq)25 are presented
in Figure 3.1 where “Total” represents all genes to which the read counts were mapped;
“Sum>0” are the genes that have at least 1 read count in at least 1 sample; and “In_analysis”
stems for the genes that have at least 1 count per million in at least 1 sample.
From this outcome, we extracted the number of genes found with signiﬁcant differential
expression using the False Discovery Rate procedure (FDR) at a cut-off of 0.05 and a fold
change >2. The results are summed up in Figure 3.2; where the background noise is very
present below 0.05 of FDR in the 6 hours time point in treated versus non-treated conditions.
Therefore, we considered the data only for the time point 3 days, and also for a FC>2 to make
sure that the changes in gene expression due to exposure to M APbI3 are at lease 2 fold.
These analysed data are generated from duplicates, they need to be normalized and correlated
among them before a more detailed comparison. As seen in Figure 3.23, pairblots, PCA and
the quality score boxplots show that data are well normalized and the correlation is good
between treated and non-Treated cells after 3 days. These results report that the quality of our
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Group Comparison FDR<0.05 FDR<0.05 Fold changes > 2
ALL UP DOWN ALL UP DOWN
6 hours Treated 6h vs.
NT 6h
0 (FDR 10%)
3 days Treaded 3d vs.
NT 3d
281 237 44 239 201 38
Table 3.2 – Number of genes with a signiﬁcant DE and FDR cut-off 0.05.
samples are very good and suggest that their corresponding RNA-seq raw data are comparable.
Therefore, based on the transcripts, we proceeded on analyzing the potential networks that
could be altered by exposure to the Pb-containing perovskite.
Figure 3.23 – Quality control of the RNA samples from A549 cells before analysis of the gene proﬁle. a) Pairplot,
b) PCA, c) Quality score boxplots, to verify the correlation among duplicates, and to normalize the samples. d)
Maplot to distinguish between affected transcripts, and e) number of over- and under-expressed genes.
Signaling pathways analysis
The transcriptome mirrors the genes being actively regulated, and therefore reﬂects the
expression proﬁle. Since it is considered as a precursor for the proteome, we identiﬁed the co-
regulated gene networks rather than individual coding genes190 that are up- or down-regulated
in our samples. The ﬁrst approach in identifying the potential signaling networks, where
M APbI3 might interfere, is gene set enrichment (or GSEA) by taking into account the log2FC,
this method is commonly called GAGE. Next we investigated the gene ontology (GO) and
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Strategy Description Advantage Disadvantage
GAGE KEGG This method veriﬁes
if speciﬁc gene sets
are signiﬁcantly dif-
ferentailly expressed
(DE) versus back-
ground. Outcome:
pathways associated
to the data.
• based on log2
fold change (as per
gene score) or on
the t-test statistics
per gene (t-student
test paired sample).
• Gage infer gene sets
Gene set test on
log2FC data is not
as powerful and sen-
sitive as the GAGE
pair wise comparison
scheme. However,
there are only two
samples in each con-
dition (Treated and
Non-Treated).
SPIA KEGG
Pathway
topology
• Test over represen-
tation of DE genes
• Combines pNDE hy-
pergeometrical model
and perturbation of
the pathway pERT
Outcome: pathways
associated to the User
Gene set.
• Take into ac-
count log2FC
• Take into account
Pathway topology
• We chose the set
of differentially ex-
pressed genes (pvalue
< 0.05)
User Gene set. Only
2 pathways with
pGFWER<0.05. No
signiﬁcant pathways
for DE genes with
adjusted pvalues <
0.05
GO Hyperge-
ometric
Gene ontology hy-
pergeometric enrich-
ment. This method
reﬂects the pathways
and larger processes
made up of the activi-
ties of multiple gene
products.
One can choose the
set of differentially
expressed genes (ad-
justed pvalue<0.05).
• Expression value not
taken into account
• User Gene set
REACTOME
Hypergeo-
metric
This method is an hy-
pergeometric model
to assess whether the
number of selected
genes associated with
reactome pathway is
larger then expected.
Complementary re-
sults to KEGG. We
chose the set of dif-
ferentially expressed
genes (adjusted
pvalue<0.05).
Expression value not
taken into account
User Gene set
Table 3.3 – Summary of the four methods used in this study to analyze the RNAseq data a short
description of the main characteristics of each method is given, as well as the advantages and
the inconveniences in the present study.
then analysed the signaling pathway impact (SPIA). A comprehensive table compares these
methods and sums up their advantages and inconveniences (Figure 3.3). By descriminating
the data, we have found around 23 down-regulated and 17 up-regulated pathways following
the exposure of M APbI3. Among them: the cell cycle protein network, DNA replication, RNA
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transport, mismatch repair and adherens junction. Figure 3.24 shows an example of pathway
where the signaling cascade of proteins and peptides involved in regulating the cell cycle are
affected: the mRNA of almost all the actors signiﬁcantly undergo a fold change greater than
2: down-regulation (green boxes), or up-regulation (red boxes). Some of the other affected
pathways mentioned previously are presented in appendix C.
Figure 3.24 – Cell cycle down-regulated pathway at the transcriptome level of Treated vs. Non-Treated A549
cells exposed to M APbI3 for 3 days.
In summary, this genome proﬁling study exposed the effects of perovskites on gene expression,
with the spotlight on transcripts. Computation and model ﬁtting of the results allowed to
identify changes in subcellular signaling pathways. Although the results are conjectures,
because they are based on the proﬁle of expressed genes, they are clearly in line with our
previous ﬁndings, and shed light on the microscopic mechanisms of toxicity. Nevertheless, for
a complete picture, further investigation on protein expression levels is needed.
3.9 Discussion and main conclusions of the in vitro study
The discovery of the M APbI3 perovskite as a cheap and extremely efﬁcient material to convert
sunlight to electricity represents a major breakthrough in the development of photovoltaic
cells. However, one serious drawback of its large scale exploitation is its lead content that
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raises major concerns94 about its potential toxicity during device production, handling and
disposal. Replacement of Pb by Sn is an option widely accepted whithin the photovoltaic
community. However, in this ﬁeld nothing is granted, one has to check the consequences
of exposure both to M APbI3 and M ASnI3 before large-scale production. The toxicity of the
entire perovskite materials has not been documented at all before this dissertation.The group
of Conings32 claimed to report the toxic effects of Pb- and Sn-based perovskites, however they
showed in their publications hazards related to PbI2 and SnI2. Both halides are available in
the market with safety data sheets adocumenting their negative effects together with regula-
tions about their use.8,176 Moreover, they study very high concentrations of PbI2 and SnI2,
which are not realistic in an exposure scenario. In this chapter I have presented the in vitro
results of our zoom-in approach of perovskites’ toxicity. In our study, we observed that when
M APbI3 or M ASnI3 are dispersed in cell culture media, a part forms a precipitate, while the
other stays in solution (6% of Pb, 85% of Sn and 90% of I, see Chapter 2). Methylamine is
known to be highly soluble in a water-rich environment.181 In this study, we considered the
soluble part of the perovskite only. Herein, we showed that M APbI3/M ASnI3 perovskites
penetrate our cellular models and cause a time-and-dose-dependent toxicity in both SH-SY5Y
neuroblastoma cell line and in differentiated mice primary hippocampal neurons. In both
neuronal cell types, they damaged the plasma membrane and triggered apoptotic cell death
via the activation of the mitochondrial/intrinsic pathway signaled by caspase 9. The heavy
metal could be the main cause of this effect since it is known to depolarize cells mitochondria
resulting in cytochrome c release, caspases activation, and apoptosis.206,226 In humans, a
blood lead level > 0.1 μg/ml is considered to be elevated even though clinical symptoms
are rarely seen below 0.6 μg/ml in chronic poisoning.28 Moreover, in vivo, the accumulation
of lead in the organism ampliﬁes the toxic effect. In our in vitro cellular studies the effect
of accumulation was substituted by the increased concentration. Remarkably, in the case
of epithelial cells such as A549 human lung cells, exposure to the perovskites did not result
in cell death, but the proliferation rate decreased without cell cycle arrest leading to severe
morphological changes and signiﬁcant increase in the mitochondrial mass and activity. Upon
exposure to M APbI3, A549 cells became giant and polynucleated; their mitochondria showed
an unusual polymorphic arrangement of the cristae. Lead ions are known to enter some
cells through calcium channels, then bind to calmodulin (with a higher afﬁnity than calcium)
which alters enzyme activities, gene transcription and cell signaling.90,124 On the other hand,
methylamines are also known to inhibit protein turnover resulting in a modiﬁcation the cells’
DNA and RNA content.96 The solubility of M APbI3 could be at the origin of the polynucle-
arity and the modiﬁed mitochondria. Paradoxically, the metabolic activity rate produced
by the mitochondria increased signiﬁcantly in response to M APbI3 and M ASnI3 exposure,
whereas cell proliferation kinetics and conﬂuency decreased. At ﬁrst sight, this observation
seems controversial but as the cells become giants and escape death, they must expand their
energy production for survival. Mitochondria are essential regulators of metabolism, stress
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responses, cell survival and cell death.85 One reason for the different response of the lung and
neuronal cells to M APbI3 and M ASnI3 exposure might be the presence of lamellar bodies in
the former ones and their absence in the latter cells. These structures are naturally present in
the cytoplasm of mucosal cells; they are part of the cellular protective mechanisms against
environmental inﬂuences188 of the lung alveoli. A549 cells exposed to M APbI3 show an
increase in the number of lamellar bodies in the cytoplasm. A similar increased number of
lamellar bodies was observed in epithelial cells exposed to single-walled carbon nanotube
exposure.66 The cell survival strategies involve countless coordinated physiological and ge-
netic changes that serve to escape cell demise.174 It seems that one of these strategies consists
of increasing the number of lamellar bodies, which have a protective function. Genome
proﬁling of treated and non-treated cells provide a preliminary understanding of the cellular
mechanisms underlying the differences in cellular toxicity and cellular phenotypes observed
in A549 cells. The analyzed transcriptome given by RNA sequencing provides a signiﬁcant
hint on the observed effects following exposure to M APbI3 and conﬁrms the outcomes of
molecular and cellular biology assays performed using immunoblotting, microscopy, FACS
and/or speciﬁc probes. The genome proﬁling was run in duplicate not only due to the high
cost of the assay but also to the high reliability and reproducibility for technical and biological
replicates.58,147 However, validating data might be necessary to ensure that the analysis is
operating on clean and correct genes or molecular networks. Validation of the candidates
obtained using RNA-seq can be conﬁrmed in the future by cheap and conventional tests at
the mRNA level. Speciﬁc primers of the gene-candidates obtained from the RNA-seq test
should be designed for reverse transcription-polymerase chain reaction (RT-PCR). RT-PCR
is a routinely used technique in molecular biology to amplify targeted DNA sequences (via
their primers) and then quantify them at a speciﬁc time point after exposure to the material.
This assay (from RNAseq to RT-PCR) should also be done on cells exposed to M ASnI3. Vali-
dation could also be performed at the protein level for quantiﬁcation and comparison with
the bioinformatics data. Cells exposed to M APbI3 or M ASnI3 should be lysed and the total
protein content extracted. Speciﬁc antibodies against the protein-candidates (related to the
transcript analysed by RNAseq) should reveal by immunoblotting the actual change in protein
content. This in vitro study is alarming, and suggests: 1) reconsidering the use of M APbI3 as a
light harvester, 2) revisiting replacement of Pb by Sn, 3) ﬁnding alternative materials less toxic
for “green energy” collection, 4) to the scientiﬁc community to understand the necessity of
toxicity study for each novel material before its large-scale production and industrialization.
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Identiﬁcation of the biochemical
ﬁngerprints of perovskites toxicity by
Infrared spectroscopy
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4.1. Introduction to IR spectroscopy
The released ions after PV perovskites dissolution (Pb2+, Sn2+ etc.) are chemically very active,
and can enter easily into cells through calcium channels. Moreover,they are able to interact
with proteins, lipids and DNA, and potentially catalyze chemical reactions. During these
processes,
changes within the cell in biochemical activity or conformation of proteins and polypeptides
may occur. Infrared (IR) spectroscopy is able to ﬁnely detect such ﬁngerprints of toxicity,
and this feature of IR is frequently used e.g. in detecting the hallmarks of neurodegenerative
diseases, but it is the ﬁrst time that it applied in a toxicity study. My goal was to zoom-in
further at the microscopic level in order to detect the biochemical changes following exposure
of cells to M APbI3 and M ASnI3. Since the approach is radically new to the ﬁeld of toxicity,
I separated it in a new chapter. For a better understanding of the working principles of the
technique, ﬁrst I give a short introduction to it.
4.1 Introduction to IR spectroscopy
Within molecules, the covalent bonds between atoms are in a constant state of vibration at
speciﬁc temperatures. The energy required to stretch or bend a bond corresponds to the
infrared (IR) region of the electromagnetic spectrum (typically between 1 meV and 1 eV).
Consequently, IR spectroscopy is used mainly to differentiate between bond types.79 By a
technique, called Fourier-transform infrared spectroscopy (FTIR), one can ﬁnd the main
components of vibrational frequencies, which for historical reasons are expressed in units of
cm−1 (8000 cm−1 corresponds to 1 eV). In a molecule with two atoms of mass m1 and m2 the
frequency of vibrations could be expressed as:
f = 1
2π
√
k
μ
(4.1)
Where μ is the reduced mass m1m2m1+m2 , and k is the strength of the chemical bonds between the
two atoms. If the atomic vibrations result in an electrical dipole moment, light is absorbed at
the characteristic frequency of the vibration. In other words, when IR illuminates a complex
matter, like a cell or a protein or DNA, one could detect the absorption spectrum of the IR
light.
A typical experimental conﬁguration of IR absorption and a biological spectrum are depicted
in Figure 4.1. The advantage of FTIR is that it detects all the components at the same time.
Bending and stretching vibrations of functional groups have spectral ﬁngerprints in speciﬁc
regions and thus provide a diagnostic by compound class. In the case of organic and bio-
chemical compounds, the corresponding bands appear in the region 1000-4000 wavenumbers
(cm−1). Figure 4.1 displays a spectrum of a single human neuroblastoma cell in which the IR
signature of the biochemical content can be observed. In this spectrum, each peak represents
the vibrational frequency of a cellular biochemical component. The variation in absorption
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intensity or in the wavenumber (energy) of the spectral peaks brings information about the
biochemical and structural changes in the sample. The main spectral features observed in the
cell with their associated assignments are represented in Figure 4.1.
Figure 4.1 – Typical Fourier transformed infrared spectrum recorded for a single human neuroblastoma cell over
a 7x7 μm aperture. The cell was grown on a CaF2 window. For the assignment of the vibrational modes: a. N-H
and O-H stretching; b. Aliphatic C-H stretching; c. C=O stretching; d. Amid I stretching; e. Amid II stretching; f.
PO2− asymmetric stretching. The details of these assignments can be found in Figure 4.1
Evaluation of an IR spectrum consists on identifying the chemical details in a sample based on
the measured vibrational frequencies. The value of the characteristic frequencies depend not
only on the chemical bond (covalent or not), whether the vibration is symmetric or asymmetric
(bending of the bonds), but also on the environment. The vibrational frequencies of a sample
measured by IR can provide valuable information on the non-local structure of molecules (e.g.
folding, unfolding of a protein), as well.
Generally, the source of IR is a black body radiation of a glowing SiC rod (also called Globar
source, for “glowing bar”). It is less efﬁcient in the far infrared region since the intensity of
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the emission falls with the fourth power of the wavelength (Wiener-law). Therefore, such
equipment has a very limited spatial resolution, which prevents the exploitation of ﬁne and
short spectral peaks. To overcome this problem, another source of IR light called synchrotron
radiation (SR) can be used. The light is generated when electrons are accelerated in a ring,
conﬁning the charges by bending magnets, and undulators give additional acceleration to
them.
Wavenumber Biological assignments
a 3300 cm−1 (gray
arrow)
Originates from both the N–H and O–H bonds present in water
traces, polysaccharides, carbohydrates and proteins.
b 2995−2800 cm−1
(green arrow)
arises from the symmetric and asymmetric stretching modes of
the carbon – hydrogen bond in methylene (CH2) and methyl
(CH3) group mainly present in lipids and protein.
c 1740−1725 cm−1
(blue arrow)
the resulting shoulder is attributed to the contributions of the car-
bonyl ester group (>C=O) in non-hydrogen bonded and hydrogen-
bonded states respectively, found in phospholipids.
d,e The two ab-
sorption peaks
at 1650 and
1545 cm−1
correspond to the intensity of Amide I (orange arrow) and Amide
II (dashed gray arrow) respectively. Amide I originates from the
C=O hydrogen bonded stretching vibrations. The Amide II peak,
is also representative of a protein-based structure, and arises from
C-N stretching and C-NH bending vibrations.
f The bands
at 1240 and
1085cm−1
originate mainly from asymmetric phosphate (asPO2−, red arrow)
and symmetric phosphate (sPO2−, dotted gray arrow) stretching
vibrations, respectively. They are attributed to the phosphodiester
groups of nucleic acids from DNA. These two bands are also at-
tributed to the C-O-P stretching modes present in phosphorylated
lipids or proteins.
Table 4.1 – Assignment of the main IR features in biological spectra.71,143,200,225
SR offers many advantages as compared to the Globar source, because the spectral range is
broader and the high intensity photon beam allows accurate experiments.72 Moreover, its
naturally high brilliance and polarization allows the study of very small biological samples,
like individual cells or scanned tissues with small aperture size. One might consider that
the high brilliance is a disadvantage in measurement of biological samples because it could
induce thermal heating which could damage the biological specimen. Nonetheless, M.C.
Martin et al. conducted a study on temperature ﬂuctuations over acquisition time and have
shown a maximum local rise of temperature under IR synchrotron irradiation of 0.5 ± 0.2◦K.137
Consequently, Synchrotron-based FTIR microspectroscopy (or S-FTIRM) can be considered
as a powerful non-destructive tool to probe bio-systems to monitor the chemical changes
without using labels. In addition, when SR is used in a scanning mode, it offers the possibility
to generate a vibrational map of cells or tissues, to display the chemical content in 3D and in
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a submicron high-stability.143 In the next parts of this chapter, I discuss the methods and a
few results on ﬁxed and living cells following exposure to M APbI3. The S-FTIRM experiments
were conducted using SR at the Swiss Light Source (SLS), Villigen, Switzerland; the Brookhaven
National Laboratory, New York, USA, and at the Source Optimisée de Lumière d’Énergie
Intermédiaire du LURE (SOLEIL), Gif-Sur-Yvette, France. The three laboratories are equipped
with synchrotron radiation, and we used the mid-infrared range to investigate the biochemical
ﬁngerprints of M APbI3 and M ASnI3 toxicity on single cells. A major drawback is not solved
yet in the application of IR spectroscopy: when studying living cells in a native physiological
environment, strong water absorption frequencies in the mid-IR range prevent the access to
some regions of interest. For this reason, biological samples are usually ﬁxed and desiccated
before acquisition of IR spectra in order to obtain resolvable data. Nevertheless, in the last
part of this chapter, I report my attempt to study living cells in a liquid environment.
4.2 Use of IR to assess toxicity ﬁngerprints on ﬁxed samples
4.2.1 Experimental conditions
Samples preparation
SH-SY5Y and A549 Cells were maintained as previously described in chapter III. In this part,
cells were plated on calcium ﬂuoride (CaF2) optical windows transparent for IR light (Crystran,
UK) at a density of 20’000 cells. 5 days before administration to cells, M APbI3 and M ASnI3
powders were suspended at concentrations of 50, 100 and 200 μg/ml in preheated culture
medium. Solutions were prepared at RT and vortexed under laminar ﬂow. They soaked during
5 days at RT, then ﬁltered at 220 nm pore size ﬁlter (Merck Millipore, Switzerland) then stored
at 4◦C. Cells were rinsed with warm PBS (1x) after 5 days of exposure to the perovskite solution,
then ﬁxed using increasing concentrations of ethanol for few seconds (20%, 40%, 60% and
80%). Then samples were rinsed with ddH2O 3 times and left overnight for drying under a
laminar ﬂow then stored in a desiccator for maximum 5 days before measurements.
IR measurements using S-FTIRM
Synchrotron-based Fourier Transform Infrared Microspectroscopy (S-FTIRM) measurements
were performed on dried cells. We used a Thermo Nicolet Continum IR microscope set-up144
coupled to a Thermo Nicolet Magna 860 FTIR (Thermo Nicolet Instrument, Madison, WI). We
performed sample scanning using an automated X–Y mapping stage that has a step accuracy
of 1 μm. The IR beam, with an aperture of 7x7 μm2, was positioned on a clean area of the
CaF2 window for the background collection then centered on single cells chosen randomly
using a traditional optical microscope. Spectra were collected in transmission mode, at a
spectral resolution of 4 cm−1, and 256 to 512 scans were co-added to enhance the S/N ratio.
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Data analysis
Data were analyzed using Omnic 7.4 (Thermo Fisher Scientiﬁc Inc), and Opus (Bruker). Few
bad pixels were removed and replaced by the mean value of their neighbor’s pixel (e.g. for odd
absorbance values). The baseline was corrected using the software’s algorithm. To facilitate the
resolution of different overlapping spectral contributions, we also used the second derivative
of the absorbance spectra to follow the changes following exposure to M APbI3 and M ASnI3.
4.2.2 Results and discussion
Figure 4.2 A shows the infrared absorption spectrum of a SH-SY5Y cell recorded in the photon
energy range 1000 – 4000 cm−1 (i.e. 0.125, 0.50 eV). The main vibrational features are marked
on the ﬁgure, and the spectroscopic changes are expected in the 1200 – 1800 cm−1 range as
presented in Figure 4.2 B. Results are shown for cells exposed to 100 μg/ml of M APbI3 (blue
line) and M ASnI3 (red line) and for non-treated cells (black line).
The main contribution to the spectral region detailed in Figure 4.2 B arises from the absorp-
tion bands of carbonyl and imide containing compounds, although contributions from the
absorption of other organic molecules are also present. The dominant contribution is usually
provided by the so-called Amide I and Amide II around 1650 cm−1 and 1550 cm−1 respectively.
The two bands mostly arise from the amide groups of polypeptides and are both sensitive
to their secondary structure. Application to complex biological samples is challenging and
limited by the compositional complexity of the samples themselves. Cells and tissues are
characterized by a complex mixture of polypeptides and other organic molecules absorbing in
the same spectral region. In most cases, performing a detailed analysis of secondary structure
composition is unreliable in such samples because of overlapping contributions from multiple
absorbing molecules. This is particularly true for the Amide II band region, where the amide
contribution overlaps with the absorption of ionized carboxylate groups, which are abundant
both in protein themselves and in many small metabolites.
For this reason, the Amide I band is employed more frequently than the Amide II because of its
stronger molar absorbance. The Amide I itself overlaps with contributions from nucleic acid
carbonyls on the higher energy side. Yet, no signiﬁcant overlap from non-protein molecules
is reported to date in the low energy side of the Amide I (i.e. below 1660 cm−1), where the
dominant contributions are provided by α-helices and β-sheets. Despite these difﬁculties, the
Amide I band can be used to report protein conformational changes of proteins within cells or
tissues. This has been especially true for some studies on neurodegenerative diseases where
the formation of amyloid deposits (or misfolded polypeptides) were shown to aggregate into
a β-sheet conformation,194 and thus fall in the Amide I peak deconvolution when analyzed
with S-FTIRM.42,43 Since they are compositionally nearly pure, they can be detected from
the characteristic Amide I absorption at ca. 1625-1628 cm−1.218 In Figure 4.3, we show the
second derivative of the absorbance spectra to ﬁnely probe the changes following exposure to
M APbI3 and M ASnI3. In the 1500 cm−1 – 1800 cm−1 spectral region, the thick line shows the
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Figure 4.2 – (a) Typical spectrum of a SH-SY5Y cell with the characteristic vibrational bands (b) zoom on the
absorbance in the 1350-1750 cm−1 range of non-treated (blue), M APbI3 (red) and M ASnI3 (green) treated cells
using concentration of 100 μg/ml in both cases. Cells were cultured on CaF2 windows and IR measurements
were performed 5 days post-treatment.
average trace from at least 50 spectra of individual cells. The spectra in Figure 4.3 a show the
effect of exposure to M APbI3 and M ASnI3 on the spectra of SH-SYS5 cells. Figure 4.3 b shows
the corresponding measurements performed on A549 cells. Average spectra are measured
ﬁve days after treatment, and reported as their 2nd derivative, showing that exposure to either
metal containing agent induces major spectral changes. In treated SH-SYS5 cells, the most
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obvious change is observed the region of the Amide I, where two major contributions are
present, at 1655 cm−1 and 1628 cm−1. If we accept that no other contributions are present in
this spectral interval except from polypeptides, the change corresponds to a marked alteration
in the secondary structure of proteins within the cell. An Amide I absorption peak at 1628 cm−1
is characteristic for some β-sheet polypeptides. The most obvious change is the region of
the Amide I, where two major contributions are observed, at 1655 cm−1 and 1628 cm−1.
If we assume that no other contributions are present in this spectra interval except from
polypeptides, the change corresponds to a marked alteration in the secondary structure of
proteins within the cell. A weaker contribution is also observed at 1691 cm−1, which can
arise from a variety of molecules, including β-sheet polypeptides, nucleic acids and small
molecules, such as ketones and sphingolipids. This pattern is common to most eukaryotic
cell types, and is due to the abundance of α-helical proteins absorbing around 1650 cm−1.
Another recurrent feature is the doublet at 1740 cm−1 and 1720 cm−1, from ester carbonyl
groups, mostly from phospholipids. A contribution to this region from the protonated form
of carboxylic acids is also known. Due to the preparation protocol of the samples, involving
repeated washings and ﬁxation, it is likely that contributions from small molecules, such as
metabolites and transmembrane molecules, have been removed, except for acyl lipids, which
are at least partially retained by ﬁxation protocols.
Production of uric acid, as expected from a nucleic base derivative, can be induced by lead
exposure. However, its absorption falls in the 1690 cm−1 region and the bulk of the compound
is expected to be washed away during the ﬁxation protocol, together with other small molecule
metabolites. Possible M APbI3 degradation products, including lead oxides and salts, acetoni-
trile and iodine anions, do not absorb in the spectral region of Amide bands. Most of them
are also water soluble and removed during sample preparation. Therefore the contribution
from any small molecules to absorption around 1630 cm−1 is ruled out. We propose that the
strong band at 1628 cm−1 arises from extensive conformational changes in the polypeptide
complement of the cells. Major changes are also seen in the Amide II region, with new lower
frequency components appearing within this multiplet. Although the latter components are
unresolved and this spectral region overlaps with carboxylate absorptions, the observation of
parallel changes in the Amide I and Amide II regions is a necessary condition to assign the
latter to polypeptides. An additional change induced by M APbI3 exposure is the relative de-
crease in intensity of the doublet at 1740 and 1728 cm−1. Absorption from this doublet mostly
arises from the headgroups of acyl lipids, mainly from intracellular membranes. The decrease
of this contribution can arise from the disruption of some of the membrane systems inside the
cell. The intensity of the band at 1628 cm−1 relative to the one at 1655 cm−1 is surprising, as
the two bands are of comparable intensity (Figure 4.3 a, b), indicating the presence of a similar
amount of polypeptides in the β-sheet and in the α-helix conformation. This corresponds
to a massive change in the composition and/or the structure of the cellular proteome. These
observations are consistent with the report that exposure of cells to M APbI3 induces degra-
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Figure 4.3 – Average 2nd derivative of IR absorbance spectra in the 1200-1800 cm−1 range for SH-SY5Y cells
exposed and non-exposed to M APbI3 and M ASnI3 (a), and for A549 cells, exposed and non-exposed to M APbI3
and M ASnI3 (b). All measurements were performed ﬁve days after exposure. (c) The ratio of 2
nd derivative of
IR absorbance at 1628 cm−1 and 1656 cm−1 for SH-SY5Y and A549 cells ﬁve days following exposure. The small
negative value of the ratio for untreated cells is due to the lack of a signiﬁcant contribution from a 1628 cm−1 peak.
dation of the subcellular structures while triggering an apoptosis-like cell death, as reported
in chapter 3 and published recently by our group.36 Figure 4.3 c compares the ratio of the
second derivative of absorption at 1655 cm−1 over 1628 cm−1 for untreated SH-SY5Y cells
and for cells treated with M APbI3 or M ASnI3. The effect of M APbI3 on the relative structure
of the proteome appears to be about four times larger. By raster-scanning single cells using
S-FTIRM, IR maps of cells can be collected at various frequencies. Figure 4.4 shows IR maps of
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cells measured at 1652 cm−1 and 1628 cm−1, allowing us to appreciate the distribution of the
respective absorptions throughout the cell. The maps plot the value of the second derivative
of absorption at the chosen wavelength (see the caption for each panel). Absorption at 1652
cm−1 is present in all cells, both treated and untreated. Its distribution approximately follows
the topographic proﬁle of the cell, as observed previously. Absorption at 1628 cm−1 has been
observed only in treated cells and also tracks the proﬁle of the cell. The resolution of the
mapping measurement is close to the value allowed by diffraction, approximately 6−7 μm for
the Amide I region. The ﬁxed and dried cells measured in these experiments are about 60 μm
in size when untreated, and about 10−40 μm when treated. As a consequence, it is difﬁcult to
resolve the distribution of IR absorption at 1628 cm−1 within the cell itself.
In summary, I used S-FTIRM on ﬁxed and dried samples to investigate the biochemical and
structural ﬁngerprints of the cytotoxicity of M APbI3 and M ASnI3. The main changes in IR
spectra following perovskites treatment were observed in the Amide I region. The effect of
exposure to M APbI3 and M ASnI3 on A549 cells is similar to what is observed for SH-SY5
cells in the mid-IR region. Both compounds induce the formation of a strong band around
1628 cm−1. The main difference between the spectroscopic response of the two cell lines
is that the intensity of the band at 1628 cm−1 is comparable between M APbI3 treated and
M ASnI3 treated A549 cells. These IR ﬁngerprints of toxicity on ﬁxed cells should be pursued
at the protein level by probing the proteome proﬁle of treated vs. untreated cells. Meanwhile,
we have also measure IR absorption on living cells, to probe the real-time toxic effects of
perovskites. This is reported in the following subsection.
4.3 Toxicity investigation by IR on Live cells
Cells live in a water-rich environment, and this is the major challenge for IR studies, because
the vibrational frequency of O-H in water molecules overlaps with the stretching C=O from
the amide bonds in proteins, which prevents access to the protein region and makes real-time
imaging in situ of living cells difﬁcult. Different solutions have been explored to overcome this
restriction. For example, supplementing the physiological medium with D2O, which shifts
the water absorption peak away from the mid-IR range. Another option employed by Jamin
et al.112 consisted in growing cells on a barium ﬂuoride (BaF2) infrared window, and then
apply a low-speed cytospin centrifugation. Thus cells were deprived of culture medium, and
examined for 2–3 hours only. With such methods, IR measurements on living cells are possible,
and images of proteins, lipids, and nucleic acids can be obtained with a spatial resolution of
a few microns without labels. However, cells are not in physiological conditions, their vital
processes are altered, and their viability is reduced.118,202 The second objective in IR studies
was then the elaboration of a system to grow cells and measure their infrared absorption
spectra in physiological environment. With such a device, I could run preliminary tests to
assess the toxic effects of perovskites in real time.
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Figure 4.4 – Transmission IR absorption maps of SH-SYS5 cells. A – Bright Field (BF) micrograph of SH-SY5Y
untreated cell, B- Map at 1652 cm−1 of an untreated cell following ﬁxation. C – Map at 1628 cm−1 of the same cell
as in B. D – BF micrograph of 100 μg/ml M APbI3 treated SH-SY5Y cell, E– Map at 1652 cm
−1 of a cell following
treatment with 100 μg/ml M APbI3 and ﬁxation. F – Map at 1628 cm
−1 of the same treated cell as in E. G - BF
micrograph of 100 μg/ml M ASnI3 treated SH-SY5Y cell, H– Map at 1652 cm
−1 of a cell following treatment with
100 μg/ml M ASnI3 and ﬁxation. I – Map at 1628 cm
−1 of the same cell as in H. Maps A to D were recorded
by using a 10 x 10 μm2 aperture and 10 μm steps. Maps E to F were recorded by using a 10 x 10 μm2 aperture
and 3 μm steps. All maps show the distribution of minus the intensity of the second derivative of absorbance
at the given wavenumber value. The cells treated with M APbI3 or M ASnI3 show an intense absorption band
at 1628 cm−1 with approximately the same distribution as the 1652 cm−1 component of the Amide I band. The
1628 cm−1 band is absent in the untreated cell. The scale bar in the micrographs represent 10 μm.
4.3.1 Methodology
Samples preparation
Human neuroblastoma and lung epithelial cells (respectively SH-SY5Y, and A549 cell lines)
were maintained as previously described in chapter 3. For S-FTIRM live imaging experiments,
cells were grown on CaF2 optical windows, 0.5 mm thick and 13 mm in diameter, at 50%
conﬂuence. M APbI3 perovskite was used in S-FTIRM in situ tests for preliminary toxicity
assessment, at a concentration of 100 μg/ml .
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Flow cell incubator for S-FTIRM measurements
The scheme of our IR ﬂow cell is shown in Figure 4.5. It consists of ametallic chamber where an
inlet and outlet were drilled for medium exchange, and for a closed water circuit to maintain
the temperature at 37◦C. A CaF2 window of 1 mm in diameter is deposited on a rubber O-ring,
and covered by a topCaF2 window in which cells are grown. A gold spacer less than 5 μm thick
separates the two CaF2 windows and assures a homogenous thermal conduction. Medium
exchange is assured via Teﬂon tubing connected to a 1 μL micro syringe (Hamilton Bonaduz
AG, Switzerland). Medium ﬂow was as low as possible since it could induce relatively high
hydrostatic pressure, and causing the cells to detach. The ﬂow cell was designed to ﬁt the
shallow 1.9 and 1.0 mm working distance of the high-magniﬁcation 52 x or 74 x Schwarzschild
objectives.
S-FTIRM data collection
S-FTIRM experiments were conducted at the National Synchrotron Light Source (Brookhaven
National Laboratory, NYS), at beamline U10B.16 The infrared microscope was equipped with
a focal plane array (FPA) imaging detector. All spectra were collected in transmission mode
every 20 minutes using OPUS (v. 6.5, Brucker, Germany), and the aperture size was 10*10 μm2.
The spectral resolution was from 8 to 32 cm−1, and 256 scans were co-added in order to
improve the S/N ratio. Prior to each spectrum collection, a background spectrum was carefully
taken on an empty spot as close as possible to the targeted cell. Then, a linear baseline was
subtracted. Experiments were done at room temperature, 3h following the extraction of cells
from the incubator to avoid bubbling inside the medium exchange tubing. Bright ﬁeld images
were taken simultaneously to spectra collections.
4.3.2 Results
From the bright ﬁeld images (Figure 4.6), I could already observe during spectral collection
the same morphological effects caused by exposure to perovskites as discussed in chapter 3 .
Moreover, our ﬂow cell has the potential to maintain cell culture for several hours, without
causing loss in viability, thanks to the continuous ﬂow of culturing medium, and temperature
stabilization at 37◦C.
Interestingly, the collected IR transmission spectra between treated and non-treated living
cells, the protein region looked similar. However, a visible change in intensity could be
observed at 1041 cm−1 and 1128 cm−1 (Figure 4.7), likely due to lactates and lactic acid
contribution.52 Lactates are both waste products and active metabolites in cells, which may be
oxidized as a fuel, or reconverted to pyruvate or glucose in the liver by lactate dehydrogenase
isoforms and gluconeogenesis respectively.171 When lactates are over-secreted by cancer cells,
pH is slightly modiﬁed in the microenvironment, which increases tumour cell survival and
proliferation, but it also stimulates angiogenesis, as lactate is consumed as a substrate.180
Moreover, lactate accumulation in tissues has been found in many diseases including cancer
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Figure 4.5 – 3D view of the S-FTIRM ﬂow cell set-up: (a) microscope sample holder (b) gold spacer / rubber
o-ring (c) rear window (CaF2) / Cell holder (d) front cover (f) screw for water circuit at 37
◦C, and screw for medium
exchange between the optical windows.
Figure 4.6 – a) image of the liquide cell designed for S-FTIRM measurements. The optical window is of 15 mm.
b) A549 lung cells exposed to perovskite for 10 min and c) after 150 min. The changes on the cell membrane and
nucleus densiﬁcation are already visble.
and diabetes.20 A study conducted on rat lungs after acute exposure to cadmium chloride
showed a signiﬁcant increase in lactate and other metabolites. These changes were correlated
with a dysfunction of dehydrogenase activity and consequently leading to mitochondrial
injury.102 The differences in IR signature between ﬁxed and dried cells are certainly due
to the time-lapse in which I explored the biochemical changes: ﬁxed cells were exposed to
perovskites during 5 days, whereas living cells during less than 12 hours. In situ studies of
toxicity using SR do not allow several days of time frame because of the availability of the
synchrotron beam on the one hand, and because the ﬂow cell does not represent an ideal
physiological environment for the living cells on the other hand. Although temperature is
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maintained at 37◦C, and the medium is renewed via the ﬂow exchange system, cells are
constantly exposed to light, the circuit of medium exchange is closed and limited in volume to
the syringe capacity, and CO2 is not maintained at 5%. For these reasons, the two methods are
complementary since they do not cover the same exposure time to perovskites.
Figure 4.7 – Live IR transmission spectra of A549 cells non-exposed (a) and exposed to M APbI3 (b), 3 and 6
hours after the beginning of the measurement. The respective substraction from t0 are shown for non-exposed (c)
and exposed (d) cells.
4.4 Discussion and outlooks
This study, with clear biochemical ﬁngerprints, conﬁrms the severe consequences of M APbI3
on human cells. I have used the common methods to prepare biological samples for S-
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FTIRM to perform, for the ﬁrst time, a toxicity study showing notable biochemical changes.
We assume that the potential of the observed toxic effects of M APbI3 are mainly due to
the release of lead after dissolution, and uptake by the cells. It has been proposed that the
chemical origin of toxicity of lead ions is their capability of replacing Zn2+ in a native binding
site in proteins, while altering the coordination geometry of the site, from tetrahedral to
trigonal pyramid. Pb2+ is known to bind tightly to Zn2+ binding protein under physiologically
relevant conditions, thereby disrupting their function. The change in geometry leads in turn
to a destabilization of the polypeptide conformation which is normally stabilized by Zn2+
and to overall conformation changes.134 This mechanism results in loss of function many
proteins with a zinc ﬁnger. Overall, studies in the coordination chemistry of Pb2+ –bound
polypeptides support the notion that binding of Zn2+ by Pb2+ can in general induce major
conformational changes of polypeptide conformation. Identifying the protein or proteins that
are associated to the conformational changes observed in both Figure 4.2 and Figure 4.3 is of
great interest in understanding the biochemical origin of Pb2+ and Sn2+ toxicity. Therefore, a
correlation can be achieved between our results together with previous reports in the literature
and our own ongoing study of modiﬁcation of gene expression upon exposure to M APbI3
and M ASnI3. Binding of lead to metallothioneins has been studied in vitro and proposed
to occur in vivo.92 Zinc ﬁnger proteins and model peptides are among the known targets of
Pb2+ binding in vitro and in vivo.98 Many of these proteins are transcription factors and use
their Zn2+ binding domain for DNA binding. Disruption of their conformation results in loss
of regulatory function and subsequent aberrations in cellular development. These ﬁndings
are consistent with the results on cellular cycle impairment, which were recently reported
from our toxicological studies.36 In addition to IR spectroscopy, the proteome proﬁle in both
the cytosolic and vesicular fractions should be quantiﬁed. This approach is only quantitative,
because it will identify the size of up- or down-regulated proteins upon perovskites exposure,
which will strengthen the spectral outcomes of IR, and to validate the structural changes,
circular dichroism could be applied.
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5.1. Introduction to the in vivo study
5.1 Introduction to the in vivo study
Within the ﬁeld of biology, much of our knowledge relies on scientiﬁc testing using in vivo
and in vitro models. In the case of disease studies, drug trials or toxicity, preliminary tests
are ﬁrst conducted in vitro, then in vivo by using a whole living model organism. In vivo
testing is often employed over in vitro because it is better suited for observing the overall
effects of an experiment on a living subject. However, each laboratory animal model has its
strengths and limitations, and none is scientiﬁcally perfect, even studies on humans show
unpredictable results for a large population.110 The most used models in the laboratory are
rodents. Many publications discuss the limitations of these models in terms of cost (money-
and time-wise),148,209 unpredictable outcomes in humans,101,160 and throughput.120 Beside
these limitations, ethic regulations often represent an additional hurdle. An alternative to
rodents could be the use of invertebrate small organisms widely applied in ecotoxicology. Such
small organisms can be handled in laboratory by using in vitro techniques and can provide
data for a whole animal with a metabolically active digestive, reproductive, endocrine, sensory
and neuromuscular systems.110 Moreover, trials on invertebrates are short (for example few
weeks only for life span studies), not expensive and do not require ethical approval. We wanted
to check how do the in vitro observed anomalies translate on small organisms treated by
M APbI3 and M ASnI3 perovskites. For this purpose I have selected Drosophila melanogaster
(the common fruit ﬂy) and Caenorhabditis elegans (soil nematode) to investigate the toxic
effects. In this chapter I introduce the two models and the methodology used for toxicity
screening and the related results.
5.2 Ecotoxicity of MAPbI3 and MASnI3 on Drosophila melanogaster
5.2.1 Introduction to the model
Drosophila melanogaster, commonly referred to as the fruit ﬂy is a small organism that has
rapidly become a model due to the huge contributions in developmental biology studies
and the ﬁeld of genetics. Thomas Hunt Morgan popularized the use of D. melanogaster
with his ﬁrst studies on heredity at Columbia University in 1910.55 The genomes of
Drosophila melanogaster and eleven other species have been fully sequenced and annotated.
Approximately 75 % of known human disease genes have a recognizable match in the fruit ﬂy
genome. In consequence, Drosophila is used in many biological studies as a gold standard to
investigate the molecular mechanisms of diverse human diseases and conditions including
cancer,232 infertility,103,125 neurodegenerative disorders,83,185 immunity128 and toxicity.29,56
In addition, it is very easy to maintain ﬂies culture in the laboratory, their food is made of an
agar mixture containing mainly cornmeal and yeast. In addition, their rapid development
allows a generation time of 10 days from egg to young adult at 25◦C (see the life cycle in Fig-
ure 5.1). Other advantages to use Drosophila as a model include their short life span (about
two months at 25◦C), high fecundity (a mated female can generate an extensive progeny),
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adjustable life cycle by temperature and relative ease to perform genetics and cell biology
experiments. Moreover, this organism has been widely studied and there is a large amount of
(genetic) resources available, essentially mutants, and spatio-temporal RNAi for every gene.
Figure 5.1 – Life cycle of the fruit ﬂy Drosophila melanogaster at 25◦C. The development includes 4 stages: egg,
larva, pupa and adult. The transition from egg to larva is called hatching, and from larva to pupa called pupariation,
Finally, the transformation from pupa to an adult insect is called metamorphosis.131
In this study, we used two genotypes D. melanogaster (Figure 5.2): Oregon-R with red eyes (Or)
and white minus (w-) that has white eyes because the alleles “white” responsible for the eye
pigmentation are recessive.158 Both strains are wild types and are used commonly in research
on diseases, drug development, chronic and acute stress.39 We mixed the culturing food with
the M APbI3 and M ASnI3 perovskites at different concentrations and investigated the life
span, fertility and the life cycle of the ﬂies. We used concentrations ranging from 50 to 1000
μg/vial administered as a single dose. In this case, ﬂies were exposed to 10 to 200 μg/ml of
food during 2 days, at a single dose. The dry mass of an adult fruit ﬂy is 0.25 mg (±0.05),229
therefore these concentrations represent in total 4 mg per 100mg of body weight. This dose
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is below the range of previous acute and chronic toxicity studies of silver and aluminium
nanoparticles on Drosophila melanogaster.117,168
Figure 5.2 – Wild type D. melanogaster genotypes used in our study: Or (red eyed) and w- (white eyed).
5.2.2 Materials and methods
Culturing and treatment of D. melanogaster strains
The wild type ﬂies used for this study are Oregon (Or) and White – (w-) strains, obtained
from the Bloomington stock center.1,5 The ﬂy medium recipe that we used is the following
(for 1 l water): 6.2 g agar powder (ACROS N. 400400050), 58.8 g Farigel wheat (Westhove N.
FMZH1), 58.8 g yeast (Springaline BA10), 100 ml grape juice, 4.9 ml propionic acid (Sigma N.
P1386), 26.5 ml of methyl 4- hydroxybenzoate (VWR N. ALFAA14289.0) solution (400 g/l) in
95% ethanol and 1 l water. Fly culture was maintained at 25◦C in speciﬁc culturing vials of 28.5
mm in diameter (Fischer Scientiﬁc) and capped using cotton lids. Each vial contained 5 ml of
food. 20 mg of perovskite powder was ﬁrst suspended in 200 μl of water, and after vortexing,
the suspension was added to the preheated ﬂy medium at a ﬁnal concentration of 50, 100, 200,
500 and 1000 μg per vial with 5 ml of food, then placed at room temperature overnight (RT,
O/N), and kept at 4◦C. Before treatment, ﬂies were food-deprived for one hour.
Lifespan assay
Female fruit ﬂies represent a reference in life cycle studies because they are capable of laying
hundreds of eggs allowing the population to multiply. Therefore, we isolated 30 mated adult
females on CO2 pads and placed them into vials containing regular ﬂy medium alone or
supplemented with perovskites (M APbI3 or M ASnI3 from 50 to 1000 μg/vial). Flies were
incubated at 25 ◦C and the number of dead ﬂies was counted on a daily basis until the whole
population perished. Flies were transferred into new vials containing regular food every 3
days because the medium becomes sticky due to the presence of eggs on the surface. Each
condition was prepared in triplicate, and the life span test was performed on both Ore and w-
strains three times independently.
Fertility and life cycle study
The fruit ﬂies were maintained at 25 ◦C on regular culturing media. Virgin females and males
were isolated as soon as they emerged and placed inside regular vials during 2 days in regular
medium or medium spiked with 50 μg of M APbI3 or M ASnI3 (10 μg/ml ). Mating was then
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allowed inside home-made demography cages covered with a petri dish (60 mm in diameter)
containing agar as follows: virgin females exposed to perovskites during 2 days (V2d) mated
with untreated males (UM), virgin untreated females (VU) coupled with males exposed to
perovskites for 2 days (M2d), and virgin untreated females with untreated males as a negative
control. Eggs were collected the following day using the Jove protocol,2 and transferred into
culturing vials as follows: eggs generated by V2d + UM and VU + M2d were transferred into
regular ﬂy medium, and eggs from VU + UM placed into regular medium or medium spiked
with 50 μg of M APbI3 or M ASnI3. The number of mature larvae together with the number of
emerged young adults was counted twice per day for three weeks (Figure 5.3). This experiment
was performed independently two times and in duplicate for each condition.
Figure 5.3 – Illustration of the fertility and development assays on Drosophila melanogaster.
Statistical analysis
Charts show the combination of minimum two independent repeats for life span and life cycle
experiments; each condition was prepared in duplicate or triplicate. All data were cumulated
by time point for each condition, and plotted as the mean standard deviation (S.D) using One-
way ANOVA test followed by a Tukey-Kramer post-hoc test (non-treated vs. treated conditions).
The p-value is represented as follows: *<0.05, **<0.005 and ***<0.0005.
5.2.3 Results
Effects on the lifespan
The lifespan study consisted on exposing the ﬂies to culturing food with or without perovskites
at increasing concentrations, and then we monitored the survival rate on a daily basis until the
end of the life cycle and compared the different concentration of treated conditions to non-
treated. The non-treated ﬂies exhibit a standard life span curve where half of the population
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dies after approximately 60 days (Figure 5.4 dark blue lines). Exposure of Or ﬂies to M APbI3
induces a decrease in their survival rate in a time- and dose-dependent manner (Figure 5.4 a).
Moreover, after approximately 50 days, half of the ﬂy populations did not survive in almost
all treated conditions with concentrations from 10 to 200 μg/ml of food. Interestingly, we
observed the same effects following M ASnI3 exposure (Figure 5.4 b). The life span of w- strain
was affected in the same trend as Or, and the time where half of the population perished
remained 60 days for the negative controls and 50 days for the exposed ﬂies (Figure 5.4 c, d).
However, w- ﬂies started to die earlier following M ASnI3 exposure (after 10 days) at a faster
rate.
Figure 5.4 – Life span curves of treated vs. non treated ﬂies treated with increasing doses of M APbI3 or M ASnI3
(0-1000 μg in 5 ml of food): Percentage of Or ﬂies surviving the exposure of M APbI3 (a), or M ASnI3 (b), and the
percentage of w- surviving the exposure of M APbI3 (c), or M ASnI3 (d).
Effects on fertility and life cycle
We next investigated how exposure of young adult ﬂies to perovskites affects their fertility and
the development of their progeny. To do so, we sorted the young adults by gender, as soon as
they freshly emerged from the pupae stage. The isolated virgin females and males were imme-
diately incubated at 25◦C into different culturing environments (regular food with or without
perovskites). After two days of age, we transferred them into cages for mating and collected
the eggs after 24 hours. Fertilized eggs were collected then exposed to different culturing
media (details in the materials and methods section). Finally, we probed the development
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rate by quantifying the mature pupae and the emerged young adults. This test also identiﬁes
whether the origin of toxicity is endogenous (coming from the parent male and/or female) or
exogenous (due to the presence of perovskites in the food).
Figure 5.5 – Development test of eggs to the pupa stage generated by treated vs. non-treated ﬂies that were
exposed to 50 μg of M APbI3 (green bars) or M ASnI3 (blue bars). The x-axis shows the different conditions of
progeny generated as follows: Male x Female – Final food; where NT is non treated, Pb refers to exposure to
M APbI3 and Sn to treatment with M ASnI3. The number of mature Or pupae over exposure to M APbI3 (a) or
M ASnI3 (b), and the number of mature w- pupae over exposure to M APbI3 (c) or M ASnI3 (d) were probed
during 25 days. All histograms show an average of standard deviation (S.D.) using One-way ANOVA test followed
by a Tukey-Kramer post-hoc test (non-treated vs. treated conditions), p-value<0.005.
Figure 5.5 shows the quantiﬁcation of mature pupae in Or (a, b) and w- (c, d) strains that were
generated by parents exposed to a single dose of 50 μg of M APbI3 (green bars) or M ASnI3
(blue bars). Eggs generated in regular food by non-treated ﬂies developed normally to larvae
then to pupae within 9 to 10 days (cf. “NTxNT-NT” conditions). Remarkably, eggs that were
generated by non-treated parents and transferred to the perovskite-containing food were
unable to develop further than the 1st instar larva stage and died (cf. Figure 5.5 “NTxNT-
Pb” or “NTxNT-Sn” conditions and Figure 5.6). This observation suggests that perovskites
do not have a pronounced effect neither on embryonic development of D. melanogaster
eggs nor on the hatching phase (transition from egg to larva), however they are extremely
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toxic to the 1st instar larvae since they inhibit their development and induce their death.
Regarding the progeny of Or parents that were exposed separately to perovskites (Figure 5.5 a,
b), the embryonic development was heavily accelerated since mature pupae could already
be observed after 5 days. In the case where the male parents were exposed (“NTxPb-NT” or
“NTxSn-NT” conditions), the number of mature pupae continued to increase and stopped at
16 days for M APbI3 and at 11 days for M ASnI3. On the other hand, the progeny of treated
females (“PbxNT-NT” or “SnxNT-NT” conditions) exhibited a similar amount of mature pupae
after 10 days and very few after 15 days. We can also appreciate that M ASnI3 has a stronger
effect on the progeny development than M APbI3.
Figure 5.6 – Photographies of the progeny generated by treated or non-treated ﬂies: 1st generation of mature
pupae grown on non-treated food (a) from non-treated ﬂies (NTxNT-NT); treated male parent only (NTxPb-NT);
or treated female parent only (PbxNT-NT); and progeny transferred into food containing M APbI3 (b) in which the
development is altered.
Although w- strain is known to have a slower proliferation rate than Or, w- pupae also suffered
a premature development when one of their parents was exposed to perovskites (Figure 5.5
c, d). As described for Or, the same trend can be observed on w-; where 1) no development
could be observed when eggs generated from non-treated parents were transferred into food
mixed with perovskites; 2) the total number of mature pupae between 15 and 21 days notably
decreased upon treatment with perovskites; and 3) M ASnI3 had a higher impact on the
development than M APbI3. Nevertheless, the only difference can be observed from the
conditions where female progenitors were exposed to M APbI3 or M ASnI3. Interestingly, the
total amount of mature pupae is higher than control conditions and continued to increase
even at 21 days. We assume that w- females tend to lay more eggs when sensing an external
stress to assuremultiplication of the population. The next step of the life cycle test was to follow
the development of progeny until the young adult stage. Figure 5.7 shows the quantiﬁcation
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of emerged adults in the same conditions as for the quantiﬁcation of mature pupae for Or
(a, b) and w- (c, d) strains. Progeny from ﬂies exposed to M APbI3 are presented in brown
and those exposed to M ASnI3 in purple. We clearly see from the charts that less young adults
emerge from the pupae stage when one of the parents was exposed to M APbI3 or M ASnI3.
Once again, tin-containing perovskite impacts the life cycle more than its counterpart, and
interestingly, w- strain is more sensitive to the exposure than Or. What is even more striking
is that at 12 days post-fertilization, no young adult was recorded in the treated conditions
(except for Or NTxSn-NT), although they showed a precocious development of mature pupae
(5 days instead of 9 or 10, see Figure 5.1 and Figure 5.5).
Figure 5.7 – Number of emerged young adults generated by treated vs. non-treated ﬂies that were exposed to
50 μg of M APbI3 (brown bars) or M ASnI3 (purple bars). The x-axis shows the different conditions of progeny
generated as follows: Male x Female – Final food; where NT is non treated, Pb refers to exposure to M APbI3 (a, c)
and Sn to treatment with M ASnI3 (b, d). Emergence of young adults was probed during 28 days on Or strain (left
panels) and w- strain (right panels). All histograms show an average of standard deviation (S.D.) using One-way
ANOVA test followed by a Tukey-Kramer post-hoc test (non-treated vs. treated conditions), p-value<0.0002.
Another observation from the development/life cycle charts consists on correlating the num-
ber of mature pupae (Figure 5.1) with the total amount of emerged young adults generated
by treated vs. non treated ﬂies. This analysis shows between 50 and 60% of young adults
(Or and w-) emerging from mature pupae in non-treated samples, whereas less than 50% of
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mature Or and w- pupae generated by M APbI3-treated ﬂies metamorphose to young adults,
and this number is even lower in the case one of the parents is exposed to M ASnI3: 46%
in Or and 28% in w- strains. These data coherently demonstrate the adverse effects that
photovoltaic perovskites cause to both the survival of adult ﬂies and the development of
Drosophila melanogaster. The doses administered to the selected wild type strains are based
on our in vitro studies, and the published studies of toxicity of nanomaterials on this biological
model. There is room for debate regarding all the parameters used for the in vivo study, and to
understand more the eco-toxicity of perovskites, we investigated the response of C. elegans.
5.3 Ecotoxicity of MAPbI3 and MASnI3 on C. elegans
5.3.1 Introduction to the model
C. elegans is a free living, non parasitic soil nematode that can be cheaply and easily cultivated
in the laboratory, where it is grown on agar plates with liquid cultures with E. coli as the
food source. The 1 mm long organism is transparent, which facilitates organs observation
and dissection, and can be housed in large numbers (10’000 worms per Petri dish). Its life
span is about 3 weeks and its genome has been fully sequenced and annotated.201 The
adult body-plan is anatomically simple with 959 somatic cells and produces up to 300 eggs
per adult. It reproduces within a life cycle from egg to young adult of about 3 days under
optimal conditions (Figure 5.8). Another key advantage of C. elegans model is that feeding
by RNAi facilitates gene silencing.116 These unique properties make the worm an important
model system for biological research in many ﬁelds including not only genomics, cell biology,
neuroscience and aging but also toxicity.110 Therefore we used this model to compare the
dose-time response to the fruit ﬂy’s, and better understand the negative effects of perovskites.
Thus we cultivated a wild type strain and used high-resolution optical microscopy to probe
the changes in real-time. The major limitation of using C. elegans model in biology is sorting
the worms by age, and regarding their fast development rate, the experimenter needs to be
highly trained to sort a consequent number of worms quickly by hand for a large statistic,
and isolate groups for all the test conditions without biasing the experiment. Furthermore,
in our study, the continuous worm feeding as well as the high-resolution imaging implicate
manual removal of the worms from the incubator to the bench at each time point, which is not
applicable, and triggers undesirable temperature changes. To overcome this issue, we opted
for a radically new method using a microﬂuidics platform combined with optical microscopy
to allow sorting, continuous feeding and imaging of the worms at the same time. This novel
system was developed at EPFL by our collaborators M. Cornaglia and L. Mouchiroud, who
described it and tested it for a neurodegenerative disease study.62,63
The microﬂuidics device offers a fully automated and highly accurate study for time-resolved
tests. It contains a matrix of microﬂuidic chambers (Figure 5.9) that considerably monitors the
growth and development of each worm from the L1 larval stage (onset of worm larval develop-
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Figure 5.8 – Development phases of Caenorhabditis elegans: Hermaphrodite worms form eggs in their body.
Once laid, the egg undergoes embryonic development during approximately 14 hours before entering the larval
stage, where maturation phases of the larvae include four phases. The young adult stage is reached after 40 to 45
hours depending on the physiological conditions.
ment, upon hatching) to mature adult stage. The presence of many chambers allows following
various conditions for a comparative test at the same time. It is a high throughput method.
Consequently, we could easily investigate the life span, fertility, life cycle and development of
the worms in real time.
5.3.2 Materials and methods
Culturing and treatment of the worm strain
Caenorhabditis elegans wild type Bristol N2 strain was cultured at 20◦C on nematode growth
media (NGM) agar plates seeded with the Escherichia coli strain OP50. For microﬂuidic
experiments, the E. coli strain HT115 was suspended in S-medium at a concentration of
1.4 · 109 cells/ml. Worms were exposed to perovskite compounds from L3 stage the day of the
experiment. The injected media and perovskite solutions were freshly prepared the day of
the experiment as follows. M APbI3 and M ASnI3 were suspended in S-medium of 50 mg/ml.
After ﬁltration at 0.22 μm, this stock solution was diluted in bacteria-containing S-medium to
50, 100 and 200 μg/ml .
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Figure 5.9 – Schematic representation of the main constitutive components of the microﬂuidic platform (a).
Photograph of the device, with schematic picture of the closed-loop temperature control system(b). Schematic
representation of the worm loading process(c). A pressure pulse triggers the fast deformation of the PDMS valving
channels and allows the injection of worms of desired size into the culture chamber. Time-lapse pictures of a
valving channel, as obtained during the injection of L3 worm in the chip(d). Scale bars = 10μm (with permission)62
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Microﬂuidics experiments
The microﬂuidics device fabricated and tested by Cornaglia et al.62 contains 8 separated
channels and allows for testing 8 biological conditions during one experiment. Each channel
is subdivided into 6 connected chambers offering the possibility for biological replicates. The
whole setup was placed within an inverted microscope (Axio Observer, Zeiss) equipped with
two illumination systems: (i) a precisExcite High-Power LED illumination system (Visitron,
Puchheim, Germany) for brightﬁeld imaging. The microscope had a motorized xy-stage and
the automated imaging process was controlled using VisiView Premier Image acquisition
software (Visitron, Puchheim, Germany). Images were acquired every 20 minutes during one
week through a Hamamatsu Orca-ER CCD camera (Hamamatsu, Solothurn, Switzerland).
Data analysis and statistics
The recorded images allowed for survival studies, growth measurements, and fertility assess-
ment. Image processing was performed using Fiji software186 (version 2.0.0-rc-15/1.49k). For
Survival, we plotted the time point where we observed a dead worm in each condition. Worm
areas were measured by processing time-lapse brightﬁeld pictures as follows; Each frame was
ﬁrst converted to a binary image by applying a threshold to the full stack of time-lapse images
and transforming it into a set of binary masks. Each stack of masks was then analysed using
the “particle analysis” Fiji plugin, which allows directly extracting area values for each picture
in the stack. For fertility assessment, we tracked the sequence where the ﬁrst egg was laid, and
then we probed the time point where the ﬁrst larva emerged. The experiment was repeated 3
times independently using new batches of media, perovskites and by inverting the position
of the conditions in the device channels. We analysed each dataset alone by averaging the
sextuplicate of each condition and measuring the standard deviation (S.D.) using One-way
ANOVA test followed by a Tukey-Kramer post-hoc test (non-treated vs. treated conditions).
5.3.3 Results
In this section, we will present the toxicity data we obtained from real-time imaging (Fig-
ure 5.10), by combining 3 independent repeats performed on C. elegans by continuous injec-
tion of S-medium containing E. coli with or without perovskites during one week.
Effects on the worms’ survival
The survival rate of treated worms was normalized to controls and plotted as a function of
time (Figure 5.11) for samples containing 50, 100 and 200 μg/ml of M APbI3 (top panels) or
M ASnI3 (bottom panels). Non-treated worms (blue line) exhibited a survival rate of 100 %
then started to decay after 6 days. When worms were exposed to M APbI3, the population
began to die after 60 hours from the beginning of the experiment. This trend was more
pronounced with higher doses (green and red lines), especially at the highest dose where no
living worm could be observed after 5 days of exposure. M ASnI3 started interrupting the
106
5.3. Ecotoxicity of MAPbI3 and MASnI3 on C. elegans
Figure 5.10 – Bright ﬁeld images of C. elegans cultured inside microﬂuidic chambers at 20◦C, and fed by contin-
uous injection of S-medium spiked with bacteria (top panels, NT for non-treated), and M APbI3 at 100 μg/ml
(medium panels), or M ASnI3 at 100 μg/ml (lower panels), during 10, 50 and 100 hours. The videos can be found
at: http://go.epﬂ.ch/Worms_NT for non treated worms, http://go.epﬂ.ch/Worms_L100 for worms exposed to
M APbI3 at 100 μg/ml , and http://go.epﬂ.ch/Worms_Sn100 for worms exposed to M ASnI3 at 100 μg/ml .
worms’ survival as early as 20 hours, also in a time and dose-dependent fashion. At 200 μg/ml ,
the population suffered extensively the exposure and perished after 60 hours.
Effects on the worms’ growth size
The body area of living worms was measured using a logarithm and the values are reported
in Figure 5.12. The blue-lined curves show the increasing body area of non-treated nematodes.
Due to their natural sinusoidal movement allowed by muscular contraction, and the lack of
space inside the microﬂuidic chambers, the body size shrinks after 70 hours. After treatment
with M APbI3 at 50 μg/ml (orange line), the worms’ body size reaches a plateau at the same
time point as control, however it has a smaller area. This observation is even more striking
with the curve proﬁle of worms exposed to 100 μg/ml (green line) and to 200 μg/ml (red line)
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Figure 5.11 – Survival rate of treated vs. non treated worms treated with M APbI3 (top panels) or M ASnI3
(bottom panels) at 50 μg/ml (a), 100 μg/ml (b) and 200 μg/ml (c). All curves show an average of standard
deviation (S.D.) using One-way ANOVA test followed by a Tukey-Kramer post-hoc test (non-treated vs. treated
conditions), p-value (<0.0005) is indicated on each panel.
of M APbI3.
Figure 5.12 – Development curve of C. elegans from the larval stage to adults over M APbI3 (top panels) or
M ASnI3 (bottom panels) exposure at 50 μg/ml (a), 100 μg/ml (b) and 200 μg/ml (c). All curves show an average
of standard deviation (S.D.) using One-way ANOVA test followed by a Tukey-Kramer post-hoc test (non-treated vs.
treated conditions), p-value (<0.003) is indicated on each panel.
On the other hand, exposure of nematodes to M ASnI3 resulted in a much stunning body size
freezing (Figure 5.12 bottom panels). In addition, the area values reached a plateau earlier
than non-treated samples, and this effect was dose-dependent. From these observations we
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assumed that perovskites prevent the larvae to reach the young adult stage. Therefore, we
sought to verify if the decrease in the worms’ size is due to an affected development by tracking
the young adults and quantifying the time-lapse when they developed.
Effects on the development of worms
Figure 5.13 – Young adult stage reached by C elegans after the 3rd larval stage, when exposed or not to M APbI3
(a) or M ASnI3 (b) at increasing concentrations: 50 (orange), 100 (green), and 200 μg/ml (red). All plots show
an average of standard deviation (S.D.) using One-way ANOVA test followed by a Tukey-Kramer post-hoc test
(non-treated vs. treated conditions), p-value<0.002.
The ﬁrst young adult observed in control samples was between 20 and 22 hours from the L3
stage(Figure 5.13). Injection of M APbI3 delayed the developmental process by 3 hours at the
lowest concentration and by 5.5 hours at the highest one. Treatment with M ASnI3 induced an
even worse delay in development already at 50 μg/ml , where the majority of larvae became
adults after 30 hours. For higher concentrations, as observed in the previous parts (5.3.3
Effects on the worms’ survival and 5.3.3 Effects on the worms’ growth size), most of nematodes
either perished or remained small, which explains the absence of young adult “phenotype”.
Effects on fertility
The next live-imaging analysis concerned the extraction of the time point where the ﬁrst egg
was observed. This was acquired for the non-treated nematodes before 23 hours after the
3rd larval stage (Figure 5.14 a, b. Blue boxes). As for the worms exposed to M APbI3, the ﬁrst
egg was observed after 23 hours at the lowest dose, and after 26 hours at the highest one
(Figure 5.14 a, orange, green and red boxes). Clearly, there is a shift in the worms’ fertility over
exposure to perovskites, especially the tin-based one (Figure 5.14 b.), where we can observe
a more marked delay for a concentration as low as 50 μg/ml . The ﬁrst generation of eggs
from the non-treated worms progressed to the larval stage for the ﬁrst time before 36 hours
(Figure 5.14 c, d. Blue boxes) and continued to proliferate until the end of the experiment
(140 hours), where space in the chambers represented a limitation to continue the study. In
parallel, eggs generated by treated nematodes developed to larvae much later for M APbI3
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Figure 5.14 – Fertility investigation of C. elegans over M APbI3 (left panels) or M ASnI3 (right panels) exposure
at increasing concentrations: 50 (orange), 100 (green), and 200 μg/ml (red). The time point where the ﬁrst egg was
observed in each of the six chambers in all channels (or conditions) was monitored after the 3rd larval stage and
extracted using live-imaging then plotted in the top panels (a, b); and time point of the ﬁrst observed larva in all
chambers of each condition is plotted in the bottom panels (c, d). All plots show an average of standard deviation
(S.D.) using One-way ANOVA test followed by a Tukey-Kramer post-hoc test (non-treated vs. treated conditions),
p-value (<0.003) is indicated on each panel.
(between 36 and 42 hours). Additionally, the delay was even more pronounced in the case of
exposure to M ASnI3 (around 38 hours at 50 μg/ml ). Finally, the absence of progeny at 100
and 200 μg/ml of perovskites conﬁrms the retard in development.
In summary, the marked changes observed in C. elegans’ viability, growth, development and
fertility; reinforce the results obtained on D. melanogaster, and clearly demonstrate the toxic
impact of photovoltaic perovskites on the environment. Furthermore, the microﬂuidic de-
vice used in our study simpliﬁed the screening of worms and allowed for analysing many
parameters including development, lifespan and fertility in a single assay. The device is revo-
lutionizing the ﬁeld of toxicology when using C. elegans as a model, and could be employed in
other disciplines such as neurodegeneration, immunology and pharmacology.
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Figure 5.15 – Photography of a microﬂuidic chamber 4 days after the beginning of the toxicity test on C. elegans.
Lack of space is the main limitation in the current state of our microﬂuidic device.
5.4 Conclusions and outlooks of the in vivo study
The in vivo experimentation presented in this chapter strengthens the in vitro outcomes pre-
sented in chapter 3, and validates toxic proﬁle of perovskites, which will potentially constitute
the next generation of solar panels that will cover our buildings. The eco-toxic effects observed
in our study demonstrate the hazards on small model organisms (fruit ﬂy and nematode), and
are translated in a decrease of viability, a retard in growth and development, as well as in an
altered fertility. These effects may be due in both models by an induced mitochondrial stress,
as predicted by the RNA-seq data in chapter III. We believe a homolog of the transcription
factor p53 in D. melanogaster (dp53)115 and in C. elegans (CEP-1)105,189 may be at the origin
of the mitochondrial stress, which, together with DNA damage, could be responsible of the
adverse effects of perovskites observed on the whole organisms. Mitochondrial stress and
DNA damage may target in both models the hormone ecdysone, which directs progression
through larval stages.21,175 Moreover, in embryonic development, such a stress could alter
oogenesis as shown by a recent study on D. melanogaster treated with magnetite nanoparti-
cles, and metal traces were found along the anterior–posterior axis of the fertilized eggs.54
Additionally, the molecular signaling pathway of the dorso-ventral axis formation was found
to be affected by perovskite exposure of human cells (Appendix E). On C. elegans, strong
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correlation of mitochondrial or DNA damage and cell cycle or apoptosis have been made
to evidence developmental impacts and even a shortened life span.199 These publications
may hold an explanation of our results, and encourage our research to assess mitochondrial
imbalance as well as metal traces in our in vivo models. Considering the genome conserva-
tion between humans and D. melanogaster or C. elegans,39 and the analysis of the genome
expression proﬁle obtained from human cells using RNA-seq (Chapter 3), the data presented
in this chapter could predict the potential hazards of the photovoltaic perovskites on humans.
As an outlook of this in vivo study, our protocols must obviously be improved for a more
accurate and predictable outcome. There is room for debate regarding dose, time lapse and
pathway of exposure on each organism. Nevertheless, the adverse effects observed in the
laboratory are indisputable, and they can be even pursued to verify whether generations n2
and n3 still suffer the exposure of their grand-parents, and determine when the observed toxic
effects stop inter-generation transmission. For C. elegans, because of a lack of space after one
week(Figure 5.15), worms should be transferred into petri dishes and evaluation of toxicity
should be continued without adding extra perovskites.
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5.5 Summary of the dissertation
The broad context of my PhD program reported in this dissertation is the toxicity study of
a novel class of materials. The methylammonium lead iodide (CH3NH3PbI3, or M APbI3)
compound is the biggest surprise in the last 4 years to come out in the ﬁeld of photovoltaics.
With a relatively simple architecture, devices based on this material show an amazing 21 %
efﬁciency in converting light into electricity. The biggest hurdle to overcome in terms of
its large-scale application is its lead content. It is known that in contact with the human
body, lead represents a severe danger. I addressed this issue with detailed in vivo and in vitro
studies, and documented that the material is heavily toxic. Some researchers have high hopes
of replacing lead with other elements and maintaining a comparable efﬁciency. The most
discussed candidate is tin, and the CH3NH3SnI3 perovskite (M ASnI3) is considered to be
non-toxic. I focused on verifying this material, as well and its toxicity is comparable or worse
to the lead-containing mother compound. The physical appearance of the two compounds is
Figure 5.16 – Characteristic image of the two photovoltaic perovskites used in the present studies.
shown in Figure 5.16. I have characterized the materials, and the initial crystalline perovskite
dissolves entirely in water, while in physiological media a precipitate forms. Iodine and the
metal contained in the perovskite were detected in the precipitate as well as in the ﬁltered
solution. For this reason, the shape and size of the photovoltaic perovskites are not critical in
toxicity studies. The ﬁltered solution of the perovskites was the main subject of our toxicity
evaluation because when the material is in contact with body ﬂuids or released into the
environment, it is likely to degrade because of humidity, and the soluble part may propagate
rapidly.
In our in vitro toxicity study, the response is not only dose- and time-dependent but also
cell-type dependent. Neuronal human cells (SH-SY5Y) suffered an apoptosis-like cell death
in the presence of the perovskites (see illustrative Figure 5.17). Apoptosis occurs 24 hours
following perovskites exposure via the intrinsic-mitochondrial pathway through the activation
of caspase 9.
Regarding the human epithelial lung cell line A549, the effect was different, not any of the
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Figure 5.17 – The density of live SH-SY5Y cells exposed to M APbI3 or M ASnI3 decreases signiﬁcantly with
increasing concentrations.
caspases were not activated, however, the morphology was affected since the cells became
giant and polynucleated ( Figure 5.18). Further analysis showed that the mitochondria were
heavily damaged, although their activity drastically increased compared to the untreated
cells. While the cell cycle phases were not altered, the kinetics of cell division into daughter
cells were slowed down. Detailed investigations of the genome proﬁle by RNA-sequencing
suggested many differences in gene expression levels. Some pathways that are critical to basic
cellular functions were heavily affected by M APbI3 exposure (regulation of the metabolism,
cell division, cell signaling etc.). These data are clearly in line with the results obtained from in
vitro manipulations. For a better comprehension, I used a method which is very sensitive to
Figure 5.18 – Electron microscopy images of human lung cells (A549) before and after exposure.
biochemical and structural changes: S-FTIRM. This was the ﬁrst time this method was used to
evaluate toxicity. One reason for this is the availability of synchrotron radiation in the mid-IR
range. Few laboratories are equipped with synchrotrons worldwide, which means there is
little accessibility to the beamlines. Another problem with this technique is water absorption.
As discussed in Chapter 4, the water signature overlaps with biological matter in IR spectra.
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That is why biological samples have to be ﬁxed and dried before IR measurements.
Figure 5.19 – Microﬂuidic chambers to conduct toxicity tests. a. Image of a liquid cell for infrared investigation
of the toxicity effect of the perovskites on living cells. b. Microﬂuidic platform to assess toxicity in real-time on C.
elegans.
I also developed an interesting platform to conduct S-FTIRM measurements on living cells
( Figure 5.19 a.) and shift the water signal from the biological one. Our approach consisted in
combining a chamber for cellular growth with an inlet and an outlet to allow ﬂuid exchange,
as well as a heating stage for long experiments. I studied the effects of M APbI3 in real-time
using live S-FTIRM, and I observed speciﬁc changes in the resulting IR spectra. Since the cells
grow in between two optical windows, the focus on the cell layer was difﬁcult, therefore the
use of a big aperture (20 μm x 20 μm) was necessary. This kind of aperture can also be used in
standard FTIR microspectroscopes (with a thermal source instead of a synchrotron), because
at an aperture of 20 μm2, the S/N is comparable using both sources.143 This makes the ap-
plication of IR to real-time toxicity studies more accessible in terms of cost and availability.
A second novelty I introduced into my investigations is the use of a microﬂuidic platform
for in vivo toxicity studies on nematodes (Caenorhabditis elegans ) (see Figure 5.19.b.). The
multichannel conﬁguration of the device combined with a CCD camera for real-time imaging
enabled a high throughput analysis not only of the perovskite but also of other nanoparticles
on the nematodes. Aside from nematodes, I also designed a detailed protocol to study the
effects of perovskites on fruit ﬂies (Drosophila melanogaster). These two model organisms
are the gold standards for in vivo eco-toxicological tests. I have found that the life span and
development of larvae were reduced by perovskite exposure. Moreover, the fertility of the
organisms was drastically affected. This eco-toxicity study was set as a starting program for
the in vivo toxicity. In summary, both the in vitro and in vivo studies I conducted showed that
the current photovoltaic perovskites are acutely and chronically toxic compounds, even at low
concentrations. Our studies also showed that the ad hoc idea to replace Pb with Sn is not a
viable option, sinceM ASnI3 produces the same effects as the parent compound. Therefore,
replacing both M APbI3 and M ASnI3 with less toxic compounds, or adding a hydrophobic
encapsulation that still maintains the high energy efﬁciency, underlines the importance of
more chemical engineering of new photovoltaic materials, which could still preserve the high
conversion efﬁciency. Today, solar panels containing cesium, gallium, indium and arsenide
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can be found easily on themarket, and the problemof toxicity cannot be addressed in the same
manner because these compounds are more stable in humid conditions than perovskites, nev-
ertheless we should have a critical view on them, as well, especially for recycling approaches.
On the other hand, the development of new compounds for many applications, including
photovoltaics, is progressing rapidly. Therefore, the community requires straightforward and
reliable methods to assess their toxicity in a rapid and signiﬁcant manner. Some conventional
methods could be used (such as ﬂow cytometry or ﬂuorescence microscopy), but often trained
scientists are required to perform the assays. We also suggest the use of innovative methods
like IR spectroscopy or organ-on-a-chip to rapidly screen the toxicity of novel materials.
5.6 Future development
Future studies should address the details of the toxicitymechanismof photovoltaic perovskites,
since there is no doubt that these materials represent a danger to public health. For the in vitro
study, a detailed comprehension of the cellular uptake is very important. For this ﬁrst study,
I investigated the clathrin-dynamin pathway, and so a next step and signiﬁcant follow-up
would be to study the caveolae-dependent pathway. Furthermore, revealing subsequent
signaling pathways could indicate more about the uptake dynamics38,46,49,70,122,135 . One of
themain hallmarks of toxicity could be caused by an induced oxidative stress. Evaluation of the
latter can be assessed in vitro using either label-based trials (such as ﬂuorescent kits against
free radicals or mitochondrial proteins), or label free assays (e.g. Electron spin resonance
or IR spectroscopy). We have noticed that the induced phenotypical changes in A549 cells
upon perovskites exposure (i.e. giant size and polynucleation) are comparable to the typical
standard morphology of senescent cells. Verifying a potential correlation between senescence
and perovskite exposure, at the molecular signaling level, would be extremely important.
Today, detection kits can be found on the market that reveal the activation of the signaling
cascade of senescence in vitro. Furthermore, Doxorubucin (DXB, a therapeutic drug in cancer)
could be used as a positive control, because DXB induces senescence in mammalian cells.
Although genomeproﬁling indicated several signaling pathways that were affected by M APbI3
exposure, tests should also be done following M ASnI3 exposure, and the results should be
validated at the RNA level (using RT-PCR) and at the protein level by immunoblotting the up-
and down-regulated proteins. We are aware that tests on primary cells from human lungs
would be more relevant for all these assays as compared to cell lines. These can be obtained
from hospitals via biopsy. Finally, recent advances in bioengineering make it possible to
reconstitute organs on a chip. For example, Donald Ingber and colleagues have published
remarkable papers on the development of devices that emulate the biology of human tissues,
organs and circulation in vitro.23,35,77,109,138 Lung-on-a-chip was hence modeled in vitro
to test the efﬁcacy and toxicity of drugs and chemicals ( Figure 5.20). The 3D Co-culture
of various cell types constitutes both the mucociliary bronchiolar epithelium on the upper
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air-liquid layer, and the underlying microvascular endothelium, which is exposed to ﬂuid
ﬂow. The device is also able to stretch, in order to mimic tissue extension during respiration.
This important development could be considered as a follow up in the toxicity assessment of
photovoltaic perovskites, and extended to other nanomaterials.
Figure 5.20 – The human lung-on-a-chip microsystem is constructed in a multilayered microﬂuidic device
comprising the upper (blue) and lower (red) cell culture microchannels with a microfabricated porous elastic
membrane sandwiched in-between. The microdevice is also equipped with two full-height, hollow microchambers
alongside the cell culture channels. (b) Physiological breathing motions in the living human lung are reproduced
by applying a vacuum to the side chambers. This action causes the lateral elongation of the intervening elastic
membrane, which induces mechanical stretching of the adherent tissue layers in the central channels.109 (With
permission)
Also, IRmicrospectroscopy can be considered as a reinforcement of the toxicity study. Our data
on living and ﬁxed cells are promising, and we are aiming to measure IR absorption of tissue
co-cultures (mainly macrophages, ﬁbroblasts and epithelial lung cells) for both compounds.
The in vivo tests on Drosophila melanogaster could be pursued by observing the treated and
non-treated ﬂies at the organ level. Routine procedures to section the ﬂies’ brain and gut
could be used, then followed by ﬂuorescence staining of stress markers such as inﬂammation,
apoptosis, heat shock proteins etc. Caenorhabditis elegans presents a greater advantage
than D. melanogaster in genetics because of the possibility to make mutants easily via siRNA
feeding. With the perspective of understanding the toxic effects of M APbI3 and M ASnI3,
transfecting worms with GFP-tagged markers would shed light on the pathways involved in the
worms’ toxicity response. For example, observing p53-GFP worms upon perovskites exposure
could reveal a potential mitochondrial stress.208 This leaves ample room, of course, for more
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Conclusion
eco-toxicity tests on small organisms such as zebraﬁsh (Danio rerio) or plants (Arabidopsis
thaliana. . . ). Ultimately, however, the most important development in photovoltaic devices
should replace perovskites with less toxic compounds or involve a hydrophobic encapsulation
that would still maintain the high-energy efﬁciency.
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History of asbestos
Asbestos was ﬁrst used for thermal and ﬁre isolation mainly: Finnish strengthened their
cooking pots by using the ceramic form of asbestos (or anthophyllite), then ancient Greeks
described it as the “unquenchable” before modern Greeks entitled it “Amiantos” (meaning
“pure”). Few hundred years later, Persians used it in napkins then clothes; where they cleaned
the fabrics by throwing them into ﬁre. Some archeologists believe that ancients made grave-
clothes of asbestos, wherein they incinerated the bodies of their kings, in order to preserve
only their ashes, and prevent them from being mixed with those of the combustible materials
commonly used in funeral rituals.68 In the 17th century, asbestos was considered as the “magic
mineral”,184,212 it was also used in lamps or candlewicks or even prescribed for diseases of
the skin. Extensive mining began at the end of the 19th century in Canada with the industrial
revolution. New properties of the mineral were exploited and patents started to be established.
Mining of asbestos continued worldwide and production of derived-products included ﬁre
retardant coatings, concrete, bricks, pipes and ﬁreplace cement, heat, ﬁre, and acid resistant
gaskets, pipe and ceiling insulation, ﬁreproof drywall, ﬂooring, rooﬁng, lawn furniture, and
drywall joint compound. Asbestos was even incorporated in rice manufacturing in Japan. The
very ﬁrst observation of toxicity was found in a letter addressed by Pliny the Younger (61-113
AD)86 and the second one appeared in 16th century but fell into oblivion again until 1898 in
a letter of Lucy Deane, one of the ﬁrst Women Inspectors of Factories in the UK. In 1899, Dr.
Montague Murray reported death related to asbestos chronic exposure via inhalation.184,211
All types of asbestos ﬁbers are toxic to humans and animals, and a consequent exposure results
in asbestosis or mesothelioma (the most common diseases). Litigation regarding asbestos is
one of the heaviest cases in legal history in terms of duration, claim size, and scope: on the
one hand, the use of asbestos was extremely widespread across many applications; industries;
sectors and countries. On the other hand, the knowledge of toxicity was not solicited although
suspected long time ago. Since there is no safe level of asbestos exposure for any type of
asbestos ﬁber,95,195,217 its use is strictly banned in many countries from 2011.
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Composition of the cell culture media
We used DMEM and DMEM:F12 to maintain A549 and SH-SY5Y cell lines, respectively. In
order to evaluate the perovskite precipitate composition, once formed after contact with
cell culture media, knowing the complete formulation of the latter is crucial to interpret the
analytical chemistry results.The following information was taken from the provider’s website.
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Count of viable cell using a Neubauer chamber
The number of viable cells was counted using a haemocytometer (or a Neubauer chamber,
Figure C1 a) and bright ﬁeld microscopy. Viable cells are easily distinguished from nonviable
ones, where the former present clear cytoplasm and dead cells are darker. For the counting,
only clear cells were considered as follows: A glass cover was centred on top of the counting
chamber, and 10 μl of a homogenous cell suspension was injected uniformly in between using
a pipet. The cell suspension diffuses by capillarity. (Figure C1 b).
Figure C1 – Cell counting using a haemocytometer. Picture of the improved Neubauer haemocytometer
(a), injection of cell suspension in between the glass cover and the Neubauer chamber (b), Appearance of the
haemocytometer grids under microscope (c). Cells within the large square and those crossing the edge on two out
of the four sides are counted (c). Source: Google image gallery.
The haemocytometer grid (Figure C1 c) was observed under a microscope and using a hand
tally counter, the number of viable cells was counted in the four primary corner squares. The
number of cells in one primary corner square is equivalent to the number of cells · 104/mL.
The cell concentration per mL= The total count in 4 large squares·10
4
4
·dilution factor (C1)
The dilution factor is 2 if trypan blue is used at 1:1 dilution. The conversion factor to convert
104 mL to 1ml.
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Dye exclusion method using ﬂow cytometry
The cell membrane integrity was assessed using Sytox green and ﬂow cytometry. The latter
generated two dimensional plots displaying the side scattering of cells vs. their forward
scattering (SSCA vs. FSCA). The population of interest was gated in non-treated cells, and
the pattern was conserved for the other conditions of cells exposed to M APbI3. (Figure C2
upper panels). From the gating, histograms of ﬂuorescence are extracted (Figure C2 lower
panels). The percentage of ﬂuorescence of sytox green can then be quantiﬁed. The highest
peak corresponds to the autoﬂuorescence of cells.
Figure C2 – Flow cytometry plots of membrane integrity assessed by exclusion of Sytox Green performed on
A549 cells. Dot plots of SSCA vs. FSCA with a gate on the population of interest (upper panels), and Sytox Green
ﬂuorescence histograms (lower panels) of A549 cells for the following concentrations of M APbI3: non-treated
(NT), exposed to 50 μg/ml (50), 100 μg/ml (100) and 200 μg/ml (200).
Transfection with siRNA protocol
A549 cells were transfected with siRNA for gene silencing of clathrin and dynamin. The
reagents were purchased from Life technologies and the related protocol was applied for a
volume corresponding to 6 well plates.
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Protocols used for molecular biology
Cell lysis
Preparation of the lysing buffer:
• 0.25 g Tris
• 0.35 g NaCl
• 11.75 mg EDTA
• 100 μNP-40
• 100 μ Triton X-100
• 40 ml ddH2O
Alicots of 1 ml and add :
• 10 μl PI (protease inhibitor, 1:100)
• 1 μl PMSF (1:1000)
• 10 μl Phosphatase inhibitor
On ice / 4◦C,
Harvest cells, Wash 1x with cold PBS, Resuspend in 500 μl Lysis buffer. Incubate on ice for
20 minutes (if cells clumped into a snot, vortex 5-6 times, and put 5 extra minutes of incuba-
tion on a rotation shaker). Scrape each well and transfer to labelled 1 ml tubes. Centrifuge
20 minutes at 14’000 rpm, 4◦C, then transfer supernatant, which contains the cytosolic soluble
fraction.
At room temperature,
Resuspend pellet in the same amount of lysis buffer (200 μl ) + 5% SDS 20% (50 μl ). Sonicate
(3s interval for 15 seconds, 60% amplitude). This part contains the vesicular content which is
detergent-insoluble.
Quantiﬁcation of proteins by BCA
We quantiﬁed proteins using Pierce BCA (Pierce BCA kit + BSA 1 μg/ μl stock + ELISA plate)
as follows:
In a 96 well plate: pipet into the 3 ﬁrst lines (ABC) a triplicate of BSA -> 1 μg/ μl BSA stock,
then duplicate the sample in the following lines (DE).
Prepare a mixture of 1:50 Reagents B:A from the kit (200 μl x number of wells = Vtot ). . Add 200
μl of the mixture B:A in each well of the 96 well-plate, and protect from light and evaporation.
. Incubate 30 minutes at 37◦C, then read absorbance at 562 nm on spectrophotometer .
- Calculate the concentration and prepare the sample for migration.
- Vortex, quick spin - Boil samples for 10 minutes. - Use directly for migration on the gels
according to calculated volumes. (60 μl maximum, and 20 μg minimum per well)
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Electrophoresis
The gels for electrophoresis should be prepared in advance according to the size of proteins of
interest (Table 5.1).
Protein size (kDa) Gel percentage (%)
4-40 20
12-45 15
10-70 12.5
15-100 10
25-200 8
Table 5.1 – Electrophoresis gel percentage according to the size of protein of interest.
Western blotting
After gel migration, Blot should be transferred semi-dry:
Cut 6 ﬁlter papers and 1 nitrocellulose membrane to cover all gels, and prepare a tray with
Transfer buffer. Uncast the gel and cut out the upper part of wells.
On the Transblot machine drawer, place the ﬁrst stack soaked ﬁlter papers, place the mem-
brane, place the gel, and ﬁnally, place the other stack of soaked ﬁlter papers. Eliminate bubbles
between each step. Wet the machine plate with Transfer buffer, then launch the transfer at
13V for 90 minutes.
After transfer, block the proteins using 1:3 of Licor blocking buffer diluted in PBS, then wash
with PBS/Tween (100 ml in 900 ml + 1ml tween) We immunoblotted using primary antibodies
(1:1000), and secondary at (1:2000) diluted in the blocking buffer as follows:
- To prepare the TBS/Tween: 10 ml Tris/HCl pH 7.5 30 ml NaCl 5M Fill until 1 L with mQ H2O
500 μl Tween 20 Stir using a magnetic bar.
- Cut themembrane according to the gel: Harvest it and place it in cuves containing TBS/Tween
for 10’ under agitation. Repeat the washing step.
- Prepare the 5% blotto by mixing 2.5 g of milk powder and 50 ml TBS/Tween. Prepare blotto
3% by mixing 3 g of milk powder 100 ml TBS/Tween
- Place the membrane in 25 ml of the 5% blotto for 1 hr, then prepare primary antibodies in 3%
blotto.
- Discard the 5% blotto, Add 10 ml of the 3% blotto containing the Ab - Cover the box, place it
O/N in the cold room under agitation (50 rpm)
- When primary incubation is over: . Wash membrane 3x 10 minutes with PBS/Tween . Prepare
secondary Ab diluted in blocking buffer . Incubate 1hr at RT on shaker . Wash membrane 3x
10 minutes with PBS/Tween
- Revelation: We used LICOR system to scan the membranes.
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Genome proﬁling methods for analysis
Details on the quality control tests
The total RNA from A549 cells (exposed or non-exposed to perovskites), was encoded by
Sanger, Illumina 1.9 at GTF Lausanne. As mentioned in chapter 3, a quality score boxplot
was drawn for each sample. The higher the score the better the base call. The background
of the graph divides the y axis into very good quality calls (green), calls of reasonable quality
(orange), and calls of poor quality (red) (Figure C3).
Figure C3 – Quality score across all bases within the same RNA sample.
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This module is used to check if reads coverage is uniform and if there is any 5’/3’ bias.
This module scales transcripts to 100 nt and calculates the number of reads covering each
nucleotide position. Finally, it generates a plot illustrating the coverage proﬁle along the
gene body.
When genome features are overlapped, they are prioritize as: CDS exons > UTR exons > Introns
> Intergenic regions. Tags: reads spliced once will be counted as 2 tags, reads spliced twice will
be counted as 3 tags, etc.
Details on the bioinformatics tools to analyze the genome proﬁle
SPIA combines: the over-representation of DE genes in a given pathway and the perturbation
of that pathway. These two aspects are captured by two independent probability values: PNDE
(Number of DE genes) and PPERT (amount of perturbation measured in each pathway). PNDE
is the probability of observing the given number of DE genes or higher. PPERT assesses the sig-
niﬁcance of the observed total pathway perturbation as p-value calculated in a bootstrapping
process. We use the parameter number of bootstrap iterations=2000. PPERT will become sig-
niﬁcant only if the observed fold change in the considered pathway nodes yields a signiﬁcant
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different impact compared compared with what is observed on the same pathway when the
same number of fake DE genes is thrown in random loactions throughout the same pathway.
The two types of evidence, PNDE and PPERT, are ﬁnally combined by the Fisherf method into
one global probability value, PG, that is used to rank the pathways and test the hypothesis
that the pathway is signiﬁcantly perturbed in the condition under the study (low P-value).
The SPIA two-way evidence plot show the pathways that meet the criterion (PNDE< α) and
(PPERT < α). We ﬁxe α=0.05 (red dot line-log(0.05) 3). Pathways above the oblique red line
are signiﬁcant at 5% after Bonferroni correction, while those above the oblique blue line are
signiﬁcant at 5% after FDR correction. After GAGE and SPIA, we use Pathview to map our data
onto pathway graphs and visualize very intuitive, informative and well annotated pathways.
Other affected networks
In this part, I present some of the affected signaling pathways in A549 cells exposed to M APbI3.
These pathways were common in GAGE and SPIA methods, for a fold change > 2, and signiﬁ-
cant with a p-value < 0.05. On each ﬁgure, the over-expressed genes are displayed in red and
the under-expressed ones in green
Among these pathways, we can ﬁnd the calcium signaling cascade, where Pb2+ and Sn2+
ions are strong competitors to Ca. We can also ﬁnd an altered regulation of the programmed
cell death (apoptosis and autophagy), which is in accordance with our ﬁndings on caspases
cascade inactivation when A549 cells were exposed to perovskites.
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Proteome proﬁling of A549 cells exposed to perovskites
To test whether changes in Amide I absorption are accompanied by corresponding changes in
cellular protein expression we ran gel electrophoresis measurements on fractions extracted
from untreated and treated cells.
Cells were lysed as previously described in the molecular biology protocols (5.6 Cell Lysis).
After centrifugation, the pellet (insoluble fraction containing the vesicles), and the supernatant
(soluble fraction containing the cytoplasmic proteins) were conserved for subsequent analysis.
The pellet was sonicated as follows, in order to quantify vesicular proteins.
1. Pellets were washed once with 200 μ of lysis buffer.
2. To each tube containing pellet, 100 μ of Lysis buffer + 5% SDS was added and brieﬂy
sonicated at 60% amplitude, 3 sec on/ 3 sec off, 18 sec total time.
3. Proteins were heated for up to 5 minutes, then quantiﬁed using BCA kit. Concentration of
each tube 1.2-1.7 μg/ml
4. Proteins were loaded on the gels together with a protein marker as a reference (Stacking gel
at 4%, and resolving gel at 12%), and electrophoresis run during 30-50 minutes at 220 V.
5. The gel cassette is disassembled and the gel placed in a box and covered with bidistilled
water, then heated in the microwave oven for 30 sec. Heating should be stopped before boiling
occurs. The box with the gel is then placed on a shaker for 3-5 minutes. and this washing step
is repeated twice with fresh water.
6. Coomassie staining solution is added to cover the gel in the box, then heated in the
microwave for 10 sec. without boiling. The box with the gel is then placed on a shaker for
15-30 minutes for complete staining. Already after 1 minute, protein bands can be observed.
7. The staining solution is poured off and 50-100 ml bidistilled water is added in order to
further unstain the light blue background of the gel on a shaker. The water can be replaced by
fresh water for further unstaining if needed.
8. The gel can be scanned, photographed or dried for long-term storage.
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Figure D1 – SDS gels with Coomassie blue staining of A549 lysates from the soluble fraction of the cell composed
of the cytoplasmic content (left), and the insoluble fraction composed of vesicles and other internal compartments.
Figure D1 shows a preliminary SDS-PAGE tracks from the cytoplasmic and microsomal frac-
tions of cells that were untreated or treated with 100 μg/ml of M APbI3 or M ASnI3. It is
apparent that the proteome of the cytoplasmic fraction is barely affected by exposure to
M APbI3 or M ASnI3. In contrast, major differences are observed in the microsomal fractions
of treated cells. The most striking difference is observed following treatment with M APbI3,
which reduces expression of several proteins in the 48 – 100 kDa range while increasing expres-
sion of at least one protein of approximately 32 kDa mass. Similar changes are also induced
by exposure to M ASnI3, although the effect is much reduced for a comparable dose and
exposure time.
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Molecular signaling pathway affected by perovskite exposure
Figure D1 – The molecular signaling pathway of the dorso-ventral axis formation affected by perovskite exposure
of A549 cells.
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